GT,Diagnosis 1,ERN Category
['Vitamin B12-unresponsive methylmalonic acidemia'],"1. Methylmalonic acidemia due to methylmalonyl-CoA mutase deficiency: The patient's decreased methylmalonyl-CoA mutase activity, death in infancy/childhood, and metabolic acidosis are all consistent with this diagnosis.

2. Propionic acidemia: Another organic acidemia that can present similarly with metabolic acidosis and early death. However, it would not typically cause decreased methylmalonyl-CoA mutase activity.

3. Cobalamin C deficiency: A disorder of vitamin B12 metabolism that can lead to methylmalonic acidemia and homocystinuria. May present with metabolic acidosis and early death, but would not directly cause decreased methylmalonyl-CoA mutase activity.

4. Cobalamin A deficiency: Another disorder of vitamin B12 metabolism leading to methylmalonic acidemia. Similar presentation to cobalamin C deficiency.

5. Cobalamin B deficiency: A third disorder of vitamin B12 metabolism leading to methylmalonic acidemia, with a similar presentation to cobalamin A and C deficiencies.",Hereditary metabolic disorders
['Succinic semialdehyde dehydrogenase deficiency'],"1. Very long-chain acyl-CoA dehydrogenase deficiency (VLCADD): The patient's motor delay, hypotonia, elevated urinary carboxylic acid, and death in infancy are consistent with this severe fatty acid oxidation disorder. Additional symptoms like cardiomyopathy and hepatomegaly were not reported.

2. Mitochondrial DNA depletion syndrome: This group of disorders can cause motor delay, hypotonia, metabolic crisis, and early death. The patient's pneumonia could be related to neuromuscular weakness. Other common features like seizures and liver dysfunction were not mentioned. 

3. Pompe disease (glycogen storage disease type II): Infantile-onset Pompe disease is characterized by hypotonia, motor delay, cardiomegaly, and respiratory difficulties that could predispose to pneumonia. The patient's elevated urinary carboxylic acid is not a typical finding.

4. Spinal muscular atrophy type 1: This disorder presents with severe hypotonia, weakness, motor delay, and respiratory failure leading to early death. While consistent with the patient's hypotonia and motor delay, it would not explain the metabolic abnormalities.

5. Congenital disorder of glycosylation (CDG): CDGs can have highly variable presentations, but often include hypotonia, failure to thrive, and multi-system dysfunction. More specific findings like abnormal fat pads, inverted nipples, and pericardial effusions were not noted in this patient.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Tyrosinemia type I: Characterized by hypertyrosinemia, hyperphenylalaninemia, and can be fatal in infancy if untreated. The patient's neonatal presentation and death in infancy fit with the severe acute form of the disease.

2. Phenylketonuria (PKU): Classic PKU presents with hyperphenylalaninemia and can cause irreversible neurological damage if untreated, but death in infancy would be atypical. A milder hyperphenylalaninemia could be seen in milder variants like non-PKU hyperphenylalaninemia.

3. Tyrosinemia type II: Also known as Richner-Hanhart syndrome, this disorder causes hypertyrosinemia but does not typically involve hyperphenylalaninemia or neonatal death, making it less likely.

4. Transient tyrosinemia of the newborn: A benign condition that causes temporary elevations in tyrosine. It would not explain the patient's hyperphenylalaninemia, abnormal prenatal development, or death in infancy.

5. Hawkinsinuria: A rare disorder of tyrosine metabolism that can cause hypertyrosinemia, metabolic acidosis, and failure to thrive. However, it does not typically involve hyperphenylalaninemia or death in infancy, so it is less likely than tyrosinemia type I or PKU.",Hereditary metabolic disorders
['PMM2-CDG'],"1. Congenital disorder of glycosylation (CDG): The multisystem involvement including diaphragmatic hernia, failure to thrive, neurological abnormalities, and early death fit with the phenotype of a CDG. However, additional features like inverted nipples and abnormal fat pads are not reported.

2. Pontocerebellar hypoplasia: The cerebellar atrophy/agenesis and motor delay could fit with pontocerebellar hypoplasia. However, the congenital diaphragmatic hernia and lipodystrophy are atypical.  

3. Zellweger spectrum disorder: The combination of cerebellar abnormalities, failure to thrive, and early death could suggest a peroxisomal biogenesis disorder like Zellweger syndrome. However, other key features like seizures, liver dysfunction, and characteristic facial features are not noted.

4. Congenital muscular dystrophy: The abnormal muscle physiology, motor delay, and failure to thrive could indicate a congenital muscular dystrophy. However, the diaphragmatic hernia and cerebellar agenesis are not typical of this group of disorders.

5. Walker-Warburg syndrome: This condition can cause congenital muscular dystrophy, cerebellar abnormalities, and brain malformations. However, other characteristic features like hydrocephalus, eye abnormalities, and seizures are lacking.",Hereditary metabolic disorders
['Maple syrup urine disease'],"1. Maple syrup urine disease: Characterized by elevated branched-chain amino acids (leucine, isoleucine, valine), intellectual disability, hypotonia, feeding difficulties, and high mortality if untreated. Urine may have a characteristic sweet odor.

2. Isovaleric acidemia: An organic acidemia causing elevated isovaleric acid and other carboxylic acids, as well as intellectual disability, hypotonia, poor feeding, and episodes of metabolic decompensation. Can be life-threatening if untreated.

3. Methylmalonic acidemia: Features elevated methylmalonic acid, intellectual disability, hypotonia, feeding problems, and metabolic decompensation leading to early mortality. Additional common symptoms include failure to thrive and megaloblastic anemia.

4. Propionic acidemia: Causes elevated propionylcarnitine and other carboxylic acids, intellectual disability, hypotonia, poor feeding, and episodes of life-threatening metabolic crises. Can also cause seizures and movement disorders.

5. 3-Methylcrotonyl-CoA carboxylase deficiency: A milder organic acidemia that can cause intellectual disability, hypotonia, feeding difficulties, and elevated 3-hydroxyisovaleric acid. Life-threatening symptoms are less common than in other organic acidemias.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Tyrosinemia type I: Hypertyrosinemia, diarrhea, gastrointestinal inflammation, skin rash, risk of early death. Key missing symptom is liver dysfunction.

2. Phenylketonuria: Hyperphenylalaninemia, skin rash (eczema), intellectual disability (not reported in this case). Usually not fatal in infancy/childhood if treated.

3. Severe combined immunodeficiency (SCID): Recurrent viral infections, diarrhea, risk of death in infancy. Skin rash and metabolic abnormalities are atypical.

4. Glycogen storage disease type Ia: Obesity, hyperlipidemia (not reported), lactic acidosis (not reported), delayed puberty (not assessable in infancy), hepatomegaly (not reported), hernia, risk of early death.

5. Propionic acidemia: Metabolic acidosis (not reported), hyperammonemia (not reported), hypotonia (not reported), seizures (not reported), gastrointestinal symptoms, risk of early death. Skin rash and specific amino acid abnormalities are atypical.",Hereditary metabolic disorders
['Biotinidase deficiency'],"1. Mitochondrial disorder: The increased lactate in blood and CSF is a hallmark finding in mitochondrial diseases, which impair cellular energy production. Some mitochondrial disorders can present with skin abnormalities and lead to early death.

2. Propionic acidemia: This inherited metabolic disorder can cause skin rashes, alopecia, metabolic acidosis with increased lactate, and early death if untreated. However, it does not typically feature eczematoid dermatitis.

3. Methylmalonic acidemia: Another organic acidemia that can have dermatological manifestations along with metabolic derangement and lethal complications in infancy if severe. Eczematoid dermatitis would be atypical.

4. Holocarboxylase synthetase deficiency: A disorder of biotin metabolism that causes skin rash, alopecia, and metabolic acidosis in infancy. It can be fatal if not recognized and treated promptly. Eczematoid dermatitis is not a classic finding.

5. Menkes disease: A disorder of copper metabolism that leads to neurodegeneration, abnormal hair, and failure to thrive in infancy. It can be associated with skin laxity but not usually eczematoid dermatitis. Elevated lactate would be unusual.",Hereditary metabolic disorders
['PMM2-CDG'],"1. Neuronal ceroid lipofuscinosis: Consistent with rod-cone dystrophy, intellectual disability, cerebellar atrophy, and early death. Other features like seizures and vision loss were not reported.

2. Congenital disorders of glycosylation (CDG): Can present with cerebellar hypoplasia, intellectual disability, abnormal fat distribution, and liver dysfunction. Facial dysmorphism and thromboembolism are reported in some subtypes. Screening tests would show abnormal glycosylation of proteins.  

3. Niemann-Pick disease type C: Matches the intellectual decline, cerebellar atrophy, and liver disease. Lipodystrophy is not typical. Other expected symptoms include vertical gaze palsy and organomegaly.

4. Zellweger spectrum disorders: Peroxisomal biogenesis disorders causing cerebellar dysfunction, liver disease, and early death. Facial dysmorphism can be seen but rod-cone dystrophy and lipodystrophy are less common.  

5. NBIA disorders (neurodegeneration with brain iron accumulation): Consider PLAN (PLA2G6-associated neurodegeneration) which includes cerebellar atrophy, intellectual decline, and lipodystrophy. Liver disease is possible. Rod-cone dystrophy is not a typical feature.",Hereditary metabolic disorders
['Glutaryl-CoA dehydrogenase deficiency'],"1. Glutaryl-CoA dehydrogenase deficiency: The patient's macrocephaly, neurological symptoms, glutaric aciduria, and early death are all consistent with this disorder. Other supporting features include the cystic hygroma and decreased plasma carnitine.

2. Propionic acidemia: Another organic acidemia that could explain the patient's presentation. Key features include lethargy, hypotonia, vomiting, and early death. However, glutaric aciduria would be unexpected.

3. Methylmalonic acidemia: Similar to propionic acidemia, this could cause the neurological symptoms, metabolic crisis signs, and neonatal presentation. Glutaric aciduria is not a typical finding though.

4. Canavan disease: This leukodystrophy is characterized by macrocephaly, hypotonia, and early death. It would not explain the glutaric aciduria or decreased carnitine.

5. Molybdenum cofactor deficiency: A rare metabolic disorder that can present with neurological symptoms, dysmorphic features, and early death. Glutaric aciduria is not expected but other metabolic abnormalities would be seen.",Hereditary metabolic disorders
['Isovaleric acidemia'],"1. Glycine encephalopathy: The combination of lethargy, hyperammonemia, elevated glycine, and early death is classic for this disorder. The abnormal prenatal development and feeding difficulties are also consistent. Key missing symptom is seizures, which are common but not always present.

2. Propionic acidemia: Can cause lethargy, hyperammonemia, abnormal glycine and carnitine, and death in infancy. However, the glycine elevation is usually not as prominent as in glycine encephalopathy.

3. Methylmalonic acidemia: Similar presentation to propionic acidemia with lethargy, hyperammonemia, metabolic abnormalities and infantile death. Elevated glycine is possible but less common than in glycine encephalopathy.

4. Carnitine palmitoyltransferase I deficiency: The lethargy and hyperammonemia fit, as does the abnormal carnitine level. However, this disorder typically does not cause abnormal prenatal development or as prominent glycine elevations.

5. Molybdenum cofactor deficiency: Can present with lethargy, hyperammonemia, feeding difficulties and infantile death. May cause some prenatal abnormalities. However, glycine elevation would be unusual, and seizures would be expected.",Hereditary metabolic disorders
['PMM2-CDG'],"1. Pontocerebellar hypoplasia: Consistent with microcephaly, cerebellar atrophy/agenesis, intellectual disability, motor delay, hypotonia, and early death. Additional features like seizures and spasticity are not reported.

2. Congenital disorder of glycosylation: Can cause microcephaly, cerebellar atrophy, intellectual disability, hypotonia, strabismus, and failure to thrive. Specific findings like inverted nipples and abnormal fat pads are not mentioned.

3. Joubert syndrome: Matches cerebellar vermis agenesis, intellectual disability, hypotonia, ataxia, and abnormal eye movements. Other classic features like abnormal breathing and polydactyly are not noted.

4. Zellweger spectrum disorder: Peroxisomal biogenesis disorders can lead to microcephaly, intellectual disability, hypotonia, nystagmus, and early death. Hearing loss, renal cysts, and hepatic dysfunction are not reported.

5. Walker-Warburg syndrome: A congenital muscular dystrophy that causes microcephaly, cerebellar abnormalities, intellectual disability, hypotonia, and eye anomalies. Seizures, hydrocephalus, and congenital cataracts are not described.",Hereditary metabolic disorders
"['Methylmalonic acidemia with homocystinuria, type cblC']","Based on the provided symptoms, the top 5 potential diagnoses are:

1. Methylmalonic acidemia: The patient's methylmalonic aciduria, hyperammonemia, metabolic abnormalities, neurological symptoms, and early death fit with this disorder of amino acid metabolism.

2. Propionic acidemia: Similar to methylmalonic acidemia, this condition could explain the patient's metabolic disturbances, cardiomyopathy (ventricular septal defect), hypotonia, and poor outcome. 

3. Homocystinuria: The hyperhomocystinemia, cognitive impairment, and ocular findings are consistent with this disorder. However, the patient is missing some key features like marfanoid habitus and thromboembolism.

4. Glutaric acidemia type 1: This disorder is characterized by encephalopathic crises, neurological deterioration, and metabolic abnormalities. The patient's motor delay, hypotonia, and death in childhood could fit, but the methylmalonic aciduria would be atypical.

5. Multiple carboxylase deficiency (biotinidase deficiency): This condition can present with neurological symptoms, metabolic acidosis, organic aciduria, and hyperammonemia in infancy. The specific pattern of metabolic abnormalities would need to be reviewed.

Note: The patient is not reported to have some cardinal features of these conditions, such as metabolic acidosis, ketosis, or specific patterns of organic aciduria. Additional testing is necessary for a definitive diagnosis.",Hereditary metabolic disorders
['Medium chain acyl-CoA dehydrogenase deficiency'],"1. Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency: This fatty acid oxidation disorder can present with hypoglycemia, vomiting, lethargy, and liver dysfunction. It can be life-threatening, especially in infancy.

2. Propionic acidemia: Symptoms of this organic acid disorder can include poor feeding, vomiting, hypotonia, lethargy, and hypoglycemia. It is associated with high mortality in untreated patients. Additional findings may include ketoacidosis and hyperammonemia.

3. Carnitine palmitoyltransferase I (CPT I) deficiency: Another fatty acid oxidation defect that can manifest with hypoketotic hypoglycemia, liver enlargement, elevated liver enzymes, and high mortality. Symptoms may be triggered by fasting or illness.

4. Ornithine transcarbamylase (OTC) deficiency: This urea cycle disorder often presents in the neonatal period with poor feeding, vomiting, lethargy, and respiratory alkalosis. Hyperammonemia is a key feature. It can rapidly progress to coma and death without prompt treatment.

5. Mitochondrial DNA depletion syndrome: A group of disorders causing inadequate mtDNA. Symptoms vary but can include hypoglycemia, lactic acidosis, liver dysfunction, and vomiting. Onset is usually in infancy with rapid progression, often leading to early death.",Hereditary metabolic disorders
['Succinic semialdehyde dehydrogenase deficiency'],"1. Propionic acidemia: Consistent with neonatal onset, coma, hyperkalemia, and elevated urinary carboxylic acid. May also present with metabolic acidosis and hyperammonemia.

2. Methylmalonic acidemia: Similar presentation to propionic acidemia, with neonatal onset, coma, hyperkalemia, and elevated urinary carboxylic acid. May also have metabolic acidosis, neutropenia, and hyperammonemia.

3. Isovaleric acidemia: Can present with early-onset coma, respiratory distress, and elevated urinary carboxylic acid. Characteristic ""sweaty feet"" odor may be present.

4. Glutaric acidemia type II (multiple acyl-CoA dehydrogenase deficiency): Can cause neonatal death, coma, hypoglycemia, and metabolic acidosis. Elevated urinary organic acids and acylcarnitines are typically found.

5. Molybdenum cofactor deficiency: Rare disorder presenting with neonatal seizures, coma, and early death. May have elevated urinary sulfite, thiosulfate, and S-sulfocysteine. Facial dysmorphism and brain abnormalities are common.",Hereditary metabolic disorders
['Homocystinuria due to cystathionine beta-synthase deficiency'],"1. Homocystinuria due to cystathionine beta-synthase deficiency: This disorder fits well with the patient's hyperhomocystinemia, ectopia lentis, intellectual disability, and early mortality. However, additional features like thromboembolism and osteoporosis were not mentioned.

2. Marfan syndrome: The patient's ectopia lentis, large hands, and long feet could fit with this connective tissue disorder. However, Marfan syndrome does not typically cause intellectual disability or amino acid abnormalities.

3. Sulfite oxidase deficiency: This disorder can cause ectopia lentis, intellectual disability, and early death, but is not typically associated with skeletal changes or hyperhomocystinemia.

4. Methylenetetrahydrofolate reductase (MTHFR) deficiency: This disorder can lead to hyperhomocystinemia, developmental delays, and neurological symptoms. However, it does not usually involve ectopia lentis or skeletal changes.

5. Homocystinuria due to MTHFR deficiency: A severe form of MTHFR deficiency can present similarly to cystathionine beta-synthase deficiency, with hyperhomocystinemia, ectopia lentis, intellectual disability, and early death. Skeletal features would be less typical.",Hereditary metabolic disorders
[],"1. Donohue syndrome (Leprechaunism): Wide mouth, sparse hair, hyperinsulinemia, hypoglycemia, feeding difficulties, death in infancy. Key missing symptom is severe growth restriction.

2. CDG syndrome type Ib: Wide mouth, seizures, feeding difficulties, death in infancy/childhood. Other symptoms like inverted nipples, abnormal fat pads, and liver dysfunction were not reported.

3. Mitochondrial DNA depletion syndrome: Seizures, hypoglycemia, feeding difficulties, death in infancy/childhood. Additional symptoms may include liver dysfunction, muscle weakness, and lactic acidosis.

4. Pompe disease (Infantile-onset): Wide mouth, hypotonia, feeding difficulties, cardiomegaly, death in infancy. Cardiomegaly and muscle weakness were not reported in this patient.

5. Zellweger syndrome: Wide mouth, seizures, hypotonia, feeding difficulties, death in infancy. Other expected symptoms include high forehead, hepatic dysfunction, and renal cysts.",Hereditary metabolic disorders
['Propionic acidemia'],"1. Nonketotic hyperglycinemia: Characterized by elevated glycine levels, intellectual disability, seizures, hypotonia, and early death. The patient's hyperglycinemia, neurological symptoms, and death in infancy fit this diagnosis.

2. Propionic acidemia: Features hyperammonemia, intellectual disability, seizures, and can be life-threatening in infancy. Consistent with the patient's hyperammonemia, neurological symptoms, and early death. Hepatomegaly and anemia can also occur.

3. Methylmalonic acidemia: Can present with intellectual disability, seizures, metabolic crisis, hyperammonemia, and early death, matching the patient's symptoms. Anemia and hepatomegaly are also reported.

4. Carnitine palmitoyltransferase II deficiency: Typically presents later but severe neonatal form can have hypotonia, seizures, hepatomegaly, and early death, fitting some of the patient's key symptoms. Abnormal carnitine levels are characteristic.

5. Glutaric acidemia type II: Can feature intellectual disability, hypotonia, seizures, and is often fatal in infancy or childhood, aligning with the patient's course. Hyperglycinemia, hyperammonemia, and abnormal carnitine levels can be seen. Hepatomegaly is not a classic finding.",Hereditary metabolic disorders
['Vitamin B12-unresponsive methylmalonic acidemia'],"1. Methylmalonic aciduria, mut(0) type: The patient's symptoms of hypotonia, apnea, feeding difficulties, and early death, along with the hallmark findings of decreased methylmalonyl-CoA mutase activity and methylmalonic aciduria, are highly consistent with this severe form of methylmalonic acidemia. The hematologic abnormalities of thrombocytopenia and leukopenia can also occur.

2. Propionic acidemia: Another organic acidemia that can present similarly in the neonatal period with poor feeding, hypotonia, metabolic acidosis, and potentially early death if untreated. However, methylmalonic aciduria would not be expected.

3. Methylmalonic aciduria and homocystinuria, cblC type: This disorder can have a severe early-onset form with hypotonia, lethargy, seizures, and metabolic acidosis. Both methylmalonic aciduria and homocystinuria would be seen, but the patient was not reported to have homocystinuria.

4. Holocarboxylase synthetase deficiency: A biotin metabolism disorder that can present in the neonatal period with hypotonia, lethargy, apnea, metabolic acidosis, and organic aciduria. However, the methylmalonic aciduria and decreased methylmalonyl-CoA mutase activity point more towards a primary methylmalonic acidemia.

5. Transient neonatal hypotonia: While the patient's hypotonia could be due to various causes like birth injury or sepsis, the metabolic acidosis, methylmalonic aciduria, and decreased enzyme activity make a metabolic disorder much more likely. Transient hypotonia also would not explain the early death.",Hereditary metabolic disorders
['Systemic primary carnitine deficiency'],"1. Propionic acidemia: Consistent with the patient's coma, hypoglycemia, vomiting, and metabolic changes. Key features not reported include hyperammonemia, ketoacidosis, and abnormal urine organic acids.

2. Methylmalonic acidemia: Can present similarly to propionic acidemia with coma, hypoglycemia, vomiting, and death in infancy. Methylmalonic acid would be elevated in the urine organic acids.

3. Very long-chain acyl-CoA dehydrogenase (VLCAD) deficiency: A fatty acid oxidation disorder that can cause coma, hypoglycemia, sudden death in infancy, and a low carnitine level. Characteristic changes on acylcarnitine profile.

4. Glutaric acidemia type II: Can present in infancy with coma, hypoglycemia, and sudden death. Would have a characteristic urine organic acid profile and acylcarnitine profile.

5. Carnitine palmitoyltransferase II (CPT II) deficiency: Another fatty acid oxidation disorder that can present with coma, hypoglycemia, and sudden death in infancy. Low plasma carnitine and abnormal acylcarnitine profile.",Hereditary metabolic disorders
['3-methylcrotonyl-CoA carboxylase deficiency'],"1. Carnitine palmitoyltransferase II deficiency: Lethargy, poor coordination, decreased plasma carnitine, and early death are consistent with this disorder of long-chain fatty acid oxidation. Feeding difficulties and sleep abnormalities are also common.

2. Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency: Another fatty acid oxidation disorder that can present with lethargy, drowsiness, poor feeding, and risk of sudden death in infancy or childhood. Low carnitine levels can also be seen.

3. Carnitine-acylcarnitine translocase deficiency: A severe disorder of carnitine transport that presents in the neonatal period with lethargy, poor feeding, and rapid progression to early death. Plasma carnitine is low.

4. Very long-chain acyl-CoA dehydrogenase (VLCAD) deficiency: Can cause a severe infantile form with hypotonia, cardiomyopathy, and early death, or milder childhood-onset forms with episodes of lethargy and hypoglycemia. Low carnitine and poor coordination are consistent findings.

5. Glutaric aciduria type II: A multiple acyl-CoA dehydrogenase deficiency that can present in infancy or childhood with hypotonia, lethargy, feeding difficulties, and risk of metabolic crises and death. Decreased plasma carnitine is a key finding, but other metabolic abnormalities would also be expected.",Hereditary metabolic disorders
[],"1. Combined oxidative phosphorylation deficiency 13: Characterized by early-onset encephalopathy, spastic tetraplegia, dysarthria, ethylmalonic aciduria, and cytochrome C oxidase-negative fibers. Other features like hypothyroidism and immune dysfunction can occur. Reduced life expectancy.

2. Leigh syndrome: Progressive neurodegenerative disorder with developmental delay, dysarthria, spasticity, hyperreflexia, and encephalopathy. Can have hypothyroidism and abnormal metabolic findings. Often fatal in childhood.

3. Ethylmalonic encephalopathy: Rare mitochondrial disorder with developmental delays, dysarthria, spasticity, encephalopathy, ethylmalonic aciduria, and recurrent infections. Elevated glycine can be seen. Usually fatal in the first decade.

4. MELAS syndrome: Mitochondrial disorder that can present with encephalopathy, spasticity, elevated lactate, and stroke-like episodes. Hypothyroidism sometimes occurs. Onset and severity is variable but reduced lifespan is common. Does not typically have the specific muscle pathology findings noted here.

5. Succinic semialdehyde dehydrogenase deficiency: Rare metabolic disorder with developmental delay, hypotonia or spasticity, dysarthria, and elevated glycine. However, ethylmalonic aciduria and COX-negative fibers would be unusual. Reduced lifespan is possible but not as consistently seen as in the other conditions listed.",Hereditary metabolic disorders
['Medium chain acyl-CoA dehydrogenase deficiency'],"1. Carnitine palmitoyltransferase I deficiency: Consistent with neonatal death, abnormal carnitine levels. Can also cause prenatal abnormalities.

2. Carnitine-acylcarnitine translocase deficiency: Also fits with infant death and carnitine abnormalities. Severe neonatal form is usually fatal.

3. Glutaric acidemia type II: Can present with abnormal prenatal development, neonatal death, and abnormal carnitine profile. Does not always have the distinctive urine organic acid profile.

4. Long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency: Another fatty acid oxidation disorder that can be severe in infancy with abnormal carnitine levels. May have lower frequency of prenatal abnormalities compared to the other conditions.

5. Very long-chain acyl-CoA dehydrogenase deficiency: Can cause fetal complications, infant death, and carnitine abnormalities. Symptoms may be milder and later-onset compared to the other diagnoses.",Hereditary metabolic disorders
['Glutaryl-CoA dehydrogenase deficiency'],"1. Glutaric acidemia type 1 (GA1): The patient's macrocephaly, neurological symptoms (hypotonia, dystonia, lethargy), metabolic acidosis, glutaric aciduria, and decreased plasma carnitine are all consistent with GA1. The early death also fits with the severe, life-threatening nature of this disorder if untreated.

2. Canavan disease: This leukodystrophy could explain the patient's macrocephaly, hypotonia, lethargy, and early death. However, the patient is missing other typical symptoms like optic atrophy and the acidosis and glutaric aciduria would be unusual.

3. Mitochondrial encephalomyopathy (e.g. Leigh syndrome): Mitochondrial disorders can present with hypotonia, dystonia, metabolic acidosis, and multi-organ dysfunction. The glutaric aciduria would be atypical though.

4. Propionic acidemia or Methylmalonic acidemia: These organic acidemias can cause metabolic acidosis, hypotonia, lethargy, vomiting, and early death. However, they are usually associated with ketoacidosis and hyperammonemia rather than pure glutaric aciduria.

5. Alexander disease: This rare leukodystrophy is characterized by macrocephaly, hypotonia, and seizures. It would be unusual to have glutaric aciduria and metabolic acidosis though, and cystic hygroma is not a typical feature.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Tyrosinemia type I: Characterized by hypertyrosinemia, abnormalities of prenatal development, and high risk of early death if untreated. Hyperphenylalaninemia is not typically seen.

2. Tyrosinemia type II: Also presents with hypertyrosinemia, but tends to be less severe than type I. Congenital abnormalities and early death are less common. Hyperphenylalaninemia is not expected.

3. Phenylketonuria (PKU): The classic form presents with hyperphenylalaninemia and can cause congenital abnormalities and intellectual disability if untreated. However, early death is uncommon with modern newborn screening and treatment. Hypertyrosinemia is not a primary feature.

4. Alkaptonuria: A disorder of tyrosine metabolism that causes hypertyrosinemia, but is generally less severe and not associated with congenital abnormalities or early death. Hyperphenylalaninemia is not seen.

5. Hawkinsinuria: A rare disorder that can present with hypertyrosinemia and metabolic acidosis in infancy. However, it is generally compatible with survival if treated and hyperphenylalaninemia is not expected.",Hereditary metabolic disorders
['L-2-hydroxyglutaric aciduria'],"1. Metachromatic leukodystrophy: Consistent with the patient's delayed development, intellectual disability, motor difficulties, hyperreflexia, and abnormal cerebral white matter. Key features not reported include peripheral neuropathy and sulfatide excretion in urine.

2. Krabbe disease (Globoid cell leukodystrophy): Also fits the patient's presentation of developmental delays, intellectual impairment, motor deterioration, and white matter abnormalities. Krabbe disease often presents in infancy. Additional symptoms not mentioned include irritability, feeding difficulties, and vision loss.

3. Canavan disease: Another leukodystrophy characterized by developmental delays, intellectual disability, white matter changes, and early death. Macrocephaly is a key feature of Canavan disease not reported in this patient.

4. GM1 gangliosidosis: A lysosomal storage disorder that can present with developmental delays, intellectual disability, hyperreflexia, and motor impairment. Other typical features include facial dysmorphism, hepatosplenomegaly, and skeletal abnormalities.

5. Leigh syndrome: A mitochondrial disorder causing progressive neurological deterioration, often with motor difficulties, intellectual impairment, and white matter changes. Cardinal features of Leigh syndrome not mentioned here include eye movement abnormalities, dystonia, and brainstem lesions on neuroimaging.",Hereditary metabolic disorders
['Maple syrup urine disease'],"1. Maple syrup urine disease: The patient's symptoms of generalized hypotonia, spasticity, apathy, hypoglycemia, and elevated branched-chain amino acids are consistent with this disorder. The early mortality also fits with the severe classic form of the disease.

2. Propionic acidemia: This disorder can present with hypotonia, developmental delay, seizures, and episodes of metabolic decompensation. However, the patient's elevated branched-chain amino acids are not typically seen in propionic acidemia.

3. Methylmalonic acidemia: Similar to propionic acidemia, this condition can cause neurological symptoms and metabolic crises. However, it is not associated with the specific amino acid abnormalities seen in this patient.

4. Isovaleric acidemia: This disorder is characterized by elevated levels of the branched-chain amino acid leucine and its metabolite isovaleric acid. However, the patient's constellation of symptoms is more consistent with maple syrup urine disease.

5. Glutaric acidemia type II: This condition can present with hypotonia, hypoglycemia, and metabolic acidosis. However, it typically causes an elevation of multiple acylcarnitine species rather than isolated elevations of branched-chain amino acids.",Hereditary metabolic disorders
['Classic galactosemia'],"1. Classic galactosemia: Consistent with hypergalactosemia, abnormality of galactoside metabolism, and potentially early death if untreated. However, other features like liver dysfunction and cataracts were not reported.

2. Tyrosinemia type I: The elevated tyrosine and aspartate levels, increased bilirubin, and risk of early death fit with this diagnosis. Additional findings may include liver failure, renal tubular dysfunction, and neurological crises.

3. Phenylketonuria (PKU): While this disorder classically presents with elevated phenylalanine levels, the developmental delay, hyperalaninemia, and aminoaciduria could be consistent. However, the patient's obesity is atypical and phenylalanine levels were not specifically mentioned.

4. Maple syrup urine disease (MSUD): The abnormal circulating aspartate family amino acid concentration raises the possibility of this disorder of branched-chain amino acid metabolism. Other features would likely include poor feeding, lethargy, and a characteristic sweet odor to the urine.

5. Fructose-1,6-bisphosphatase deficiency: This disorder of gluconeogenesis can present with hypoglycemia, lactic acidosis, hyperalaninemia, and aminoaciduria. However, the galactose abnormalities and developmental delays are less typical.",Hereditary metabolic disorders
['3-hydroxy-3-methylglutaric aciduria'],"1. Propionic acidemia: Characterized by metabolic acidosis, hyperammonemia, and elevated 3-methylglutaric acid. Can present in infancy with poor feeding, vomiting, and lethargy progressing to coma and death if untreated.

2. Methylmalonic acidemia: Similar presentation to propionic acidemia with metabolic acidosis, hyperammonemia, and elevated methylmalonic acid. Can also have megaloblastic anemia and neutropenia.

3. Urea cycle disorders (e.g., CPS1 deficiency, OTC deficiency): Typically present with hyperammonemia, vomiting, lethargy, and coma. Respiratory alkalosis may be present initially, progressing to metabolic acidosis.

4. Glycine encephalopathy (nonketotic hyperglycinemia): Presents in neonatal period with hypotonia, seizures, and coma. Key finding is elevated glycine in blood and CSF.

5. Mitochondrial disorders (e.g., pyruvate dehydrogenase deficiency): Can have varied presentations but often involve metabolic acidosis, lactic acidosis, and neurologic dysfunction. 3-methylglutaconic aciduria may be present in some types.",Hereditary metabolic disorders
['Homocystinuria due to cystathionine beta-synthase deficiency'],"1. Homocystinuria due to cystathionine beta-synthase deficiency: The patient's hyperhomocystinemia, hypomethioninemia, neurological deterioration, and early death are consistent with this disorder. Other typical features like ectopia lentis, skeletal abnormalities, and thromboembolism were not reported.

2. Methylenetetrahydrofolate reductase deficiency: This could explain the hyperhomocystinemia, neurological symptoms, and abnormal folate metabolism. However, the hypomethioninemia is not typical.

3. Disorders of intracellular cobalamin metabolism (cblC, cblD, cblF, cblJ): These disorders are characterized by hyperhomocystinemia, hypomethioninemia, megaloblastic anemia, neurological deterioration, and immunodeficiency, matching the patient's presentation. The abnormal porphyrin concentration could be secondary to the severe illness.

4. Methionine synthase deficiency: The hyperhomocystinemia, hypomethioninemia, neurological symptoms, and anemia fit with this diagnosis. Recurrent infections are not a classic feature.

5. Transcobalamin II deficiency: While this could cause hyperhomocystinemia, anemia, neurological symptoms, and immunodeficiency, it typically results in hypermethioninemia rather than hypomethioninemia.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Tyrosinemia type I: Characterized by hypertyrosinemia, liver dysfunction, renal tubular dysfunction, and neurological crises. The patient's hypertyrosinemia and early death fit this diagnosis. Key features not mentioned include liver and kidney abnormalities.

2. Phenylketonuria (PKU): Causes hyperphenylalaninemia and intellectual disability if untreated. The patient has the characteristic high phenylalanine levels. However, PKU does not typically cause the severe outcomes of infant and childhood death seen in this patient.

3. Alkaptonuria: A disorder of tyrosine metabolism that causes urine to turn dark, early arthritis, and heart valve problems. The patient's hypertyrosinemia fits, but the other classic symptoms are not described.

4. Maple syrup urine disease: Causes dysfunction in breaking down certain amino acids, leading to a sweet urine odor, feeding problems, and neurological decline. Can be life-threatening but does not fit the specific amino acid abnormalities seen here.

5. Zellweger spectrum disorder: Includes abnormalities in prenatal development, infant death, and respiratory complications that fit this patient. However, the characteristic amino acid disturbances are more consistent with a disorder of phenylalanine/tyrosine metabolism specifically.",Hereditary metabolic disorders
['Biotinidase deficiency'],"1. Propionic acidemia: Consistent with seizures, spasticity, death in infancy, fatigue, and elevated urinary carboxylic acid. Other symptoms that can occur include vomiting, lethargy, and intellectual disability.

2. Methylmalonic acidemia: Also features seizures, spasticity, death in infancy, fatigue, and elevated urinary carboxylic acid. Additional symptoms may include failure to thrive, metabolic acidosis, and pancytopenia.

3. Glutaric acidemia type 1: Matches the neurological symptoms of seizures, spasticity, and death in infancy. Elevated urinary carboxylic acid is also seen. Macrocephaly and dystonia are other characteristic features.

4. Isovaleric acidemia: Another organic acidemia that could explain the seizures, spasticity, death in infancy, and elevated urinary carboxylic acid. The ""sweaty feet"" odor is a hallmark symptom.

5. Biotinidase deficiency: A consideration given the seizures, spasticity, alopecia, and fatigue, though death in infancy would be atypical. Hearing loss and skin rash are additional cardinal symptoms.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Tyrosinemia type I: Characterized by hypertyrosinemia, early death, and gastrointestinal symptoms. Patient's hyperphenylalaninemia and obesity are atypical.

2. Phenylketonuria: Classic symptoms include hyperphenylalaninemia and intellectual disability if untreated. Patient's hypertyrosinemia, early mortality and GI symptoms are not typical of PKU alone.

3. Maple syrup urine disease: Can present with poor feeding, vomiting, lethargy progressing to coma and death if untreated. Additional symptoms like sweet-smelling urine and neurological deterioration were not reported in this patient.

4. Urea cycle disorder (e.g. ornithine transcarbamylase deficiency): Typically causes hyperammonemia, encephalopathy, and early mortality. This patient's amino acid abnormalities and lack of reported neurological symptoms are less consistent with a UCD.

5. Niemann-Pick disease type C: Highly variable presentation that can include hepatosplenomegaly, gastrointestinal symptoms, developmental delay/regression, and premature death. The patient's amino acid abnormalities are not classic for NPC but could be a secondary finding.",Hereditary metabolic disorders
['Biotinidase deficiency'],"Based on the provided symptoms, the top 5 potential diagnoses are:

1. Non-ketotic hyperglycinemia: Characterized by elevated glycine, metabolic acidosis, increased CSF lactate, and severe symptoms in infancy including failure to thrive and early death. Can be associated with skin findings.

2. Propionic acidemia: An organic acidemia that presents in infancy with metabolic acidosis, increased lactate, hyperammonemia, and abnormal glycine metabolism. Can have skin manifestations and lead to early death if untreated.  

3. Methylmalonic acidemia: Another organic acidemia with similar symptoms as propionic acidemia including metabolic acidosis, elevated lactate, hyperammonemia, and abnormal urine organic acids. Skin findings have been reported. Untreated cases can be fatal in infancy.

4. Mitochondrial disorder: Mitochondrial diseases often present in infancy with multi-system involvement, metabolic acidosis, elevated lactate, and early death. Skin manifestations and alopecia have been described in some mitochondrial disorders.

5. Multiple carboxylase deficiency: A disorder of biotin metabolism leading to deficiency of several carboxylase enzymes. Presents in infancy with metabolic acidosis, organic aciduria, skin rash, alopecia, and can be fatal if untreated. Fits with the reported symptoms.",Hereditary metabolic disorders
['Vitamin B12-unresponsive methylmalonic acidemia'],"1. Methylmalonic acidemia: Characterized by decreased methylmalonyl-CoA mutase activity, leading to death in infancy, dehydration, feeding difficulties, and neonatal death if untreated. Other common symptoms not reported here include vomiting, lethargy, hypotonia, and intellectual disability in those who survive infancy.

2. Propionic acidemia: Can also cause neonatal death, dehydration, and feeding problems due to buildup of propionic acid. However, decreased propionyl-CoA carboxylase activity would be expected rather than decreased methylmalonyl-CoA mutase.

3. Holocarboxylase synthetase deficiency: A biotin-responsive multiple carboxylase deficiency that can lead to death in infancy, dehydration, and feeding difficulties. Additional findings may include skin rash, alopecia, and metabolic acidosis.

4. Glutaric acidemia type 1: While this disorder can cause dehydration and feeding problems, it more typically presents with macrocephaly, dystonia, and striatal injury. Death in infancy is less common than in methylmalonic acidemia.

5. Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency: Can potentially cause death in infancy, dehydration, and feeding issues, but episodes are often triggered by fasting or illness. Decreased methylmalonyl-CoA mutase activity would not be expected.",Hereditary metabolic disorders
['Biotinidase deficiency'],"1. Propionic acidemia: consistent with lethargy, hypotonia, metabolic acidosis, increased lactate, propionyl-CoA carboxylase deficiency, and death in infancy. May also have hyperammonemia and ketosis which were not reported.

2. Pyruvate carboxylase deficiency: matches decreased pyruvate carboxylase activity, lethargy, hypotonia, metabolic acidosis, and early death. Seizures and brain malformations are also common but were not mentioned.

3. Methylmalonic acidemia: can present similarly to propionic acidemia with lethargy, hypotonia, metabolic acidosis, and early death. Would expect to see methylmalonic acid in urine and methylmalonyl-CoA mutase deficiency.

4. Multiple carboxylase deficiency: broad disorder affecting pyruvate carboxylase and other carboxylases. Shares features like hypotonia, metabolic acidosis and early lethality. Skin rash and alopecia are frequently seen.

5. Mitochondrial DNA depletion syndrome: group of disorders causing progressive multi-organ failure and early death. Generalized hypotonia, increased lactate, and liver dysfunction are hallmark features. Specific gene defects would aid diagnosis.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Tyrosinemia type I: Characterized by hypertyrosinemia, liver dysfunction, and early death if untreated. Consistent with abnormal prenatal development, death in infancy/childhood, and hypertyrosinemia.

2. Transient tyrosinemia of the newborn: Causes hypertyrosinemia in the neonatal period but is usually benign. Matches the hypertyrosinemia but less likely to cause the other severe symptoms reported.

3. Phenylketonuria: Causes hyperphenylalaninemia and can present with neonatal issues and early death if untreated. Matches the hyperphenylalaninemia and potentially the prenatal and childhood symptoms, but hypertyrosinemia is not a typical finding.

4. Maple syrup urine disease: Can cause neonatal coma, sepsis, and death. Elevated branched-chain amino acids are characteristic, rather than tyrosine and phenylalanine.

5. Homocystinuria: May present with failure to thrive in infancy and developmental delay. Typically causes elevated homocysteine and methionine rather than tyrosine and phenylalanine.",Hereditary metabolic disorders
['3-hydroxy-3-methylglutaric aciduria'],"1. Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency: The patient's death in infancy, dicarboxylic aciduria, and elevated urinary carboxylic acids are consistent with this fatty acid oxidation disorder. However, 3-methylglutaric aciduria is not a typical finding.

2. Very long-chain acyl-CoA dehydrogenase (VLCAD) deficiency: Similar to MCAD deficiency, this disorder could explain the patient's early death and abnormal urine organic acids. Additional findings like cardiomyopathy and hypotonia would support this diagnosis.

3. Propionic acidemia: This organic acidemia classically presents in the neonatal period with poor feeding, lethargy, and death without treatment. It is characterized by elevated 3-hydroxypropionate and methylcitrate on urine organic acids, as well as hyperammonemia and lactic acidosis.

4. Methylmalonic acidemia: Another organic acidemia to consider given the patient's presentation. Urine organic acid analysis would show elevated methylmalonic acid, and there may be associated megaloblastic anemia and renal dysfunction.

5. 3-Methylcrotonyl-CoA carboxylase deficiency: This disorder of leucine catabolism could account for the 3-methylglutaric aciduria seen in this patient. However, it is usually associated with a milder phenotype than what is described here.",Hereditary metabolic disorders
['Wilson disease'],"The top 5 potential diagnoses based on the given symptoms are:

1. Wilson disease: Decreased ceruloplasmin and blood copper, increased urinary copper, and liver dysfunction are consistent with this disorder of copper metabolism. It can also cause neuropsychiatric symptoms and death if untreated. However, the abnormal porphyrins and iron are atypical.

2. Tyrosinemia type 1: This disorder of amino acid metabolism causes liver failure, kidney dysfunction, and early death. It can cause increased amino acid levels and liver enzymes. However, the specific copper and iron abnormalities are not typical.

3. Niemann-Pick disease type C: This lysosomal storage disorder causes neurological deterioration and visceral symptoms like liver dysfunction. It is associated with abnormal lipid storage and can be fatal in childhood. The abnormal copper and porphyrin levels would be unusual though.

4. Hereditary hemochromatosis: Disorders of iron metabolism can cause liver disease, diabetes, and heart problems. Abnormal iron studies and liver enzymes may be seen. However, this patient's young age and low blood iron argue against this diagnosis.

5. Congenital disorder of glycosylation: These disorders cause multi-system dysfunction and can be associated with liver disease, failure to thrive, and early mortality. Screening labs may show abnormal protein glycosylation. However, the specific findings related to copper and porphyrin metabolism would not be expected.",Hereditary metabolic disorders
['Medium chain acyl-CoA dehydrogenase deficiency'],"1. Carnitine palmitoyltransferase I deficiency: Consistent with neonatal death, abnormal carnitine levels. Can also cause prenatal abnormalities.

2. Carnitine-acylcarnitine translocase deficiency: Also fits with infant death and carnitine abnormalities. Severe neonatal form is usually fatal.

3. Glutaric acidemia type II: Can present with abnormal prenatal development, neonatal death, and abnormal carnitine profile. Does not always have the distinctive urine organic acid profile.

4. Long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency: Another fatty acid oxidation disorder that can be severe in infancy with abnormal carnitine levels. May have lower frequency of prenatal abnormalities compared to the other conditions.

5. Very long-chain acyl-CoA dehydrogenase deficiency: Can cause fetal complications, infant death, and carnitine abnormalities. Symptoms may be milder and later-onset compared to the other diagnoses.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Tyrosinemia type I: Characterized by hypertyrosinemia, early death (if untreated), and liver dysfunction. The patient's hypertyrosinemia and death in infancy/childhood are consistent, but liver involvement was not mentioned.

2. Phenylketonuria (PKU): Causes hyperphenylalaninemia and intellectual disability if untreated. Fits with the patient's elevated phenylalanine, but PKU does not typically cause death in infancy or childhood.

3. Transient tyrosinemia of the newborn: A benign condition causing temporary elevations of tyrosine in the neonatal period. Possible given the hypertyrosinemia, but would not explain the patient's death or recurrent infections.

4. Severe combined immunodeficiency (SCID): Can present with early death and recurrent infections, but the amino acid abnormalities are not typical of SCID.

5. Alkaptonuria: A disorder of tyrosine metabolism that causes darkened urine and arthritis. Less likely given the severity of this patient's presentation and lack of characteristic symptoms.",Hereditary metabolic disorders
['3-methylcrotonyl-CoA carboxylase deficiency'],"1. Propionic acidemia: Characterized by aminoaciduria, elevated glycine, abnormal carnitine profile, and elevated propionylcarnitine and methylcitrate on urine organic acids. The patient's symptoms fit this profile.

2. Methylmalonic acidemia: Also causes elevated glycine, abnormal carnitine, and a specific pattern of elevated organic acids including methylmalonic acid. Matches the patient's presentation.

3. Isovaleric acidemia: Can present with aminoaciduria, elevated glycine, and a characteristic urine organic acid profile with isovalerylglycine. Consistent with the patient's metabolic abnormalities.

4. Glutaric acidemia type 1: Typically has aminoaciduria, elevated glutaric acid and 3-hydroxyglutaric acid on urine organic acids. Can cause secondary carnitine deficiency. Fits the overall pattern of organic acidemia.

5. 3-Methylcrotonyl-CoA carboxylase deficiency: A less common organic acidemia that can present with glycine elevation, carnitine abnormalities, and a characteristic urine organic acid profile. The patient's symptoms could potentially represent a milder case.",Hereditary metabolic disorders
['Carbamoyl-phosphate synthetase 1 deficiency'],"1. Barth syndrome: Generalized hypotonia, 3-methylglutaconic aciduria, cardiomyopathy (not reported), neutropenia (not reported)

2. MEGDEL syndrome: Generalized hypotonia, 3-methylglutaconic aciduria, liver dysfunction, feeding difficulties, deafness (not reported) 

3. 3-methylglutaconic aciduria type I: 3-methylglutaconic aciduria, neurological abnormalities, death in infancy in severe cases

4. Transaldolase deficiency: Generalized hypotonia, liver dysfunction, feeding difficulties, thrombocytopenia (not reported), anemia (not reported)

5. Niemann-Pick disease type C: Hepatomegaly, neonatal jaundice (not reported), neurological deterioration, lung disease (could explain tachypnea)",Hereditary metabolic disorders
['Citrullinemia type I'],"Based on the given symptoms, the top 5 potential diagnoses are:

1. Citrullinemia type I: Delayed development, lethargy, hypoglycemia, hyperammonemia, respiratory alkalosis, and elevated plasma citrulline are consistent. Lack of seizures and coma.

2. Ornithine transcarbamylase deficiency: X-linked urea cycle disorder that can cause delayed development, lethargy, hypoglycemia, hyperammonemia, and respiratory alkalosis in severe cases. Usually no elevated citrulline.

3. Methylmalonic acidemia: Can present with delayed development, hypotonia, lethargy, hypoglycemia, and hyperammonemia. Respiratory alkalosis and elevated citrulline are less common. Typically also have metabolic acidosis.

4. Propionic acidemia: Similar presentation to methylmalonic acidemia with delayed development, hypotonia, lethargy, hypoglycemia, and hyperammonemia. Respiratory alkalosis and elevated citrulline would be unusual. Metabolic acidosis is typical.

5. Argininosuccinic aciduria: Another urea cycle disorder causing delayed development, hypotonia, lethargy, hypoglycemia, and hyperammonemia. Elevated citrulline is characteristic. Respiratory alkalosis may occur, but metabolic acidosis is more common.",Hereditary metabolic disorders
['Glutaryl-CoA dehydrogenase deficiency'],"1. Glutaryl-CoA dehydrogenase deficiency: The patient's macrocephaly, seizures, hypotonia, movement disorder, glutaric aciduria, and death in infancy are all consistent with this diagnosis. The key diagnostic finding of glutaric aciduria is present.

2. Propionic acidemia: Can also present in infancy with hypotonia, seizures, movement disorders, and early death. However, the patient would be expected to have propionic aciduria rather than glutaric aciduria.

3. Methylmalonic acidemia: Another organic acidemia that can have a similar clinical presentation in infancy, but should result in elevated methylmalonic acid rather than glutaric aciduria.

4. Canavan disease: A leukodystrophy that presents in early infancy with macrocephaly, hypotonia, and seizures. However, Canavan disease is not associated with organic aciduria or movement disorders.

5. Alexander disease: Another leukodystrophy that can present with macrocephaly, seizures, and hypotonia in infancy. Also does not cause organic aciduria. MRI findings are usually more suggestive of Alexander disease compared to Canavan disease.",Hereditary metabolic disorders
['Tyrosinemia type 1'],"1. Tyrosinemia type I: Characterized by hypertyrosinemia, 4-hydroxyphenylpyruvic aciduria, liver dysfunction, and risk of early death if untreated. The patient's delayed development and elevated delta-aminolevulinic acid are also consistent, though less specific.

2. Tyrosinemia type II: Also features hypertyrosinemia and 4-hydroxyphenylpyruvic aciduria, but liver function is typically normal. Can cause developmental delays and eye problems. Less likely than type I given the patient's early death.

3. Phenylketonuria (PKU): A disorder of phenylalanine metabolism leading to elevated phenylalanine levels and developmental delay/intellectual disability if untreated. However, PKU does not typically cause hypertyrosinemia or elevated urinary organic acids.

4. Hawkinsinuria: A rare disorder of tyrosine metabolism associated with hypertyrosinemia, metabolic acidosis, and failure to thrive in infancy. However, hawkinsinuria is not usually fatal and is not associated with elevated delta-aminolevulinic acid.

5. Alkaptonuria: Caused by a defect in tyrosine degradation, leading to buildup of homogentisic acid. Features include dark urine, early-onset arthritis, and heart valve problems. However, alkaptonuria does not typically cause cognitive delays or elevated blood phenylalanine, and is less likely to result in childhood death.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Tyrosinemia type I: Characterized by hypertyrosinemia, elevated urinary carboxylic acids, and risk of early death. Other key features like liver dysfunction and renal tubular dysfunction were not mentioned.

2. Hawkinsinuria: A disorder of tyrosine metabolism that can present with failure to thrive, metabolic acidosis, and hypertyrosinemia. However, the degree of hypertyrosinemia is usually mild.

3. Infantile Salla disease: A lysosomal storage disorder that can present with hypotonia, failure to thrive, and early death. Obesity has been reported. However, the amino acid and organic acid abnormalities are not typical.

4. Glutaric acidemia type I: Can present with hypotonia, failure to thrive, and early death. Elevated urinary carboxylic acids are a key feature. However, hypertyrosinemia and hyperphenylalaninemia are not typical.  

5. 3-hydroxy-3-methylglutaryl-CoA lyase deficiency: Can present in infancy with hypotonia, failure to thrive, and risk of early death. Organic aciduria and hyperammonemia are key features. Hypertyrosinemia and hyperphenylalaninemia would be less typical.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Tyrosinemia type II: This diagnosis is consistent with the patient's intellectual disability, hypertyrosinemia, and elevated urinary carboxylic acid. Other supporting features include the hyperactivity and potential for early death. However, seizures and obesity are not typically associated.

2. Phenylketonuria (PKU): The patient's intellectual disability, seizures, and hyperphenylalaninemia fit with PKU. Severe cases can involve early death. However, the hypertyrosinemia, short stature and obesity are not classic features.

3. Hawkinsinuria: This rare disorder of tyrosine metabolism could explain the hypertyrosinemia, intellectual disability, failure to thrive, and metabolic acidosis. However, it is not typically associated with seizures, obesity, or early death.

4. Alkaptonuria: The patient's shortened lifespan, intellectual disability and elevated urinary carboxylic acid could fit with this disorder. However, it does not usually present with seizures, developmental delays or amino acid abnormalities.

5. 4-Hydroxyphenylpyruvate dioxygenase deficiency: This disorder could account for the hypertyrosinemia, intellectual disability, seizures and elevated carboxylic acids. However, it is not classically associated with obesity or early death.",Hereditary metabolic disorders
['Vitamin B12-unresponsive methylmalonic acidemia'],"1. Methylmalonic acidemia, mut(0) type: Presents with the patient's symptoms of seizures, hypotonia, metabolic acidosis, hyperammonemia, and methylmalonic aciduria. Can be fatal in infancy without treatment.

2. Methylmalonic acidemia due to cobalamin disorders (cblA, cblB, cblC, cblD): Similar presentation to mut(0) type with methylmalonic acidemia/aciduria, hypotonia, seizures, and risk of infant death. Additional features like leukopenia and thrombocytopenia may be seen.

3. Propionic acidemia: Another organic acidemia that can present in infancy with poor feeding, vomiting, hypotonia, seizures, and lethargy progressing to coma. Lab findings include metabolic acidosis, hyperammonemia, leukopenia, thrombocytopenia, and ketoacidosis.

4. Holocarboxylase synthetase deficiency: A disorder of biotin metabolism causing seizures, hypotonia, skin rash, alopecia, and metabolic acidosis in infancy. Organic acid analysis may show elevated methylcitrate in addition to methylmalonic aciduria.

5. Succinyl-CoA ligase deficiency: A mitochondrial disorder that can present with methylmalonic aciduria, hypotonia, metabolic acidosis, hyperammonemia, and Leigh-like neuroimaging findings. Symptom onset and severity may be variable.",Hereditary metabolic disorders
['Medium chain acyl-CoA dehydrogenase deficiency'],"1. Carnitine palmitoyltransferase I deficiency: Consistent with abnormal carnitine levels and severe neonatal presentation. Key features not reported include hypoketotic hypoglycemia and hepatomegaly.

2. Carnitine-acylcarnitine translocase deficiency: Can cause abnormal carnitine levels and severe symptoms in newborns. Other typical features include cardiomyopathy, hypoglycemia, and hyperammonemia.

3. Glutaric acidemia type II: A disorder of fatty acid oxidation that can have a severe neonatal onset with abnormal carnitine levels. Additional findings may include hypoglycemia, metabolic acidosis, and ""sweaty feet"" odor.

4. Glycogen storage disease type IV: A glycogen storage disorder that can cause abnormalities in prenatal development and be fatal in infancy. Carnitine levels may be affected secondarily.

5. Pyruvate dehydrogenase deficiency: Can present with lactic acidosis and abnormalities of prenatal development. Typical features also include hypotonia, seizures, and structural brain abnormalities.",Hereditary metabolic disorders
['Vitamin B12-unresponsive methylmalonic acidemia'],"1. Methylmalonic acidemia: Consistent with methylmalonic aciduria, hyperammonemia, metabolic acidosis, vomiting and death in infancy. A key diagnostic finding not mentioned is elevated propionylcarnitine (C3) on newborn screening.

2. Propionic acidemia: Can also cause methylmalonic aciduria along with the other symptoms. Urine organic acids would show elevated 3-hydroxypropionate and propionylglycine to differentiate it from methylmalonic acidemia.

3. Vitamin B12 deficiency: Severe vitamin B12 deficiency in infancy can cause methylmalonic aciduria and the other symptoms described. Serum vitamin B12 levels would be low.

4. Transcobalamin II deficiency: A defect in vitamin B12 transport causing methylmalonic aciduria and symptoms similar to vitamin B12 deficiency despite normal B12 levels. Transcobalamin II levels would be low.

5. Methylmalonyl-CoA epimerase deficiency: A rare defect in the racemization of methylmalonyl-CoA causing methylmalonic aciduria and similar symptoms to methylmalonic acidemia. Complementation studies or genetic testing is needed to diagnose this.",Hereditary metabolic disorders
['Ornithine transcarbamylase deficiency'],"1. Ornithine transcarbamylase deficiency: Consistent with hyperammonemia, seizures, cerebral edema, and early death. Oroticaciduria can be seen. X-linked inheritance, so more common in males.

2. Citrullinemia type I: Also features hyperammonemia, neurological symptoms, and risk of neonatal death. Oroticaciduria and increased plasma citrulline are characteristic.

3. Carbamoyl phosphate synthetase I deficiency: Another urea cycle disorder causing severe hyperammonemia and early lethality. Oroticaciduria may be less prominent than in OTC deficiency or citrullinemia.

4. Argininosuccinic aciduria: Urea cycle disorder with hyperammonemia, neurological damage, and early mortality risk. Oroticaciduria and increased argininosuccinic acid are key findings.

5. Hyperornithinemia-hyperammonemia-homocitrullinuria (HHH) syndrome: Rare urea cycle-related disorder that can present with hyperammonemia and neurological symptoms in infancy. Oroticaciduria is not typically seen, however.",Hereditary metabolic disorders
['Biotinidase deficiency'],"1. Glutaric acidemia type 1: This disorder fits well with the patient's seizures, hypotonia, growth delay, and elevated urinary carboxylic acid. Alopecia and fasciculations are not typically reported. 

2. Propionic acidemia: The patient's symptoms align with this organic acidemia, including seizures, hypotonia, growth delay, and risk of infant death. Additional symptoms like vomiting and lethargy are not mentioned.

3. Methylmalonic acidemia: Similar to propionic acidemia, this condition could explain the neurological symptoms, growth issues, and metabolic abnormalities. Alopecia is not a classic feature.

4. Canavan disease: This leukodystrophy matches the patient's seizures, hypotonia, growth delay, and early death. However, it would not cause elevated urinary carboxylic acid. Macrocephaly is a key feature not reported here.

5. Menkes disease: This copper transport disorder fits the patient's neurological deterioration, growth failure, and early death. Alopecia is a classic symptom. However, urinary carboxylic acid is not typically elevated, and additional features like hypothermia and skin laxity are absent.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Alström syndrome: Characterized by childhood obesity, hypercholesterolemia, and early death. Does not fully explain the hypertyrosinemia and hyperphenylalaninemia.

2. Tyrosinemia type I: Explains the hypertyrosinemia and can lead to early death if untreated. Does not account for the obesity and hypercholesterolemia.

3. Phenylketonuria (PKU): Causes hyperphenylalaninemia and can lead to intellectual disability and other complications if untreated. Not typically associated with obesity, hypercholesterolemia, or early death.

4. Lysosomal acid lipase deficiency: Leads to accumulation of cholesterol and triglycerides, hepatomegaly, and liver failure. Can explain the hypercholesterolemia and early death, but not the hypertyrosinemia and hyperphenylalaninemia.

5. Niemann-Pick disease type B: Causes accumulation of sphingomyelin leading to hepatosplenomegaly, hypercholesterolemia, and lung disease. Does not fully align with the hypertyrosinemia, hyperphenylalaninemia, and early death.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Tyrosinemia type I: Hypertyrosinemia, liver failure, renal dysfunction, death in infancy. Key symptom not reported: Liver disease.

2. Phenylketonuria (PKU): Hyperphenylalaninemia, intellectual disability if untreated. Key symptom not reported: Musty body odor.

3. Zellweger spectrum disorder: Craniofacial abnormalities, liver dysfunction, early death, hernia. Key symptom not reported: Hypotonia.

4. Smith-Lemli-Opitz syndrome: Hypospadias, intellectual disability, failure to thrive, short stature. Key symptom not reported: Syndactyly.

5. Molybdenum cofactor deficiency: Neonatal seizures, severe developmental delay, hypertyrosinemia, early death. Key symptom not reported: Seizures.",Hereditary metabolic disorders
['Smith-Lemli-Opitz syndrome'],"1. Smith-Lemli-Opitz syndrome: The patient's microcephaly, intellectual disability, motor and speech delays, syndactyly, and elevated 8-dehydrocholesterol and 7-dehydrocholesterol levels are all consistent with this diagnosis. The severe phenotype with death in infancy or childhood is also suggestive.

2. Cornelia de Lange syndrome: The patient's craniofacial features (low-set ears, wide nasal bridge), growth retardation, and intellectual disability could fit this syndrome. However, the biochemical findings and some of the other features (e.g., syndactyly) are atypical.

3. Coffin-Siris syndrome: The intellectual disability, speech delay, and some of the craniofacial features could be consistent with this diagnosis. However, other characteristic features (e.g., hypoplastic nails, sparse scalp hair) were not reported, and the biochemical findings are not typical.

4. Peroxisomal biogenesis disorder (e.g., Zellweger syndrome): While this group of disorders can cause intellectual disability, motor delays, craniofacial dysmorphism, and early death, the patient's specific pattern of features and biochemical findings are less consistent with this diagnosis.

5. Chromosomal disorder (e.g., microdeletion syndrome): A chromosomal abnormality could explain the patient's multiple congenital anomalies and developmental delays. However, the specific combination of features and biochemical findings make a single gene disorder like Smith-Lemli-Opitz syndrome more likely.",Hereditary metabolic disorders
['Glutaryl-CoA dehydrogenase deficiency'],"1. Glutaryl-CoA dehydrogenase deficiency: The patient's ataxia, opisthotonus, athetosis, progressive neurologic deterioration, glutaric aciduria, elevated circulating glutaric acid, decreased plasma carnitine, and abnormal acylcarnitines are all consistent with this diagnosis. Key features not reported include macrocephaly and subdural hemorrhages.

2. Canavan disease: This disorder could explain the patient's ataxia, early death, and progressive neurologic deterioration. However, the specific metabolic abnormalities seen in this patient are not typical of Canavan disease.

3. Leigh syndrome: The neurological deterioration, ataxia, and early death fit with Leigh syndrome, but this condition is not usually associated with glutaric aciduria or carnitine/acylcarnitine abnormalities.

4. Propionic acidemia: Like glutaryl-CoA dehydrogenase deficiency, propionic acidemia is an inherited metabolic disorder that can cause severe neurological symptoms, metabolic acidosis, and early death. However, it is typically associated with ketoacidosis and hyperammonemia rather than glutaric aciduria.

5. Methylmalonic acidemia: Another inherited metabolic disorder that can present similarly to glutaryl-CoA dehydrogenase deficiency, but would be expected to cause methylmalonic aciduria rather than glutaric aciduria.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Phenylketonuria (PKU): Characterized by hyperphenylalaninemia, intellectual disability, motor delay, and hypotonia. The severe, untreated form can lead to early death. However, PKU does not typically cause hip dysplasia or other congenital abnormalities.

2. Tyrosinemia type I: Features hypertyrosinemia, liver dysfunction, renal tubular dysfunction, and neurological symptoms. Can present with motor delay, hypotonia, and failure to thrive. Untreated cases may result in early death. Congenital abnormalities are not a common feature.

3. Tyrosinemia type II (Richner-Hanhart syndrome): Causes hypertyrosinemia, intellectual disability, motor delay, and hypotonia. Patients may also have eye and skin abnormalities. However, it is not typically associated with congenital malformations or early death.

4. Tyrosinemia type III: A rare disorder characterized by hypertyrosinemia, intellectual disability, motor delay, and hypotonia. Like tyrosinemia type II, it does not usually cause structural abnormalities or early death.

5. Hawkinsinuria: An inherited disorder of tyrosine metabolism that can present with failure to thrive, metabolic acidosis, and liver dysfunction. However, it is not known to cause the other symptoms seen in this patient, such as congenital abnormalities, hip dysplasia, or early death.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Phenylketonuria: Characterized by hyperphenylalaninemia, intellectual disability, seizures, and hypotonia. The patient's shortened lifespan suggests a severe form. Hypertyrosinemia is not typically seen.

2. Tyrosine hydroxylase deficiency: Causes infantile parkinsonism-dystonia and hypotonia due to impaired dopamine synthesis. Elevated blood phenylalanine and tyrosine levels are seen. However, the patient's congenital anomalies and short lifespan are atypical.  

3. Dihydropteridine reductase (DHPR) deficiency: Impairs regeneration of tetrahydrobiopterin, a cofactor in phenylalanine and tyrosine metabolism. Causes hyperphenylalaninemia, hypertyrosinemia, seizures, hypotonia, and early death. Matches the patient's presentation well.

4. Aromatic L-amino acid decarboxylase (AADC) deficiency: Leads to deficient synthesis of dopamine and serotonin. Characterized by hypotonia, opisthotonus, apnea, and oculogyric crises. Elevated tyrosine levels are seen, but hyperphenylalaninemia would be unusual.

5. Sepiapterin reductase deficiency: Disrupts tetrahydrobiopterin synthesis, affecting neurotransmitter production. Causes hypotonia, intellectual disability, and oculogyric crises. Elevated phenylalanine and tyrosine levels can occur. However, seizures and shortened lifespan are not typical features.",Hereditary metabolic disorders
['Tyrosinemia type 1'],"Based on the provided symptoms, the top 5 potential diagnoses are:

1. Phenylketonuria (PKU): The combination of intellectual disability, seizures, autistic behavior, and hyperphenylalaninemia is highly suggestive of PKU, an aminoacidopathy caused by phenylalanine hydroxylase deficiency. However, additional symptoms like self-mutilation and early death are atypical.

2. Tyrosinemia type I: The patient's neurological symptoms, failure to thrive (low iron), and hypertyrosinemia fit with this disorder of tyrosine metabolism. Tyrosinemia type I can cause severe liver disease, explaining the elevated alkaline phosphatase. Untreated, it often leads to early death.

3. Maple syrup urine disease (MSUD): This disorder of branched-chain amino acid metabolism can present with intellectual disability, seizures, metabolic decompensation, and early mortality. The abnormal alanine and aspartate levels may reflect the underlying biochemical defect. However, the patient's hyperactivity and self-injurious behavior are less typical of MSUD.

4. Glutaric aciduria type I: While intellectual disability, motor delay, and early death are consistent with glutaric aciduria type I, this organic acidemia is characterized more by dystonia and basal ganglia degeneration rather than the autistic behavior and self-mutilation seen here. Urine organic acids would be expected to show elevated glutaric acid.

5. Lesch-Nyhan syndrome: The combination of intellectual disability, self-injurious behavior, and hyperuricemia (which can present similarly to hypertyrosinemia) matches the classic triad of Lesch-Nyhan syndrome, an X-linked disorder of purine metabolism. However, the additional metabolic abnormalities and early mortality are not typical features.",Hereditary metabolic disorders
['Classic galactosemia'],"1. Classic galactosemia: Characterized by hypergalactosemia, vomiting, jaundice with increased total bilirubin, and high risk of neonatal death if untreated. The patient had all of these features.

2. Tyrosinemia type 1: Can present with vomiting, jaundice, and liver failure leading to neonatal death. However, hypergalactosemia would not be expected.

3. Urea cycle disorders (e.g. OTC deficiency): Often present with vomiting, lethargy progressing to coma, and hyperammonemia in the neonatal period. Total bilirubin may be increased but hypergalactosemia is not a feature.  

4. Organic acidemias (e.g. propionic acidemia): Can cause poor feeding, vomiting, lethargy, and metabolic acidosis in neonates. Death can occur from complications like cardiomyopathy. Hypergalactosemia would be unusual.

5. Neonatal hemochromatosis: Causes liver failure and death in neonatal period, with increased total bilirubin. However, hypergalactosemia and vomiting are not typical features.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Tyrosinemia type I: Characterized by abnormal prenatal development, high neonatal mortality, hyperphenylalaninemia, and elevated tyrosine. Other key features not reported include liver dysfunction, renal tubular dysfunction, and peripheral neuropathy.

2. Phenylketonuria: Could explain the hyperphenylalaninemia and abnormal tyrosine but would not typically cause neonatal death or congenital abnormalities.

3. Neonatal liver failure: Various etiologies including galactosemia, neonatal hemochromatosis, and congenital infections could cause abnormal prenatal development, neonatal death, and liver dysfunction leading to abnormal amino acids. However, the pattern of phenylalanine and tyrosine elevation is more suggestive of a primary aminoacidopathy.

4. Neonatal adrenoleukodystrophy: Peroxisomal disorder that can present with neonatal death, hypotonia, seizures, and liver dysfunction. Elevated very long chain fatty acids would be expected rather than abnormal amino acids.

5. Zellweger syndrome: Severe peroxisomal biogenesis disorder characterized by congenital malformations, profound hypotonia, seizures, and early lethality. Can have liver dysfunction and some amino acid abnormalities but usually not the specific pattern seen here.",Hereditary metabolic disorders
['Biotinidase deficiency'],"Based on the provided symptoms, the top 5 potential diagnoses are:

1. Carnitine palmitoyltransferase II deficiency: Characterized by obesity, hypoglycemia, liver dysfunction, elevated creatine kinase, and low carnitine levels. Can be fatal in severe infantile form.

2. Medium-chain acyl-CoA dehydrogenase deficiency: Presents with obesity, hypoglycemia, vomiting, lethargy, and sudden death in childhood. Abnormal acylcarnitine profile.

3. Carnitine-acylcarnitine translocase deficiency: Causes early-onset obesity, hypoglycemia, cardiomyopathy, liver dysfunction, and high mortality. Low free carnitine but elevated acylcarnitines.

4. Glutaric acidemia type 2: Multiple acyl-CoA dehydrogenase deficiency leading to obesity, metabolic acidosis, hypoglycemia, ""sweaty feet"" odor, and early death. Abnormal acylcarnitine profile.

5. Carnitine transporter deficiency: Presents with obesity, cardiomyopathy, hypoglycemia, and muscle weakness. Very low blood and tissue carnitine levels. Can be fatal in childhood.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Tyrosinemia type I: Characterized by hypertyrosinemia, hyperphenylalaninemia, intellectual disability, and high mortality in untreated patients. The patient's prenatal onset and death in infancy/adolescence are consistent with the severe form of this disorder.

2. Phenylketonuria: Can cause hyperphenylalaninemia and intellectual disability if untreated. However, this patient's hypertyrosinemia and early death are not typical features.

3. Tyrosinemia type II: Presents with hypertyrosinemia and intellectual disability, but is generally less severe than type I and does not typically cause hyperphenylalaninemia or early death.

4. Hawkinsinuria: A rare disorder of tyrosine metabolism that can cause hypertyrosinemia and metabolic acidosis. However, it is usually milder than tyrosinemia type I and does not cause hyperphenylalaninemia.

5. Transient tyrosinemia of the newborn: A benign condition characterized by temporarily elevated tyrosine levels in newborns. However, it does not cause intellectual disability, hyperphenylalaninemia, or early death, making it an unlikely diagnosis for this patient.",Hereditary metabolic disorders
['Smith-Lemli-Opitz syndrome'],"1. Smith-Lemli-Opitz syndrome: The patient's congenital anomalies, intellectual disability, failure to thrive, and elevated 7-dehydrocholesterol are classic features. The condition does not usually include recurrent viral infections.

2. Chromosomal disorder: Some features like intellectual disability, microcephaly, low-set ears and cryptorchidism could fit, but this would not explain the elevated dehydrocholesterol levels. 

3. Peroxisomal disorder: The hypotonia, failure to thrive, and intellectual disability could fit, but skin rashes and elevated dehydrocholesterol would be unusual. Patients often have liver dysfunction and vision loss.

4. Congenital disorder of glycosylation: The combination of multiple congenital anomalies, failure to thrive, hypotonia, and eye findings could fit, but the elevated dehydrocholesterol points away from this group of disorders.

5. Inborn error of bile acid synthesis: Some forms can have intellectual disability, failure to thrive, and liver disease. However, the specific pattern of congenital anomalies and elevated dehydrocholesterol would be atypical.",Hereditary metabolic disorders
['Canavan disease'],"1. Mitochondrial disorder: Generalized hypotonia, cerebral atrophy, hyporeflexia, death in infancy. Key symptoms not reported: elevated lactate, specific MRI abnormalities.

2. Lysosomal storage disorder (e.g., Tay-Sachs disease, Niemann-Pick disease): Generalized hypotonia, cerebral atrophy, strabismus, death in infancy. Key symptom not reported: cherry-red spot on retinal exam.

3. Congenital disorder of glycosylation (CDG): Generalized hypotonia, strabismus, cerebral atrophy, death in infancy. Key symptom not reported: failure to thrive.

4. Amino acid metabolism disorder (e.g., PKU, MSUD): Generalized hypotonia, intellectual disability (implied by cerebral atrophy), abnormal amino acid levels. Key symptoms not reported: seizures, specific MRI findings. Less likely given cerebral atrophy and death in infancy.

5. Epileptic encephalopathy (e.g., early infantile epileptic encephalopathy, Ohtahara syndrome): Cerebral atrophy, death in infancy, generalized hypotonia. Key symptom not reported: seizures/epilepsy.",Hereditary metabolic disorders
['Phenylketonuria'],"Based on the provided symptoms, the top 5 potential diagnoses are:

1. Tyrosinemia type I: This disorder is characterized by hypertyrosinemia, liver dysfunction, renal tubular dysfunction, and risk of early death. The patient's hypertyrosinemia and early deaths fit with this diagnosis. Additional symptoms not reported include liver failure, rickets, and neurological crises.

2. Phenylketonuria (PKU): The patient's hyperphenylalaninemia suggests PKU, an disorder of phenylalanine metabolism. Untreated PKU can cause intellectual disability, seizures, and behavioral problems. However, the early deaths and heart defect are not typical of PKU alone.

3. Maple syrup urine disease (MSUD): MSUD is a disorder of branched-chain amino acid metabolism that can present with poor feeding, lethargy, vomiting, seizures, and a maple syrup odor to the urine. The patient's metabolic abnormalities and risk of early death could fit with severe MSUD. However, the specific amino acids elevated in MSUD (leucine, isoleucine, valine) were not reported.

4. Homocystinuria: Disorders of homocysteine metabolism can cause intellectual disability, skeletal abnormalities, eye problems, and increased risk of blood clots and early death. The patient's early deaths could fit, but the amino acid abnormalities and congenital heart defect are not classic for homocystinuria.

5. Glutaric acidemia type I: This organic acid disorder can present with macrocephaly, dystonia, and risk of metabolic crises that can be life-threatening. The recurrent infections and early deaths could fit with this diagnosis. However, the amino acid abnormalities and heart defect are not typical of glutaric acidemia type I.",Hereditary metabolic disorders
['Homocystinuria due to cystathionine beta-synthase deficiency'],"1. Homocystinuria due to cystathionine beta-synthase deficiency: Consistent with hyperhomocystinemia, hypermethioninemia, and early death. Other typical features like lens dislocation, skeletal abnormalities, and thromboembolism were not reported.

2. Methionine adenosyltransferase deficiency: Can present with hypermethioninemia, abnormal prenatal development, and neonatal death. Hyperhomocystinemia would be less expected.

3. Adenosylhomocysteine hydrolase deficiency: Rare disorder that can have hypermethioninemia, hyperhomocystinemia, abnormal development, and early death.

4. Glycine N-methyltransferase deficiency: Causes hypermethioninemia and can have aminoaciduria, but is usually a benign condition, so early death would be atypical. 

5. 5,10-methylenetetrahydrofolate reductase deficiency: Can cause hyperhomocystinemia and neurological abnormalities, but hypermethioninemia and aminoaciduria are not typical features. Early death is possible in severe cases.",Hereditary metabolic disorders
[],"1. Dihydropyrimidine dehydrogenase deficiency: Characterized by ataxia, hypotonia, intellectual disability, and abnormal uracil and thymine levels. The patient's ataxia, hypotonia, and uraciluria are consistent, though intellectual disability was not specifically mentioned.

2. Dihydropyrimidinase deficiency: Presents with ataxia, hypotonia, seizures, and excessive uracil and dihydrouracil excretion. Matches the patient's ataxia, hypotonia and uraciluria. Seizures were not reported but may develop over time.

3. Beta-ureidopropionase deficiency: Features include intellectual disability, hypotonia, ataxia, and abnormal pyrimidine metabolites in urine. Aligns with the patient's presentation, but the specific metabolites may differ from the other two conditions.

4. Hereditary orotic aciduria: Causes growth retardation, intellectual disability, ataxia, and elevated orotic acid. Some overlap in symptoms, but the patient's uraciluria suggests a defect further downstream in the pathway.

5. Mitochondrial DNA depletion syndrome: Can manifest with hypotonia, ataxia, and childhood death, but does not typically involve abnormal pyrimidine metabolism. Less likely given the patient's metabolic abnormalities.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Tyrosinemia type I: Characterized by hypertyrosinemia, hyperphenylalaninemia, and early death due to liver failure or other complications if untreated. Additional features not reported include liver dysfunction, renal tubular dysfunction, and neurological crises.

2. Tyrosinemia type II: Causes hypertyrosinemia and elevated phenylalanine to a lesser degree. Usually milder course than type I. Key features not mentioned include eye and skin lesions.

3. Phenylketonuria (PKU): Severe cases can involve hyperphenylalaninemia and early death if untreated, but hypertyrosinemia is atypical. Other cardinal symptoms not reported are intellectual disability, seizures, and light pigmentation.

4. Alkaptonuria: Can cause hypertyrosinemia but does not typically involve hyperphenylalaninemia or early death. Characteristic features not mentioned include dark urine and ochronosis (bluish discoloration of connective tissue).

5. Hawkinsinuria: A rare disorder of tyrosine metabolism that can present with hypertyrosinemia and metabolic acidosis. However, it does not usually cause hyperphenylalaninemia or early death.",Hereditary metabolic disorders
[],"1. Dihydropyrimidine dehydrogenase deficiency: The patient's death in infancy, respiratory insufficiency, abnormal pyrimidine levels, and uraciluria are all consistent with this rare disorder of pyrimidine catabolism. Key features not reported include seizures, hypotonia, and hyperammonemia.

2. Ornithine transcarbamylase deficiency: This urea cycle disorder can cause neonatal hyperammonemia, respiratory alkalosis, and early death. However, it would not typically cause abnormal pyrimidine levels.

3. Carbamyl phosphate synthetase I deficiency: Like OTC deficiency, this proximal urea cycle disorder can present with neonatal hyperammonemia and respiratory distress. Pyrimidine levels would be expected to be normal.

4. Beta-ureidopropionase deficiency: This rare pyrimidine disorder causes accumulation of N-carbamyl-beta-amino acids and can present in infancy with neurological deterioration. It is less likely to be lethal in the neonatal period compared to dihydropyrimidine dehydrogenase deficiency.

5. Hereditary orotic aciduria: Deficiency of UMP synthase causes excessive excretion of orotic acid in urine. It can cause failure to thrive and developmental delay, but is less likely to cause neonatal death compared to the other conditions listed.",Hereditary metabolic disorders
['Tyrosinemia type 1'],"1. Tyrosinemia type 1: This inborn error of tyrosine metabolism fits well with the patient's hypertyrosinemia, liver dysfunction (hypoalbuminemia, elevated alkaline phosphatase), anemia, and risk of early death. The ascites and thrombocytosis could be secondary to liver disease.

2. Galactosemia: Another metabolic disorder that can present with liver dysfunction, aminoaciduria, anemia, and risk of neonatal death. However, the specific findings of hypertyrosinemia and elevated porphyrins are less typical.  

3. Severe combined immunodeficiency (SCID): This group of genetic immune disorders can present in infancy with failure to thrive, infections, and early death. It could explain the anemia and hernia, but would not account for all of the patient's lab abnormalities.

4. Neonatal hemochromatosis: A rare, severe liver disorder causing liver failure and death in infancy. It fits with the ascites, anemia, and liver dysfunction but is less likely given the prominent amino acid abnormalities.

5. Congenital erythropoietic porphyria: A rare porphyria that can present with hemolytic anemia, red urine, and liver dysfunction. The elevated porphyrins fit, but this diagnosis would not explain the aminoaciduria and hypertyrosinemia.",Hereditary metabolic disorders
['Canavan disease'],"1. Citrullinemia type I: Characterized by seizures, developmental delay, early mortality, and elevated circulating citrulline (an aspartate derivative). The patient's aspartate levels are not specified.

2. Argininosuccinic aciduria: Can present with seizures, intellectual disability, and elevated aspartate levels. However, the patient is not reported to have the characteristic elevated argininosuccinic acid or hyperammonemia.

3. Mitochondrial encephalomyopathy: The seizures, motor delay, and early death fit, and mitochondrial disorders can cause secondary amino acid abnormalities. However, characteristic symptoms like lactic acidosis, muscle weakness, or multi-organ dysfunction are not described.

4. Ohtahara syndrome: A severe epileptic encephalopathy with seizures, developmental delay, and early mortality, but would not typically cause isolated aspartate elevation.

5. Molybdenum cofactor deficiency: Can present with neonatal seizures, severe developmental delay, and early death. May cause sulfite and S-sulfocysteine accumulation but not typically isolated aspartate elevation.",Hereditary metabolic disorders
['Isovaleric acidemia'],"1. Propionic acidemia: Consistent with early death, gastrointestinal symptoms, abnormal glycine, and body odor. Can also have immunodeficiency.

2. Methylmalonic acidemia: Similar presentation to propionic acidemia with early death, GI symptoms, and metabolic abnormalities.

3. Urea cycle disorder (e.g. ornithine transcarbamylase deficiency): The hyperammonemia in urea cycle disorders can cause early death, vomiting, and altered mental status. Abnormal glycine levels can be seen.

4. Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency: A fatty acid oxidation disorder that can present with early death, hypoglycemia, vomiting, and lethargy, often triggered by illness. Can have abnormal carnitine levels.

5. Mitochondrial disorder (e.g. pyruvate dehydrogenase deficiency): Can cause early death, lactic acidosis, gastrointestinal symptoms, and metabolic abnormalities. Immunodeficiency is sometimes seen.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Tyrosinemia type II: Characterized by hypertyrosinemia, intellectual disability, and elevated urinary carboxylic acids. However, hyperphenylalaninemia and early death are not typical features.

2. Hawkinsinuria: A disorder of tyrosine metabolism causing hypertyrosinemia, metabolic acidosis, and failure to thrive in infancy. Intellectual disability and death in adolescence/early adulthood are not commonly reported.

3. Phenylketonuria: Causes hyperphenylalaninemia and intellectual disability if untreated, but not typically associated with hypertyrosinemia, hypertension, obesity, or elevated urinary carboxylic acids.

4. 3-Hydroxy-3-methylglutaryl-CoA lyase deficiency: A disorder of leucine metabolism and ketogenesis that can present with hyperphenylalaninemia, metabolic acidosis, hyperammonemia, and hypoketotic hypoglycemia. However, it does not usually cause hypertyrosinemia or death in adolescence/early adulthood.

5. 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency: A disorder of isoleucine metabolism that can cause intellectual disability, hypotonia, and metabolic acidosis. However, it is not typically associated with hyperphenylalaninemia, hypertyrosinemia, hypertension, or obesity.",Hereditary metabolic disorders
['Medium chain acyl-CoA dehydrogenase deficiency'],"1. Propionic acidemia: Consistent with small for gestational age, neonatal death, hyperalaninemia, and abnormal carnitine levels. Other common features not reported include metabolic acidosis, ketosis, hyperammonemia, and developmental delay.

2. Methylmalonic acidemia: Matches the reported neonatal death, hyperalaninemia, and abnormal carnitine. Additional characteristic symptoms include metabolic acidosis, ketosis, hyperammonemia, neutropenia, and developmental delay.

3. Maple syrup urine disease: Aligns with the neonatal presentation, death in infancy/childhood, and hyperalaninemia. Classic symptoms also involve poor feeding, lethargy, metabolic decompensation, urine with sweet burnt sugar smell, and intellectual disability in survivors.

4. Pyruvate dehydrogenase complex deficiency: Fits with prenatal growth abnormalities, neonatal/infantile death, and elevated alanine. Other hallmarks include congenital brain malformations, hypotonia, seizures, and lactic acidosis.

5. Glutaric acidemia type 1: Although less likely given lack of reported neurologic symptoms, could explain the prenatal abnormalities, hyperalaninemia, and potential for infantile death. Typical presentation involves macrocephaly, dystonia, and striatal injury.",Hereditary metabolic disorders
['Ornithine transcarbamylase deficiency'],"1. Ornithine transcarbamylase deficiency: Lethargy, death in infancy, oroticaciduria, and abnormal ornithine levels are consistent with this urea cycle disorder. Key features not reported include hyperammonemia, respiratory alkalosis, and low citrulline.

2. Citrullinemia type I: The patient's presentation with lethargy, infant mortality, and biochemical abnormalities could fit this disorder of the urea cycle. However, the diagnostic markers of elevated citrulline and arginine were not specifically mentioned.

3. Argininosuccinic aciduria: Another urea cycle defect that can present similarly with lethargy, hyperammonemia, and early death. Defining features would be elevated argininosuccinic acid and anhydrides in the urine.

4. Carbamoyl phosphate synthetase I deficiency: The lethargy, mortality, and likely hyperammonemia fit this diagnosis, although the expected findings of very low citrulline and elevated glutamine are not reported.

5. Propionic acidemia: While not a urea cycle disorder, this organic acidemia can also present in infancy with lethargy, metabolic decompensation, and early death if untreated. Diagnostic markers would include metabolic acidosis, ketosis, hyperammonemia, and elevated propionylcarnitine.",Hereditary metabolic disorders
['Glutaryl-CoA dehydrogenase deficiency'],"1. Glutaryl-CoA dehydrogenase deficiency: The patient's ataxia, dystonia, abnormal cerebral morphology, glutaric aciduria, and death in childhood are all consistent with this diagnosis. The decreased plasma carnitine also fits. Key features not mentioned include macrocephaly and subdural hemorrhage.

2. Canavan disease: This leukodystrophy could explain the patient's abnormal cerebral morphology, abnormal myelination, and early death. However, glutaric aciduria would not be expected, and ataxia/dystonia are not typical.

3. Propionic acidemia: Another organic acidemia that can present with neurological symptoms, metabolic abnormalities, and risk of childhood death. However, glutaric aciduria is not a feature, and the brain abnormalities are less specific.

4. Methylmalonic acidemia: Similar to propionic acidemia, this could cause neurological deterioration and metabolic changes, but would not account for the glutaric aciduria. Renal dysfunction is also common but not reported here.

5. 3-Methylglutaconic aciduria type I: A rare disorder that can involve neurological symptoms, metabolic abnormalities, and childhood mortality. 3-methylglutaconic acid is typically elevated rather than glutaric acid. The specific brain findings noted are less likely.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Phenylketonuria (PKU): Hyperphenylalaninemia is the key finding. Severe, untreated cases can lead to neonatal/infantile death. Patient's symptoms fit this diagnosis.

2. Tetrahydrobiopterin deficiency: Can present similarly to PKU with hyperphenylalaninemia. Additional biochemical abnormalities in pterins and neurotransmitters would be expected. More information needed.

3. DNAJC12-deficient hyperphenylalaninemia: A rare disorder of tetrahydrobiopterin metabolism leading to hyperphenylalaninemia and neurological deterioration. Could fit patient's presentation.

4. Maternal phenylketonuria: Maternal PKU during pregnancy can lead to severely affected offspring with microcephaly, intellectual disability, and congenital heart defects. Unclear if this matches patient's presentation. Mother's PKU status would need to be checked.

5. Tyrosinemia type I: Another inborn error of metabolism that can present with severe, early-onset liver failure and death. However, hyperphenylalaninemia is not typical. Less likely than PKU and its variants in this case.",Hereditary metabolic disorders
['Systemic primary carnitine deficiency'],"1. Propionic acidemia: Consistent with the encephalopathy, hypotonia, cardiomyopathy, hypoglycemia, and abnormal amino acid levels. Propionic acid and other diagnostic organic acids would likely be elevated in urine.

2. Methylmalonic acidemia: Another organic acidemia that could explain the neurological, cardiac, hematologic and metabolic abnormalities. Methylmalonic acid would be elevated.

3. Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency: A fatty acid oxidation disorder that can present with hypoglycemia, lethargy, hepatomegaly and elevated liver enzymes. The decreased carnitine level is consistent. An acylcarnitine profile would likely show a characteristic pattern.

4. Ornithine transcarbamylase (OTC) deficiency: A urea cycle disorder that can cause encephalopathy, hypotonia and hyperammonemia (not mentioned but important to check). Amino acid abnormalities are common.

5. Mitochondrial disorder (e.g. Leigh syndrome): The multisystem involvement, including neurological, cardiac and metabolic abnormalities, could be explained by a mitochondrial disorder. Lactic acid level and mitochondrial DNA testing may provide clues. Leigh syndrome in particular is associated with early mortality.",Hereditary metabolic disorders
['PMM2-CDG'],"1. PMM2-CDG (CDG-Ia): Cerebellar hypoplasia, strabismus, hypotonia, developmental delay, failure to thrive. Key features not reported include inverted nipples and abnormal fat distribution.

2. COG7-CDG: Hypotonia, developmental delay, failure to thrive, cerebellar atrophy, dysmorphic features. Hepatomegaly and jaundice were not mentioned in this patient.

3. SEPSECS-CDG: Cerebellar atrophy, ataxia, nystagmus, hypotonia, psychomotor retardation, microcephaly. Spasticity and seizures were not reported.

4. Joubert syndrome: Cerebellar vermis hypoplasia, hypotonia, developmental delay, abnormal eye movements, breathing abnormalities. The characteristic ""molar tooth sign"" on brain imaging was not described.

5. Pontocerebellar hypoplasia: Cerebellar hypoplasia, progressive microcephaly, developmental delay, seizures, chorea. No mention of microcephaly, seizures or abnormal movements in this case.",Hereditary metabolic disorders
['Homocystinuria due to cystathionine beta-synthase deficiency'],"1. Homocystinuria due to cystathionine beta-synthase deficiency: Myopia, ectopia lentis, intellectual disability, hyperhomocystinemia, and hypermethioninemia are all consistent with this diagnosis. The early mortality also fits. Key symptom not reported is skeletal abnormalities.

2. Methionine adenosyltransferase deficiency: Could explain the intellectual disability, hypermethioninemia, and early death. However, eye findings and hyperhomocystinemia are not typical of this condition.

3. Sulfite oxidase deficiency: The intellectual disability, early mortality, and metabolic abnormalities could fit, but this condition is not typically associated with ectopia lentis or myopia. Would expect to see seizures.

4. Molybdenum cofactor deficiency: Similar to sulfite oxidase deficiency, the neurological symptoms and early death could match, but eye findings are atypical. Seizures would be expected.

5. Nonketotic hyperglycinemia: Could explain the intellectual disability and early mortality, but would not expect to see eye abnormalities or elevations of homocysteine and methionine. Glycine levels would be high.",Hereditary metabolic disorders
['Ornithine transcarbamylase deficiency'],"1. Ornithine transcarbamylase deficiency: Seizures, lethargy, hyperammonemia, and early death are consistent with this urea cycle disorder. Oroticaciduria is a key finding. Ataxia and hyperreflexia are additional neurological signs that can occur.

2. Citrullinemia type I: Another urea cycle disorder that can present with seizures, lethargy, hyperammonemia, and early death. Oroticaciduria may be present. Ataxia is not typically a prominent feature.

3. Argininosuccinic aciduria: A third urea cycle disorder to consider, given the patient's hyperammonemia, seizures, and risk of early death. Oroticaciduria is often present. Additional symptoms like intellectual disability and trichorrhexis nodosa (abnormal hair) are not reported in this case.

4. Carbamoyl phosphate synthetase I deficiency: The most severe urea cycle disorder, often presenting with neonatal hyperammonemic coma and early death. Seizures, lethargy, and metabolic acidosis fit, but oroticaciduria would be absent. Considering the later onset in this patient, CPS1 deficiency is less likely.

5. Pyruvate dehydrogenase complex deficiency: A mitochondrial disorder that can cause seizures, ataxia, lethargy, and metabolic acidosis. Hyperammonemia and oroticaciduria are not typical features, making this diagnosis less likely than the urea cycle disorders. Lactic acidosis would be expected but is not reported here.",Hereditary metabolic disorders
['Smith-Lemli-Opitz syndrome'],"1. Smith-Lemli-Opitz syndrome: Microcephaly, intellectual disability, syndactyly, failure to thrive, elevated 7-dehydrocholesterol and 8-dehydrocholesterol levels. Other supportive features include the pointed chin, short chin, strabismus, ptosis, hypotonia, and feeding difficulties.

2. Chromosomal disorder (e.g., trisomy 13, 18, or deletion syndrome): Microcephaly, intellectual disability, multiple congenital anomalies, failure to thrive, feeding difficulties, and hypotonia. Specific features would depend on the specific chromosomal abnormality.

3. Zellweger spectrum disorder (peroxisomal biogenesis disorder): Microcephaly, intellectual disability, hypotonia, failure to thrive, and feeding difficulties. May also have hepatic dysfunction and vision/hearing impairment, which were not mentioned in this patient.

4. Congenital disorder of glycosylation: Microcephaly, intellectual disability, failure to thrive, hypotonia, and feeding difficulties. Additional features may include seizures, abnormal fat pads, inverted nipples, and liver dysfunction.

5. Rubinstein-Taybi syndrome: Microcephaly, intellectual disability, short stature, feeding difficulties, and hypotonia. Characteristic facial features include downslanted palpebral fissures, broad thumbs and great toes, and beaked nose with columella extending below nares, which were not specifically mentioned in this patient.",Hereditary metabolic disorders
['Glycogen storage disease due to glycogen debranching enzyme deficiency'],"1. Mitochondrial DNA depletion syndrome: The combination of hypotonia, hepatomegaly, lactic acidosis, and early death fits this diagnosis. The abnormal circulating amino acids and elevated CK could also be seen. Key features not reported include developmental delay and seizures.

2. Propionic acidemia: An organic acidemia that could explain the hypotonia, high lactate, hepatomegaly, and early death. Would expect to see metabolic acidosis, hyperammonemia, and ketosis.

3. Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency: A fatty acid oxidation disorder that can present with hypoglycemia, lethargy, hepatomegaly, and high CK. Hypertriglyceridemia is not typical.

4. Ornithine transcarbamylase (OTC) deficiency: A urea cycle defect leading to hyperammonemia, encephalopathy, respiratory alkalosis, and early death. Hepatomegaly and the specific metabolic findings are less common.

5. Pompe disease (glycogen storage disease type II): A lysosomal storage disorder characterized by hypotonia, cardiomegaly, hepatomegaly, and elevated CK. Lactic acidosis and abnormal amino acids would be unusual.",Hereditary metabolic disorders
['Glutaryl-CoA dehydrogenase deficiency'],"1. Glutaric acidemia type 1: The patient's glutaric aciduria, microcephaly, cerebral atrophy, movement disorder, and early death are all consistent with this diagnosis. Key symptoms not reported include macrocephaly and subdural hematomas, which can also occur in this condition.

2. Canavan disease: This disorder could explain the patient's microcephaly, hypotonia, cerebral atrophy, and early death. However, Canavan disease typically causes macrocephaly rather than microcephaly, and would not be expected to cause glutaric aciduria.

3. Leigh syndrome: The patient's neurological abnormalities, hypotonia, and early death could fit with Leigh syndrome, a mitochondrial disorder. However, the specific finding of glutaric aciduria would be unusual.

4. Alpers syndrome: This disorder of mitochondrial DNA replication could cause the microcephaly, cerebral atrophy, and early death seen in this patient. However, it would not typically cause glutaric aciduria or movement disorders.

5. Zellweger syndrome: This peroxisomal biogenesis disorder can cause microcephaly, hypotonia, cerebral atrophy, and early death. However, it is not typically associated with glutaric aciduria, and would be expected to cause additional symptoms like liver dysfunction and facial dysmorphism.",Hereditary metabolic disorders
['Propionic acidemia'],"1. Glycine encephalopathy: Characterized by hyperglycinemia, hyperglycinuria, hyperammonemia, and early death. The patient's symptoms are all consistent with this diagnosis.

2. Propionic acidemia: Can present with hyperammonemia, hyperglycinemia, vomiting, and early death. Elevated urinary carboxylic acid also fits, but hyperalaninemia is less typical.

3. Methylmalonic acidemia: Another organic acidemia that can cause hyperammonemia, metabolic crisis, and early death. Hyperglycinemia and hyperalaninemia can sometimes be seen.

4. Urea cycle disorders (e.g. CPS1 deficiency, OTC deficiency): Often present with hyperammonemia, vomiting, and early death. Hyperglycinemia and ichthyosis would be less common features.

5. Nonketotic hyperglycinemia: A disorder specifically of glycine degradation causing hyperglycinemia and hyperglycinuria. However, this patient's hyperammonemia and ichthyosis are atypical findings.",Hereditary metabolic disorders
['Succinic semialdehyde dehydrogenase deficiency'],"1. Glutaric acidemia type 1: Characterized by intellectual disability, motor delay, macrocephaly, abnormal urinary organic acids. However, the abnormal facial features are less typical.

2. Canavan disease: Features intellectual disability, motor delay, macrocephaly, death in childhood, and elevated urinary N-acetylaspartic acid. Dysmorphic features are not a major finding.

3. L-2-hydroxyglutaric aciduria: Causes intellectual disability, motor delay, seizures, and elevated urinary L-2-hydroxyglutaric acid. Facial dysmorphism is not commonly reported.

4. D-2-hydroxyglutaric aciduria: Presents with intellectual disability, hypotonia, seizures, and dysmorphic facial features. Urinary D-2-hydroxyglutaric acid is elevated.

5. 3-Methylglutaconic aciduria: A group of disorders featuring intellectual disability, abnormal urinary 3-methylglutaconic acid, and variable dysmorphic features. Specific facial features and early death are more prominent in some subtypes.",Hereditary metabolic disorders
['Classic galactosemia'],"1. Classic galactosemia: Caused by galactose-1-phosphate uridylyltransferase deficiency, leading to toxic buildup of galactose. Consistent with the patient's intellectual disability, hepatic failure, hypergalactosemia, and risk of neonatal death. Does not typically cause premature birth.

2. Tyrosinemia type 1: Caused by fumarylacetoacetate hydrolase deficiency, leading to buildup of tyrosine and toxic metabolites. Can present with intellectual disability, liver failure, and early death. Associated amino acid abnormalities would be expected. Less likely given the galactose abnormalities.

3. Niemann-Pick disease type C: Lysosomal storage disorder causing abnormal cholesterol and glycolipid storage. Can present with developmental delay, intellectual disability, and liver disease. Galactose abnormalities are not typical. Onset is usually later in childhood.

4. Zellweger spectrum disorder: Peroxisomal biogenesis disorder causing abnormal very long chain fatty acid accumulation. Can present with developmental delay, intellectual disability, liver dysfunction, and early death. Galactose and amino acid abnormalities are not typical.

5. CDG syndrome type Ia: Most common congenital disorder of glycosylation. Can present with developmental delay, intellectual disability, liver dysfunction, and failure to thrive. Galactose and amino acid abnormalities are not typical. Inverted nipples and abnormal fat pads are common.",Hereditary metabolic disorders
['Neonatal intrahepatic cholestasis due to citrin deficiency'],"1. Citrullinemia type I: Consistent with neonatal onset, hyperammonemia, elevated citrulline, and early death. A key urea cycle disorder to consider.

2. Argininosuccinic aciduria: Another urea cycle disorder that can present similarly with hyperammonemia, elevated citrulline, and early mortality. Would expect to see argininosuccinic acid on further testing.

3. Pyruvate carboxylase deficiency: A disorder of energy metabolism that can cause congenital lactic acidosis, hyperammonemia, elevated citrulline, and early death. Additional findings may include hypoglycemia and ketosis.

4. Ornithine transcarbamylase deficiency: The most common urea cycle disorder, X-linked. Males tend to be more severely affected, with hyperammonemia and early mortality. Elevated glutamine and alanine rather than citrulline.

5. Carbamoyl phosphate synthetase I deficiency: A severe urea cycle disorder with neonatal hyperammonemia, often lethal in the first days of life. Citrulline would be low or absent, distinguishing it from citrullinemia.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Tyrosinemia type I: Characterized by hypertyrosinemia, recurrent infections, and early mortality if untreated. The patient's hypertyrosinemia and immunodeficiency are consistent, but hyperphenylalaninemia and porphyrin abnormalities are not typical features.

2. Phenylketonuria (PKU): Can present with hyperphenylalaninemia and intellectual disability, but not typically associated with severe immunodeficiency, porphyrin abnormalities, or death in infancy/childhood.

3. Methylmalonic acidemia: An organic acidemia that can cause recurrent infections, developmental delay, and early mortality. Elevated urinary organic acids are consistent, but this condition is not primarily associated with hypertyrosinemia or porphyrin abnormalities.

4. Propionic acidemia: Another organic acidemia with features similar to methylmalonic acidemia. Also not typically associated with hypertyrosinemia or abnormal porphyrins.

5. Erythropoietic porphyria: A disorder of heme synthesis characterized by abnormal porphyrins and photosensitivity. Does not typically cause hypertyrosinemia, hyperphenylalaninemia, severe immunodeficiency or early mortality.",Hereditary metabolic disorders
['Maple syrup urine disease'],"1. Maple syrup urine disease (MSUD): The patient's lethargy, hypotonia, tremor, opisthotonus, elevated leucine, and body odor are all consistent with this disorder. The early death also fits with the classic severe form of MSUD.

2. Isovaleric acidemia: This organic acidemia can also present with lethargy, hypotonia, odor, and neurological symptoms in the neonatal period. However, the characteristic odor is typically described as ""sweaty feet"" rather than maple syrup.

3. Propionic acidemia: Another organic acid disorder that can cause lethargy, hypotonia, and death in infancy. Key features not reported include hyperammonemia, ketoacidosis, and elevated glycine.

4. Methylmalonic acidemia: Similar to propionic acidemia, this condition can present with lethargy, hypotonia, and severe metabolic decompensation in infancy. Methylmalonic acid would be elevated in urine.

5. Urea cycle disorders (e.g., CPS1 deficiency, OTC deficiency): These disorders typically present with lethargy, hypotonia, and respiratory alkalosis due to hyperammonemia. However, the absence of reported hyperammonemia and the presence of elevated leucine and odor make this group of disorders less likely.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Tyrosinemia type I: consistent with hypertyrosinemia, hypotonia, and death in infancy. Would expect liver and kidney dysfunction.

2. Zellweger spectrum disorder: consistent with hypotonia, early death, anemia, and abnormal amino acid and vitamin metabolism. Would expect liver dysfunction and dysmorphic features.

3. Phenylketonuria (PKU): consistent with hyperphenylalaninemia. However, symptoms seem more severe than typical PKU.

4. Mitochondrial disorder: could explain hypotonia, anemia, metabolic abnormalities, and early death. Would expect lactic acidosis and other organ dysfunction.

5. Congenital disorder of glycosylation: a group of disorders that can cause a wide range of symptoms including hypotonia, failure to thrive, liver dysfunction, and metabolic abnormalities. Transferrin testing could help evaluate this possibility.",Hereditary metabolic disorders
['Smith-Lemli-Opitz syndrome'],"1. Smith-Lemli-Opitz syndrome: Consistent with the patient's hypertelorism, anteverted nares, syndactyly, intellectual disability, motor and speech delays, seizures, hypocholesterolemia, and elevated dehydrocholesterol levels. The severe phenotype with early death is also suggestive.

2. Peroxisomal disorder (e.g., Zellweger spectrum disorder): Could explain the intellectual disability, hearing impairment, and multi-system involvement. However, lacking key features like hepatic dysfunction and the characteristic biochemical abnormalities are not reported.

3. Congenital disorder of glycosylation: The multi-system presentation could fit, but the patient is missing typical features like failure to thrive, liver dysfunction, and abnormal transferrin glycosylation. The elevated dehydrocholesterol levels also point away from this diagnosis.

4. CHARGE syndrome: Some findings like intellectual disability, abnormal ear canals (if related to the hearing loss), and genital abnormalities (if present) could fit, but the biochemical profile is not consistent and other key features (e.g., coloboma, choanal atresia, cardiac defects) are not described.

5. Inborn error of bile acid synthesis: The intellectual disability and liver disease (if present, not clearly reported) could suggest this, and it can cause elevated atypical bile acids/sterols. However, it doesn't fit as well as SLOS and wouldn't be expected to cause the reported physical abnormalities.",Hereditary metabolic disorders
['Vitamin B12-unresponsive methylmalonic acidemia'],"1. Methylmalonic acidemia mut(0) type: The patient's microcephaly, developmental delays, failure to thrive, multiorgan dysfunction, metabolic acidosis, hyperammonemia, methylmalonic acidemia/aciduria, and decreased methylmalonyl-CoA mutase activity are all consistent with this severe form of methylmalonic acidemia. The life-threatening complications and early mortality are also characteristic.

2. Methylmalonic acidemia mut(-) type: While this milder form of methylmalonic acidemia could explain some of the patient's symptoms like developmental delays, growth issues, and metabolic abnormalities, the severity of this patient's presentation with early mortality is more consistent with mut(0) type.

3. Propionic acidemia: Another organic acidemia that can present similarly with poor growth, developmental delays, metabolic crises, hyperammonemia, and multiorgan involvement. However, methylmalonic acid elevations are not expected, and the decreased methylmalonyl-CoA mutase activity points away from this diagnosis.

4. Cobalamin defects (cblA, cblB, cblC, cblD): These disorders can cause methylmalonic acidemia and present similarly to isolated methylmalonic acidemia. However, the presence of megaloblastic anemia, homocystinuria, and other findings not seen in this patient help differentiate these disorders.

5. Mitochondrial depletion syndrome: Certain mitochondrial disorders can present in infancy with growth failure, developmental delays, multisystem involvement, metabolic acidosis, and elevated lactate as seen in this patient. However, the methylmalonic acidemia and decreased methylmalonyl-CoA mutase activity are not typical of mitochondrial disorders.",Hereditary metabolic disorders
[],"1. Dihydropyrimidine dehydrogenase deficiency: Characterized by ataxia, hypotonia, lethargy, seizures, and abnormal uracil metabolism. Consistent with the patient's neurological symptoms, uraciluria, and abnormal pyrimidine levels.

2. Beta-ureidopropionase deficiency: Features include neurological deterioration, hypotonia, seizures, and abnormal pyrimidine metabolism with elevated uracil. Matches the patient's presentation, though specific symptoms like ataxia are not always reported.

3. Dihydropyrimidinase deficiency: Causes neurological symptoms, seizures, and excessive uracil excretion. Consistent with the patient's clinical picture, but the disorder is very rare.

4. Hereditary orotic aciduria: Presents with hypotonia, developmental delay, and orotic aciduria. Matches some of the patient's symptoms and involves pyrimidine metabolism, but ataxia and lethality are less common.

5. Mitochondrial DNA depletion syndrome: Can cause hypotonia, neurological symptoms, lactic acidosis, and early death. While it matches the patient's age of onset and some symptoms, specific involvement of pyrimidine metabolism would be atypical.",Hereditary metabolic disorders
['Isovaleric acidemia'],"1. Propionic acidemia: Consistent with hyperammonemia, early death, and abnormal glycine levels. Would expect other features like ketoacidosis, hypoglycemia, and abnormal urine organic acids.

2. Methylmalonic acidemia: Also fits the presentation of hyperammonemia, early death, and elevated glycine. Key additional findings would be methylmalonic acid in urine and specific acylcarnitine profile elevations.

3. Ornithine transcarbamylase deficiency: A urea cycle disorder that can present with hyperammonemia, abnormal prenatal development, and early death. Typically see low citrulline and elevated glutamine and alanine on plasma amino acids.

4. Carbamoyl phosphate synthetase I deficiency: Another urea cycle disorder with hyperammonemia, neonatal onset, and high mortality. Plasma amino acid profile may show decreased citrulline and arginine.

5. Isovaleric acidemia: An organic acidemia that can cause poor feeding, vomiting, lethargy, and hyperammonemia in the neonatal period. Characteristic odor may be present, and abnormal acylcarnitine profile and urine isovalerylglycine are seen.",Hereditary metabolic disorders
['Biotinidase deficiency'],"1. Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency: The patient's seizures, hypotonia, early death, and elevated urinary carboxylic acids are consistent with this fatty acid oxidation disorder. Key features not reported include hypoketotic hypoglycemia and acute metabolic decompensation triggered by illness or fasting.

2. Propionic acidemia: This disorder of amino acid catabolism could explain the patient's symptoms, including the elevated carboxylic acids. Additional findings may include metabolic acidosis, hyperammonemia, and ketosis.

3. Methylmalonic acidemia: Another amino acid disorder that shares features with propionic acidemia and could fit the patient's presentation. Specific elevations of methylmalonic acid in urine would be expected.

4. Leigh syndrome (mitochondrial disorder): The combination of seizures, hypotonia, and early death is consistent with this severe neurological condition caused by mitochondrial dysfunction. Elevated lactate and specific MRI brain abnormalities are often seen but were not reported here.

5. Glutaric acidemia type II: This is a rare metabolic disorder affecting fatty acid oxidation and amino acid catabolism that could explain the patient's symptoms. In addition to the reported findings, patients may have metabolic acidosis, hypoglycemia, and characteristic elevations of multiple acylcarnitine species.",Hereditary metabolic disorders
['Medium chain acyl-CoA dehydrogenase deficiency'],"1. Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (LCHAD deficiency): Consistent with delayed development, abnormal prenatal development, early death, decreased plasma carnitine and 3-hydroxyacyl-CoA dehydrogenase levels. 

2. Carnitine palmitoyltransferase II deficiency: Matches the decreased plasma carnitine, and the neonatal form can be fatal in infancy.

3. Very long-chain acyl-CoA dehydrogenase deficiency (VLCAD deficiency): Also a fatty acid oxidation disorder that presents in infancy with developmental delays and risk of sudden death. Decreased plasma carnitine is common.

4. Trifunctional protein deficiency: Another fatty acid oxidation disorder caused by mutations in the same gene as LCHAD deficiency (HADHA). Presents similarly with hypoglycemia, cardiomyopathy, liver disease, and early death.

5. Glutaric acidemia type II: A disorder of fatty acid and amino acid metabolism characterized by hypoglycemia, metabolic acidosis, ""sweaty feet"" odor, and often neonatal death. Organic aciduria and low carnitine levels are seen.",Hereditary metabolic disorders
['Maple syrup urine disease'],"1. Maple syrup urine disease: This aminoacidopathy fits well with the patient's presentation of neonatal encephalopathy, seizures, hypotonia, metabolic acidosis, feeding difficulties, and the classic ""maple syrup"" body odor. The elevated branched-chain amino acids (valine, leucine, isoleucine) are diagnostic.

2. Propionic acidemia: Another organic acidemia that can present in the neonatal period with poor feeding, hypotonia, seizures, and life-threatening episodes of metabolic acidosis and hyperammonemia. Opisthotonus and spasticity are sometimes seen.

3. Methylmalonic acidemia: Similar presentation to propionic acidemia, with neonatal onset of lethargy, hypotonia, seizures, metabolic acidosis, and high ammonia levels. Can progress to coma and death if untreated.

4. Isovaleric acidemia: Can present acutely in the neonatal period with vomiting, lethargy, hypotonia, seizures, and the characteristic ""sweaty feet"" odor. Labs show metabolic acidosis and hyperammonemia.

5. Glutaric acidemia type 1: Usually presents a bit later in infancy (3-18 months) with hypotonia, spasticity, and dystonia following an infection. Macrocephaly is common. Neonatal presentation is rarer but can occur, with hypotonia, seizures, and acidosis.",Hereditary metabolic disorders
['Propionic acidemia'],"1. Propionic acidemia: Characterized by intellectual disability, osteoporosis, anemia, hyperammonemia, cerebral atrophy, kyphoscoliosis, body odor, and early death. Key diagnostic finding would be elevated urinary 3-hydroxypropionate.

2. Methylmalonic acidemia: Shares many features with propionic acidemia including intellectual disability, anemia, osteoporosis, hyperammonemia, and early death. Elevated urinary methylmalonic acid is diagnostic.

3. Isovaleric acidemia: Can present with psychosis, intellectual disability, anemia, osteoporosis, and a characteristic ""sweaty feet"" odor. Elevated urinary isovaleric acid and isovalerylglycine are seen.

4. Glutaric acidemia type 1: Associated with intellectual disability, osteoporosis, cerebral atrophy, and early death. Elevated urinary glutaric acid and 3-hydroxyglutaric acid are diagnostic.

5. Multiple carboxylase deficiency (biotinidase deficiency): Can cause intellectual disability, seizures, hearing loss, osteoporosis, and metabolic acidosis. Low biotinidase enzyme activity and elevated urinary 3-hydroxyisovaleric acid and methylcitric acid are seen.",Hereditary metabolic disorders
['L-2-hydroxyglutaric aciduria'],"1. L-2-hydroxyglutaric aciduria: The patient's intellectual disability, seizures, ataxia, tremor, and L-2-hydroxyglutaric aciduria are all consistent with this diagnosis. The early childhood death further supports a severe form of the disorder.

2. Glutaric aciduria type 1: While this disorder can present with intellectual disability, seizures, and movement abnormalities, the specific finding of L-2-hydroxyglutaric aciduria makes it less likely. Key features like macrocephaly and dystonia are also not reported in this patient.

3. Mitochondrial encephalomyopathy: Certain mitochondrial disorders can cause intellectual disability, seizures, ataxia, and early death. However, the L-2-hydroxyglutaric aciduria is not a typical finding. Other features like muscle weakness, ptosis, or hearing loss are not mentioned.

4. Canavan disease: This leukodystrophy can present with intellectual disability, seizures, and early death, but ataxia and tremor are less common. The biochemical hallmark is elevated N-acetylaspartic acid, rather than L-2-hydroxyglutaric aciduria.

5. D-2-hydroxyglutaric aciduria: While this disorder can cause intellectual disability, seizures, and ataxia, it is distinguished biochemically from L-2-hydroxyglutaric aciduria. The clinical course is also typically less severe, with survival into adulthood in many cases.",Hereditary metabolic disorders
['Canavan disease'],"1. Canavan disease: Characterized by motor delay, early death, and elevated levels of N-acetylaspartic acid (an aspartate derivative) in the blood and urine. Other common symptoms like macrocephaly and leukodystrophy were not reported in this patient.

2. Methylmalonic acidemia: Can present with motor delay, metabolic decompensation, and early death. Typically associated with elevated levels of methylmalonic acid and other abnormal metabolites, but aspartate levels may also be affected secondarily.

3. Propionic acidemia: Another organic acidemia that can cause motor delay, metabolic crises, and early death. As with methylmalonic acidemia, aspartate levels may be abnormal in addition to the primary metabolites like propionic acid and 3-hydroxypropionic acid.

4. Argininosuccinic aciduria: A urea cycle disorder that leads to the accumulation of argininosuccinic acid (which includes aspartate in its structure) and other amino acids. Can present with motor delay, hyperammonemia, and early death, but additional symptoms like seizures and hepatomegaly were not mentioned.

5. Mitochondrial encephalomyopathy: A group of disorders caused by defects in mitochondrial energy production. Can present with motor delay, neurological deterioration, and early death. Abnormal amino acid levels, including aspartate, may be seen due to impaired mitochondrial function in various tissues. However, more specific findings like lactic acidosis and specific enzyme deficiencies are usually needed to diagnose these conditions.",Hereditary metabolic disorders
['Citrullinemia type I'],"1. Citrullinemia type I: Characterized by hyperammonemia, elevated citrulline, and often early death. The patient's symptoms of neonatal death and hyperammonemia are consistent with this diagnosis.

2. Argininosuccinic aciduria: Another urea cycle disorder that can present with hyperammonemia, elevated citrulline, and early death. However, the patient's bilirubin is not a typical finding.

3. Pyruvate carboxylase deficiency: Can cause lactic acidosis, hyperammonemia, and early death. Elevated citrulline is sometimes seen. Additional symptoms like hypoglycemia and seizures were not reported in this patient.

4. Neonatal hemochromatosis: A rare disorder causing liver failure and death in infancy. It explains the increased bilirubin but is less likely given the patient's hyperammonemia and elevated citrulline.

5. Transient neonatal hyperammonemia: A milder condition that can resolve spontaneously. Less likely given the patient's early death, but could be considered if other diagnoses are ruled out.",Hereditary metabolic disorders
['3-hydroxy-3-methylglutaric aciduria'],"1. 3-Methylglutaconic aciduria type I: Lethargy, hypoglycemia, metabolic acidosis, vomiting, diarrhea, hepatomegaly, dicarboxylic aciduria, 3-methylglutaric aciduria, death in infancy/childhood. Key missing symptom: dystonia.

2. Glutaric acidemia type II: Lethargy, hypoglycemia, metabolic acidosis, vomiting, hepatomegaly, dicarboxylic aciduria, death in infancy. Additional symptoms not reported: facial dysmorphism, cardiomyopathy, polycystic kidneys.

3. Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: Lethargy, hypoglycemia, hyperammonemia, vomiting, hepatomegaly, dicarboxylic aciduria, death in infancy. Missing symptom: hypoketotic hypoglycemia.

4. Propionic acidemia: Lethargy, metabolic acidosis, hypoglycemia, hyperammonemia, vomiting, hepatomegaly, death in infancy. Additional expected findings: ketoacidosis, hyperglycinemia, elevated propionylcarnitine.

5. Medium-chain acyl-CoA dehydrogenase deficiency: Lethargy, hypoglycemia, vomiting, hepatomegaly, dicarboxylic aciduria, death in infancy/childhood. Usually presents with hypoketotic hypoglycemia and no significant hyperammonemia.",Hereditary metabolic disorders
['Cystinuria'],"1. Fetal Gaucher disease: Consistent with splenomegaly, death in infancy, and respiratory insufficiency. Other symptoms that can occur include hepatomegaly, thrombocytopenia, and ichthyosis.

2. Niemann-Pick disease type A: Can present with splenomegaly, respiratory issues, failure to thrive, and early death, usually by 3 years old. Lacking the cherry-red spot of the macula that is characteristic.

3. Infantile GM1 gangliosidosis: Matches with seizures, hepatosplenomegaly, and early death. Additional symptoms may include coarse facial features, skeletal abnormalities, and developmental delay.

4. Severe mitochondrial disorder (e.g. pyruvate dehydrogenase deficiency, GRACILE syndrome): The combination of neurologic symptoms, organ dysfunction, and early mortality could fit. Would expect to see severe hypotonia, lactic acidosis, and possibly brain abnormalities.

5. Galactosialidosis (early infantile form): Presents with coarse facies, hepatosplenomegaly, skeletal abnormalities, and early death. Seizures can occur but are not a cardinal feature.",Hereditary metabolic disorders
['Vitamin B12-unresponsive methylmalonic acidemia'],"1. Methylmalonic acidemia: The patient's methylmalonic aciduria, intellectual disability, motor delay, hypotonia, hyperammonemia, and early death are all consistent with this disorder. The abnormal amino acid levels and decreased carnitine are also commonly seen.

2. Propionic acidemia: Another organic acidemia that can present similarly to methylmalonic acidemia, with methylmalonic aciduria, intellectual disability, hypotonia, hyperammonemia, and early death. The abnormal amino acid levels would also fit.

3. Cobalamin C deficiency: A disorder of cobalamin metabolism that leads to methylmalonic aciduria and hyperhomocysteinemia. It can cause intellectual disability, hypotonia, feeding difficulties, and early death. However, the patient's amino acid abnormalities are less typical.

4. Cobalamin A or B deficiency: These are other disorders of cobalamin metabolism leading to isolated methylmalonic aciduria. They tend to be less severe than cobalamin C deficiency but can still cause intellectual disability, hypotonia, and hyperammonemia.

5. Isovaleric acidemia: While the patient's methylmalonic aciduria does not fit with this organic acidemia, it can still cause intellectual disability, hypotonia, hyperammonemia, and early death. The abnormal amino acids could potentially fit. However, isovaleric acid would be expected in the urine organic acids.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Tyrosinemia type I: Characterized by hypertyrosinemia, elevated urinary succinylacetone (a carboxylic acid), and liver failure leading to death in infancy or childhood if untreated. Recurrent infections are not typical but may occur secondary to liver dysfunction.

2. Hawkinsinuria: A disorder of tyrosine metabolism causing hypertyrosinemia, metabolic acidosis, and excretion of hawkinsin (a cyclic amino acid) in urine. Can present with failure to thrive in infancy but recurrent infections are not a classic feature.

3. Phenylketonuria: Causes hyperphenylalaninemia and intellectual disability if untreated, but not typically associated with death in infancy/childhood or recurrent infections. Elevated urinary carboxylic acids are not characteristic.

4. Mevalonic aciduria: A disorder of cholesterol biosynthesis presenting with recurrent fevers, developmental delay, hypotonia, hepatosplenomegaly, and dysmorphic features. Associated with elevated urinary mevalonic acid (a carboxylic acid) but not typically with hypertyrosinemia or hyperphenylalaninemia.

5. Glutaric aciduria type I: Characterized by encephalopathic crises, macrocephaly, and elevated urinary glutaric acid (a dicarboxylic acid). Not classically associated with hypertyrosinemia, hyperphenylalaninemia, or recurrent viral infections.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Tyrosinemia type I: Characterized by hypertyrosinemia, hyperphenylalaninemia, intellectual disability, and early death if untreated. Patient's strabismus and congenital abnormalities are also consistent. Key symptom not reported is liver dysfunction.

2. Phenylketonuria (PKU): Causes hyperphenylalaninemia and intellectual disability, but hypertyrosinemia is atypical. Strabismus can occur. Early death is possible if untreated.

3. Hawkinsinuria: A rare disorder of tyrosine metabolism that can cause hypertyrosinemia, metabolic acidosis, and failure to thrive in infancy. However, it does not typically cause hyperphenylalaninemia or intellectual disability.  

4. Alkaptonuria: Involves hypertyrosinemia due to a defect in tyrosine metabolism, but hyperphenylalaninemia and intellectual disability are not typical features. Also does not usually cause early death.

5. Transient tyrosinemia of the newborn: A benign condition causing temporary elevations of tyrosine in newborns. Resolves on its own and does not cause hyperphenylalaninemia, intellectual disability, or early death.",Hereditary metabolic disorders
['Ornithine transcarbamylase deficiency'],"1. Ornithine transcarbamylase deficiency: Hyperammonemia, oroticaciduria, and vomiting are key features. Can present in infancy with severe symptoms and risk of death. Abnormal bleeding is not typically reported.

2. Citrullinemia type I: Another urea cycle disorder that can cause early-onset hyperammonemia, vomiting, and risk of death in infancy. Oroticaciduria may be seen. Additional symptoms like seizures and lethargy are common.

3. Argininosuccinic aciduria: Urea cycle disorder with infantile-onset hyperammonemia, vomiting, and risk of early death. Can have elevated orotic acid. Bleeding diathesis is a rare complication.

4. Carbamoyl phosphate synthetase I deficiency: Severe neonatal-onset urea cycle disorder with hyperammonemia, vomiting, and high mortality. Oroticaciduria is not expected.

5. Transient hyperammonemia of the newborn: Benign condition causing temporary elevations of ammonia in the neonatal period. Vomiting may occur but other symptoms like oroticaciduria and bleeding are not typical. Rapidly improves and is not fatal.",Hereditary metabolic disorders
['L-2-hydroxyglutaric aciduria'],"1. L-2-hydroxyglutaric aciduria: The patient's intellectual disability, generalized hypotonia, hyperreflexia, hyperammonemia, abnormal brain morphology and myelination, and childhood death are all consistent with this diagnosis. The finding of L-2-hydroxyglutaric acidemia is diagnostic.

2. Canavan disease: While this leukodystrophy can cause developmental delay, hypotonia, and abnormal cerebral white matter, it would not explain the hyperammonemia or L-2-hydroxyglutaric acidemia.

3. Ornithine transcarbamylase deficiency: This urea cycle defect can present with intellectual disability, hypotonia, hyperammonemia, and early death. However, it is not associated with L-2-hydroxyglutaric acidemia or the specific brain MRI abnormalities seen here.

4. Glutaric aciduria type 1: This organic acidemia causes intellectual disability, hypotonia, dyskinesia, and characteristic brain findings. However, it is not typically associated with hyperammonemia, and would show elevations of glutaric acid rather than L-2-hydroxyglutaric acid.

5. Nonketotic hyperglycinemia: While this disorder can cause intellectual disability, hypotonia, and seizures, it is not associated with hyperammonemia, L-2-hydroxyglutaric acidemia, or the described brain abnormalities. Patients typically have elevated CSF glycine.",Hereditary metabolic disorders
['PMM2-CDG'],"1. Zellweger spectrum disorder: Intellectual disability, cerebellar abnormalities, and early death are consistent with this peroxisomal biogenesis disorder. However, other typical features like dysmorphic facies and liver dysfunction were not reported.

2. Congenital disorder of glycosylation (CDG): CDGs can present with cerebellar hypoplasia, ataxia, stroke-like episodes, and intellectual disability. Thromboembolism has been reported in some cases. Additional symptoms like inverted nipples and abnormal fat pads would support this diagnosis.

3. Menkes disease: This copper transport disorder can cause intellectual disability, cerebellar atrophy, and early death. Seizures, hypotonia, and connective tissue abnormalities are also common but were not mentioned here.

4. Joubert syndrome: Cerebellar vermis agenesis, ataxia, and intellectual disability are key features of this ciliopathy. However, the ""molar tooth sign"" on brain MRI and other systemic involvement (e.g., retinal dystrophy, renal disease) are typically seen as well.

5. Maple syrup urine disease: This amino acid metabolism disorder can present with intellectual disability, ataxia, and stroke-like episodes due to cerebral edema. Absence of the characteristic sweet urine odor and other metabolic crisis symptoms (e.g., vomiting, lethargy) makes this less likely.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Tyrosinemia type I: Characterized by hypertyrosinemia, this disorder can present with severe liver dysfunction, renal tubular dysfunction, and neurological crises. Death in infancy is common if untreated. The patient's premature birth and neonatal death fit with the severe phenotype.

2. Hawkinsinuria: A rare disorder of tyrosine metabolism causing hypertyrosinemia and metabolic acidosis. Can present in the neonatal period with failure to thrive and metabolic decompensation. However, the presence of hyperphenylalaninemia is atypical.

3. Transient tyrosinemia of the newborn: A benign condition causing hypertyrosinemia in the neonatal period, usually resolving without treatment. However, the severity of this patient's presentation with premature birth and death is not consistent with this diagnosis.

4. Tyrosinemia type II: Characterized by hypertyrosinemia and ocular/skin findings, but usually not life-threatening in infancy. The patient's neonatal death makes this less likely.

5. Phenylketonuria: A disorder of phenylalanine metabolism causing hyperphenylalaninemia and intellectual disability if untreated. Severe neonatal presentation with premature birth and death would be unusual. The presence of hypertyrosinemia is also atypical.",Hereditary metabolic disorders
['Propionic acidemia'],"1. Propionic acidemia: Consistent with intellectual disability, seizures, hypotonia, lethargy, vomiting, hyperammonemia, leukopenia, abnormal amino acid levels. Key symptom not reported is metabolic acidosis.

2. Methylmalonic acidemia: Matches the neurological symptoms, lethargy, vomiting, hyperammonemia, elevated glycine and alanine. Metabolic acidosis and methylmalonic acid in urine would be expected.

3. Isovaleric acidemia: Could explain intellectual disability, hypotonia, vomiting, hyperammonemia, leukopenia. Sweaty foot odor is a classic symptom not mentioned.

4. Citrullinemia type 1: A urea cycle defect that aligns with the neurological impairment, lethargy, vomiting, hyperammonemia, and early death. Elevated citrulline would be a key finding.

5. Argininosuccinic aciduria: Another urea cycle disorder matching the intellectual disability, seizures, hypotonia, hyperammonemia, and early mortality. Elevated argininosuccinic acid is diagnostic.",Hereditary metabolic disorders
['Wilson disease'],"1. Wilson disease: Characterized by elevated liver enzymes, low ceruloplasmin and copper levels, and risk of death from liver failure in adolescence or early adulthood if untreated. Polydipsia is not a classic symptom but could result from liver dysfunction.

2. TMEM199-CDG: A congenital disorder of glycosylation that can present with elevated liver enzymes, low ceruloplasmin, and low copper levels. However, this patient's death in adolescence and lack of other characteristic symptoms like intellectual disability make it less likely.

3. Chronic liver disease (e.g. hepatitis C, autoimmune hepatitis): Can cause elevated liver enzymes and liver failure but would not typically cause low blood copper levels.

4. Menkes disease: An X-linked disorder of copper transport that leads to low copper and ceruloplasmin levels. However, it usually presents in infancy with developmental delay, seizures, and abnormal hair, which this patient does not have. Death also typically occurs in early childhood.

5. Aceruloplasminemia: A very rare inherited disorder that causes an absence of ceruloplasmin and iron overload. It would cause low blood copper but not elevated liver enzymes, and neurological symptoms typically present in adulthood.",Hereditary metabolic disorders
['Ornithine transcarbamylase deficiency'],"1. Ornithine transcarbamylase deficiency: This is the most common urea cycle disorder, characterized by hyperammonemia, seizures, lethargy, vomiting, and early death. Oroticaciduria is a key finding. The patient's symptoms fit this diagnosis well.

2. Carbamoyl phosphate synthetase I deficiency: Another urea cycle disorder with similar symptoms to ornithine transcarbamylase deficiency, including hyperammonemia, lethargy, seizures, and death in infancy. Hyperglutaminemia is often seen.

3. Citrullinemia type I: A third urea cycle disorder to consider, also presenting with hyperammonemia, neurological symptoms, vomiting and early death. Plasma citrulline would be elevated.

4. Argininosuccinic aciduria: While the patient's oroticaciduria and hyperglutaminemia are not typical of this condition, it is still a possibility given the overall symptom profile. Elevated argininosuccinic acid in the urine would be expected.

5. Pyruvate dehydrogenase complex deficiency: Moving away from urea cycle disorders, this is a disorder of energy metabolism that can present in infancy with seizures, hypotonia, lethargy, and vomiting. Lactic acidosis would be an additional finding to support this diagnosis.",Hereditary metabolic disorders
['Classic galactosemia'],"1. Classic galactosemia: Characterized by microcephaly, intellectual disability, developmental delays, hypotonia, and feeding difficulties in infancy. Caused by deficiency of galactose-1-phosphate uridylyltransferase. Key finding is hypergalactosemia.

2. Galactokinase deficiency: Can present similarly to classic galactosemia, but symptoms are usually milder. Characterized by hypergalactosemia and cataracts.

3. Galactose epimerase deficiency: Rare disorder that can present with hypotonia, poor feeding, and liver dysfunction. Can have hypergalactosemia and abnormal galactose metabolism.

4. Congenital disorder of glycosylation (CDG): Group of disorders causing developmental delays, hypotonia, failure to thrive, and various neurological symptoms. Some types can involve liver dysfunction and elevated alkaline phosphatase.

5. Zellweger spectrum disorder: Peroxisomal biogenesis disorder causing developmental delays, hypotonia, and liver dysfunction. Can present in infancy, but does not typically involve abnormalities of galactose metabolism.",Hereditary metabolic disorders
['Biotinidase deficiency'],"1. Urea cycle disorder: The patient's hyperammonemia and death in childhood are consistent with a severe urea cycle disorder. The abnormal foot morphology could be an associated developmental abnormality. Key features not reported include developmental delay, seizures, and coma.

2. Congenital disorder of glycosylation: The combination of obesity, abnormal foot morphology, and hyperammonemia could fit with a severe congenital disorder of glycosylation. Additional features that would support this diagnosis include failure to thrive, developmental delay, and abnormal brain imaging.

3. Mitochondrial disorder: A severe mitochondrial disorder could explain the patient's multiple abnormalities and death in childhood. Other symptoms that might be seen include muscle weakness, developmental regression, seizures, and lactic acidosis.

4. Prader-Willi syndrome: This condition is characterized by obesity and can be associated with abnormal foot morphology. However, hyperammonemia and death in childhood would be atypical. More commonly associated features include intellectual disability, hypotonia, and hypogonadism.

5. Smith-Lemli-Opitz syndrome: This disorder can cause obesity, abnormal foot morphology (e.g. 2-3 toe syndactyly), and potentially hyperammonemia in severe cases. The patient's death in childhood suggests a severe presentation. Other associated features include intellectual disability, microcephaly, and underdeveloped genitalia.",Hereditary metabolic disorders
['Canavan disease'],"1. Canavan disease: Consistent with hyperactivity, early death, feeding difficulties, and abnormal myelination on brain MRI. Would expect elevated N-acetylaspartic acid on urine organic acids.

2. Maple syrup urine disease: Can present with feeding difficulties, abnormal amino acids (leucine, isoleucine, valine), and early death if untreated. Abnormal myelination is not typical.

3. Phenylketonuria (PKU): Untreated PKU can cause hyperactivity, intellectual disability, and early death. Elevated phenylalanine levels would be expected. Abnormal myelination is not typical.

4. Nonketotic hyperglycinemia: Presents with feeding difficulties and early death. Elevated glycine levels in plasma and CSF. Can be associated with abnormal myelination.

5. Methylmalonic acidemia: Can present with feeding problems, intellectual disability, and early death. Elevated methylmalonic acid in urine organic acids. Abnormal myelination not typically seen.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Phenylketonuria (PKU): Abnormality of prenatal development, death in infancy, neonatal death, hyperphenylalaninemia. Key features not reported include intellectual disability, microcephaly, and fair skin/hair.

2. Tetrahydrobiopterin deficiency: Hyperphenylalaninemia, abnormality of prenatal development, neonatal death. Additional distinguishing symptoms include microcephaly, intellectual disability, seizures, and movement disorders.

3. Tyrosinemia type I: Death in infancy, abnormality of prenatal development. Hyperphenylalaninemia is not typically seen. Other key features include liver dysfunction, renal tubular dysfunction, and peripheral neuropathy.

4. Homocystinuria: Abnormality of prenatal development, death in infancy. Hyperphenylalaninemia is not expected. Additional symptoms may include Marfanoid habitus, intellectual disability, and thromboembolism.

5. Zellweger syndrome: Abnormality of prenatal development, neonatal death, hypotonia. Hyperphenylalaninemia would be unusual. Other characteristic features include distinctive facies, hepatomegaly, and renal cysts.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Tyrosinemia type I: Characterized by hypertyrosinemia, liver dysfunction, renal tubular dysfunction, and neurological crises if untreated. Consistent with the patient's hypertyrosinemia and early death.

2. Phenylketonuria (PKU): Causes hyperphenylalaninemia and severe intellectual disability if untreated. Matches the patient's hyperphenylalaninemia and developmental delays. PKU does not typically cause death in infancy/childhood if treated.

3. Tyrosinemia type II: Presents with hypertyrosinemia, corneal ulcers, and palmoplantar hyperkeratosis. Less likely given lack of eye/skin symptoms reported, and lower mortality than type I.

4. Hawkinsinuria: A rare disorder of tyrosine metabolism characterized by hypertyrosinemia, metabolic acidosis, and failure to thrive. Could explain the hypertyrosinemia but other key features not reported.

5. Alkaptonuria: Disrupts tyrosine degradation, causing darkened urine, ochronosis, and arthritis in adulthood. Unlikely given different symptom profile and later onset compared to this patient.",Hereditary metabolic disorders
[],"1. Zellweger spectrum disorder: Consistent with the patient's hypotonia, kidney problems, congenital heart defects, and early death. Other symptoms that can occur include distinctive facial features, hepatomegaly, and seizures.

2. Barth syndrome: The combination of cardiomyopathy, hypotonia, and early mortality fits, although this patient is not reported to have neutropenia or male gender, which are typical features.

3. Infantile sialic acid storage disease: Could explain the patient's hypotonia and early death. Would expect to see coarse facial features, hepatomegaly, and cardiomegaly as well.

4. Congenital disorder of glycosylation (CDG): A large group of disorders that can cause multi-system problems like failure to thrive, hypotonia, heart defects, and kidney problems. Facial dysmorphism, hepatic dysfunction, and developmental delay are also common.

5. Pompe disease (glycogen storage disease type II): The infantile-onset form is characterized by hypotonia, cardiomegaly, hepatomegaly, and early death, usually by age 1-2 years. Kidney problems are not a major feature.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Tyrosinemia type I: Hypertyrosinemia, neurological symptoms (irritability, spasticity, hyperreflexia), death in infancy/childhood. Key symptoms not reported: liver dysfunction, renal tubular dysfunction, growth failure.

2. Phenylketonuria (PKU): Hyperphenylalaninemia, neurological symptoms (irritability, spasticity, hyperreflexia), intellectual disability (not specifically mentioned). Does not fully explain immunodeficiency and early death.

3. Severe combined immunodeficiency (SCID): Recurrent viral infections, death in infancy. Does not directly explain neurological symptoms or metabolic abnormalities.

4. Biotinidase deficiency: Can cause neurological symptoms (irritability, spasticity, hyperreflexia), immunodeficiency, and if untreated, death in infancy/childhood. Specific metabolic abnormalities not reported.

5. Maple syrup urine disease: Can cause neurological symptoms (irritability, spasticity, hyperreflexia), metabolic abnormalities (though usually branched-chain amino acids), and if untreated, death in infancy/childhood. Immunodeficiency not typically seen.",Hereditary metabolic disorders
['Medium chain acyl-CoA dehydrogenase deficiency'],"1. Carnitine palmitoyltransferase I deficiency: Consistent with abnormal carnitine levels and severe neonatal presentation. Key features not reported include hypoketotic hypoglycemia and hepatomegaly.

2. Carnitine-acylcarnitine translocase deficiency: Can cause abnormal carnitine levels and severe symptoms in newborns. Other typical features include cardiomyopathy, hypoglycemia, and hyperammonemia.

3. Glutaric acidemia type II: A disorder of fatty acid oxidation that can have a severe neonatal onset with abnormal carnitine levels. Additional findings may include hypoglycemia, metabolic acidosis, and ""sweaty feet"" odor.

4. Glycogen storage disease type IV: A glycogen storage disorder that can cause abnormalities in prenatal development and be fatal in infancy. Carnitine levels may be affected secondarily.

5. Pyruvate dehydrogenase deficiency: Can present with lactic acidosis and abnormalities of prenatal development. Typical features also include hypotonia, seizures, and structural brain abnormalities.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Tyrosinemia type I: Characterized by hypertyrosinemia, liver dysfunction, renal tubular dysfunction, and neurological crises. Consistent with this patient's hypertyrosinemia, hypotonia, developmental delays, and early death.

2. Phenylketonuria: Causes hyperphenylalaninemia and severe intellectual disability if untreated. Matches the hyperphenylalaninemia but less likely given the severity of symptoms and early death.

3. Tyrosinemia type II: Also known as Richner-Hanhart syndrome. Presents with hypertyrosinemia, eye and skin lesions, and intellectual disability. Less likely given lack of eye/skin findings and more severe course.

4. Tyrosinemia type III: The mildest form, with hypertyrosinemia, intellectual disability, and ataxia. Onset is later in childhood. Unlikely given severity of this patient's presentation.

5. Hawkinsinuria: A rare disorder of tyrosine metabolism characterized by hypertyrosinemia, metabolic acidosis, and failure to thrive. Can be severe in untreated cases. Possible but less likely than tyrosinemia type I.",Hereditary metabolic disorders
['Glutaryl-CoA dehydrogenase deficiency'],"1. Glutaric acidemia type 1: The patient's seizures, encephalopathy, early death, glutaric aciduria, and elevated glutaric acid are all consistent with this diagnosis. Opisthotonus and secondary carnitine deficiency are also frequently seen.

2. Canavan disease: This leukodystrophy can cause seizures, encephalopathy, and early death. However, the specific organic acid abnormalities are not typical.

3. Leigh syndrome: This mitochondrial disorder can present with neurological deterioration, seizures, and early death. Organic acidemias can be a rare cause. However, the metabolite profile is more suggestive of glutaric acidemia.

4. Propionic acidemia: Another organic acidemia that can cause encephalopathy, seizures, and death. However, glutaric aciduria would not be expected.

5. Molybdenum cofactor deficiency: A rare cause of neonatal seizures and encephalopathy. Can be associated with sulfite oxidase deficiency and elevated sulfocysteine, but not the specific abnormalities seen here.",Hereditary metabolic disorders
[],"1. Menkes disease: Consistent with intellectual disability, seizures, hypotonia, fair/white hair, death in infancy. Key features not reported include abnormal connective tissue and occipital horn exostoses.

2. Krabbe disease (Globoid cell leukodystrophy): Matches with spastic diplegia/tetraplegia, seizures, motor delay, hypotonia, hearing loss, irritability. MRI to look for leukodystrophy and genetic testing for GALC mutations can confirm.

3. Canavan disease: Presents with intellectual disability, seizures, spasticity, hypotonia, macrocephaly (not reported). Urine organic acid analysis shows elevated N-acetylaspartic acid. 

4. Neuronal ceroid lipofuscinosis: Could explain seizures, intellectual decline, motor deterioration, early death. Lacks characteristic macular cherry-red spot and curvilinear bodies on electron microscopy of tissue biopsy.

5. Mitochondrial disorder (e.g. Leigh syndrome): Consider given motor delay, hypotonia, seizures, metabolic acidosis, respiratory and GI symptoms. Elevated lactate, abnormal mitochondria on muscle biopsy, and mutations in mitochondrial or nuclear genes involved in oxidative phosphorylation would support this.",Hereditary metabolic disorders
['PMM2-CDG'],"1. Niemann-Pick disease type C: This lysosomal storage disorder can cause cerebellar ataxia, intellectual disability, hepatosplenomegaly, and early death. The patient's neurological symptoms, liver disease, and childhood mortality fit this diagnosis.

2. Cerebrotendinous xanthomatosis: This lipid storage disorder can present with intellectual disability, ataxia, cerebellar atrophy, and hepatic dysfunction. However, the patient is missing key features like tendon xanthomas and cataracts.

3. Gaucher disease type 2: The acute neuronopathic form of this lysosomal disorder can cause strabismus, hypotonia, brain atrophy, hepatomegaly, and death in infancy. However, thrombocytopenia and bone involvement are not reported in this patient.

4. Zellweger spectrum disorder: This peroxisomal biogenesis disorder can cause intellectual disability, hypotonia, liver dysfunction, and early death. However, the patient lacks other typical features like facial dysmorphism, renal cysts, and stippled epiphyses.

5. Alpha-1 antitrypsin deficiency: While this disorder can cause liver cirrhosis and hepatic fibrosis, it does not typically involve the neurological and hematological symptoms seen in this patient.",Hereditary metabolic disorders
['Canavan disease'],"1. Canavan disease: Presents with hypotonia, macrocephaly, seizures, and developmental delay in early infancy. The opisthotonus, hyperreflexia, and elevated aspartate levels fit well. Death often occurs by toddlerhood.

2. Molybdenum cofactor deficiency: Can cause intractable seizures, severe hypotonia, hyperreflexia, and early death. Elevated sulfite, xanthine and urate levels would be expected rather than abnormal amino acids.

3. Zellweger syndrome (a peroxisomal biogenesis disorder): Infants have profound hypotonia, seizures, and characteristic facial features. Liver dysfunction and skeletal abnormalities are common. Does not fully explain the amino acid findings.

4. Nonketotic hyperglycinemia: The seizures, hypotonia and early lethality fit, but opisthotonus is atypical, and glycine rather than aspartate levels should be high.

5. Pyridoxine-dependent epilepsy: Matches the intractable seizures and early onset, but would not expect hyperreflexia, opisthotonus or abnormal amino acids. Response to pyridoxine would be diagnostic.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Tyrosinemia type I: Characterized by hypertyrosinemia, liver dysfunction, renal tubular dysfunction, and risk of early death. The patient's symptoms of hypertyrosinemia, gastrointestinal inflammation, and death in infancy are consistent with this diagnosis.

2. Phenylketonuria (PKU): Causes hyperphenylalaninemia and can lead to severe intellectual disability, seizures, and behavioral problems if untreated. The patient has hyperphenylalaninemia, but other cardinal symptoms of untreated PKU were not reported.

3. Tyrosinemia type II (Richner-Hanhart syndrome): Associated with hypertyrosinemia, painful palmoplantar hyperkeratosis, and eye involvement. Additional dermatologic and ophthalmologic findings were not noted in this patient.

4. Tyrosinemia type III: A rare disorder causing hypertyrosinemia and variable neurologic symptoms. This patient's lack of reported neurologic abnormalities makes this diagnosis less likely.

5. Hawkinsinuria: A rare metabolic disorder characterized by hypertyrosinemia and metabolic acidosis. Other key features like failure to thrive and abnormal urinary compounds were not mentioned for this patient.",Hereditary metabolic disorders
['Maple syrup urine disease'],"1. Maple syrup urine disease: Characterized by ataxia, coma, cerebral edema, hyperleucinemia, metabolic acidosis, and early mortality if untreated. Alopecia and immunodeficiency are not typical features.

2. Propionic acidemia: Can present with metabolic acidosis, cerebral edema, abnormal white matter, reduced tendon reflexes, and early death. Hyperleucinemia is not a primary feature.

3. Methylmalonic acidemia: Similar presentation to propionic acidemia with neurological deterioration, metabolic acidosis, and early mortality. Can also be associated with immunodeficiency and recurrent infections.

4. Isovaleric acidemia: Acute presentation can include coma, metabolic acidosis, and cerebral edema. Hyperleucinemia is not typical. Survival into adolescence is more common than in the other disorders.

5. Canavan disease: A leukodystrophy characterized by ataxia, reduced tendon reflexes, abnormal white matter, and cerebral edema. Hyperleucinemia and metabolic acidosis are not typical features. Prognosis is poor but survival into adolescence is possible.",Hereditary metabolic disorders
['Acute intermittent porphyria'],"1. Acute intermittent porphyria: Abdominal pain and elevated urinary delta-aminolevulinic acid are consistent with this diagnosis. Key symptoms not reported include dark urine, peripheral neuropathy, and psychiatric symptoms.

2. ALA dehydratase porphyria: The combination of abdominal pain and elevated urinary delta-aminolevulinic acid also fits this rare disorder. Additional symptoms that would support the diagnosis include neurological dysfunction and photosensitivity.

3. Hereditary coproporphyria: Another acute hepatic porphyria that can present with abdominal pain, but urinary delta-aminolevulinic acid is usually not as elevated as in AIP or ADP. Other characteristic symptoms include neuropsychiatric disturbances and cutaneous photosensitivity.

4. Variegate porphyria: Can cause episodic abdominal pain, but urinary ALA is typically not significantly increased. The presence of blistering skin lesions would be an important diagnostic clue.

5. Lead poisoning: While not a hereditary disorder, lead toxicity can present with abdominal pain and elevated urinary delta-aminolevulinic acid due to inhibition of ALA dehydratase. Other signs of lead poisoning like anemia, encephalopathy and peripheral neuropathy are not reported here.",Hereditary metabolic disorders
['Vitamin B12-unresponsive methylmalonic acidemia'],"1. Methylmalonic acidemia, mut(0) type: Characterized by neonatal onset, seizures, metabolic acidosis, methylmalonic aciduria, and early death. Caused by complete deficiency of methylmalonyl-CoA mutase.

2. Methylmalonic acidemia, cblA type: Can present with seizures, metabolic acidosis, methylmalonic aciduria, and death in infancy. Caused by defects in MMAA gene leading to impaired adenosylcobalamin synthesis and methylmalonyl-CoA mutase deficiency.

3. Methylmalonic acidemia, cblB type: Similar presentation to cblA type with seizures, acidosis, methylmalonic aciduria, and potential for early death. Caused by defects in MMAB gene and adenosylcobalamin deficiency.

4. Methylmalonic acidemia with homocystinuria, cblC type: Presents with seizures, lethargy, metabolic acidosis, elevated methylmalonic acid, homocysteine, and early death in severe cases. Caused by defects in MMACHC gene and impaired cobalamin metabolism.

5. Propionic acidemia: Can present similarly with seizures, metabolic acidosis, and potential for neonatal death. Would expect elevated propionylcarnitine and propionic acid rather than isolated methylmalonic aciduria.",Hereditary metabolic disorders
['Alkaptonuria'],"1. Organic acidemia (e.g. propionic acidemia, methylmalonic acidemia): The patient's seizures, lethargy, hypotonia, growth delay, and dark urine are all consistent with this group of disorders. Early death is also typical without treatment.

2. Urea cycle disorder (e.g. citrullinemia, argininosuccinic aciduria): The lethargy, hypotonia, seizures and growth delay fit with the hyperammonemia seen in these conditions, which can be fatal if severe. However, dark urine is not a typical finding.

3. Mitochondrial disorder: Growth delay, seizures, hypotonia and lethargy are common symptoms. If there is muscle involvement, rhabdomyolysis could cause dark urine. The early death also suggests a severe progressive condition like a mitochondrial disease.

4. Krabbe disease: This is a lysosomal storage disorder that causes progressive neurological deterioration, with symptoms like seizures, hypotonia, feeding problems, and early death that fit this patient's presentation. However, dark urine would be unusual.

5. Zellweger syndrome: This peroxisomal disorder can cause hypotonia, seizures, growth delay and early death, matching the patient's symptoms. Liver dysfunction may lead to dark urine. Other peroxisomal biogenesis disorders can have a similar presentation.",Hereditary metabolic disorders
['Maple syrup urine disease'],"1. Maple syrup urine disease: The abnormal levels of leucine, isoleucine, and valine are characteristic of this disorder. The early-onset severe form can present with seizures, coma, and death in infancy if untreated.

2. Isovaleric acidemia: This disorder of leucine metabolism can present in the neonatal period with seizures, lethargy, vomiting, and coma. Characteristic odor may be present.

3. Propionic acidemia: Disorder of amino acid and odd-chain fatty acid metabolism that can present in infancy with seizures, hypotonia, and coma. Can have high ammonia levels.

4. Methylmalonic acidemia: Another organic acidemia that can present with seizures, lethargy, and coma in infancy. Can also have high ammonia, neutropenia, and thrombocytopenia.

5. 3-Hydroxy-3-methylglutaryl-CoA lyase deficiency: Rare disorder of leucine metabolism that can present with seizures, hypoglycemia, and metabolic acidosis in infancy. Characteristic pattern on acylcarnitine profile.",Hereditary metabolic disorders
['Very long chain acyl-CoA dehydrogenase deficiency'],"1. Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency: Consistent with early death, hypoglycemia, increased lactate, cardiomegaly, hepatomegaly, and abnormal carnitine levels. Recurrent infections are not typically reported.

2. Very long-chain acyl-CoA dehydrogenase (VLCAD) deficiency: Matches the early death, cardiomegaly, hypoglycemia, increased lactate, dicarboxylic aciduria, and abnormal carnitine. Hepatomegaly and recurrent infections are less common.

3. Carnitine palmitoyltransferase II (CPT2) deficiency, severe neonatal form: Aligns with early death, cardiomegaly, hypoglycemia, increased lactate, hepatomegaly, and abnormal carnitine. Recurrent infections are not usually seen.

4. Mitochondrial trifunctional protein (MTP) deficiency: Fits the picture of early death, cardiomegaly, hypoglycemia, increased lactate, hepatomegaly, and abnormal carnitine. Dicarboxylic aciduria may be present, but recurrent infections are atypical.

5. Glutaric aciduria type II (multiple acyl-CoA dehydrogenase deficiency): Consistent with early death, metabolic acidosis, hypoglycemia, cardiomegaly, hepatomegaly, and dicarboxylic aciduria. Recurrent infections are not characteristic.",Hereditary metabolic disorders
['3-hydroxy-3-methylglutaric aciduria'],"1. Glutaric acidemia type 1: The patient's seizures, lethargy, neurologic deterioration, early death, glutaric and 3-methylglutaric aciduria, and metabolic acidosis are all consistent with this disorder. The recurrent infections and abnormal glycine are not typical but could be secondary.

2. Propionic acidemia: Can present with lethargy, metabolic acidosis, hypoglycemia, seizures, and death in infancy. However, the urine would show elevated 3-hydroxypropionate and methylcitrate, not glutaric and 3-methylglutaric acid.

3. Methylmalonic acidemia: Similar presentation to propionic acidemia with lethargy, metabolic acidosis, hypoglycemia, and seizures. Urine would show elevated methylmalonic acid, not glutaric and 3-methylglutaric acid.

4. Isovaleric acidemia: Can cause lethargy, seizures, and metabolic acidosis, but typically presents with a ""sweaty feet"" odor and elevated isovalerylglycine in urine, not glutaric and 3-methylglutaric acid.

5. 3-Methylcrotonyl-CoA carboxylase deficiency: Can present with seizures, hypoglycemia, and death in infancy. Urine organic acids would show elevated 3-methylcrotonylglycine and 3-hydroxyisovaleric acid, but not typically glutaric and 3-methylglutaric acid.",Hereditary metabolic disorders
['MODY'],"1. Acute intermittent porphyria: Characterized by abnormal porphyrin metabolism, which can lead to neurological symptoms, abdominal pain, and sometimes hypoglycemia. The patient's abnormal circulating porphyrin concentration is consistent with this diagnosis.

2. Hereditary tyrosinemia type 1: A disorder affecting tyrosine metabolism, which can cause liver dysfunction, renal tubular dysfunction (potentially leading to glycosuria), and porphyria-like symptoms due to the accumulation of toxic metabolites. The patient's hypoglycemia, glycosuria, and abnormal porphyrin levels could fit this diagnosis.

3. Glycogen storage disease type I (von Gierke disease): A disorder characterized by the inability to break down glycogen, leading to hypoglycemia, hepatomegaly, and sometimes glycosuria. The patient's hypoglycemia and glycosuria are consistent with this diagnosis, but the abnormal porphyrin concentration is not typically associated with this condition.

4. Fanconi-Bickel syndrome: A rare disorder affecting glucose and galactose metabolism, causing glycogen accumulation in the liver and kidneys. It is characterized by hepatomegaly, hypoglycemia, and renal tubular dysfunction (which can lead to glycosuria). The patient's hypoglycemia and glycosuria fit this diagnosis, but the abnormal porphyrin levels are not a common feature.

5. Congenital disorders of glycosylation (CDG): A group of disorders affecting the glycosylation of proteins and lipids, which can lead to a wide range of symptoms, including liver dysfunction, hypoglycemia, and abnormal glycosylation of transferrin. Some CDG subtypes may also involve abnormalities in heme synthesis. The patient's hypoglycemia, glycosuria, and abnormal porphyrin levels could potentially fit within the spectrum of CDG disorders.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Phenylketonuria (PKU): Abnormality of prenatal development, death in infancy, neonatal death, and hyperphenylalaninemia are all consistent with untreated severe PKU. Additional expected symptoms include microcephaly, seizures, intellectual disability, and light pigmentation.

2. Tetrahydrobiopterin deficiency: This group of disorders affects synthesis or recycling of a cofactor needed for phenylalanine metabolism, leading to hyperphenylalaninemia and symptoms similar to PKU. Differentiating symptoms like prominent neurological deterioration and unresponsiveness to phenylalanine restriction are not reported here.

3. Tyrosinemia type I: Another inborn error of amino acid metabolism that can present with failure to thrive, liver dysfunction, and renal tubular dysfunction. However, the primary amino acid elevation is tyrosine rather than phenylalanine.

4. Homocystinuria: Defects in methionine metabolism lead to accumulation of homocysteine and its toxic metabolites. Key symptoms include intellectual disability, skeletal abnormalities, eye problems, and thromboembolism. Hyperphenylalaninemia would be unusual.

5. Zellweger spectrum disorder: This peroxisomal biogenesis disorder can present with profound hypotonia, distinctive facial features, seizures, and liver dysfunction. While intellectual disability and early death are common, hyperphenylalaninemia is not a typical finding.",Hereditary metabolic disorders
['Glutaryl-CoA dehydrogenase deficiency'],"1. Glutaryl-CoA dehydrogenase deficiency: The combination of macrocephaly, dystonia, seizures, and glutaric aciduria is highly suggestive of this inborn error of lysine and tryptophan metabolism. Additional consistent symptoms include fever, lethargy, and cerebral atrophy.

2. Canavan disease: This leukodystrophy could explain the patient's macrocephaly, seizures, lethargy, and cerebral atrophy. Canavan disease typically also causes developmental delay and hypotonia, which were not mentioned in this case.

3. Leigh syndrome: Some forms of this mitochondrial disorder can present with dystonia, seizures, cerebral atrophy, and early mortality. However, the glutaric aciduria would be atypical.

4. Alexander disease: This rare leukodystrophy is characterized by macrocephaly, seizures, and progressive neurological deterioration. It does not usually cause metabolic aciduria, but can result in early death.

5. Niemann-Pick disease type C: This lysosomal storage disorder can cause dystonia, seizures, and cognitive impairment. Hepatosplenomegaly and vertical gaze palsy are additional hallmark signs not reported in this patient.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Tyrosinemia type I: Characterized by hypertyrosinemia, liver dysfunction, renal tubular dysfunction, and risk of early death. Consistent with the patient's hypertyrosinemia and death in infancy/childhood.

2. Transient tyrosinemia of the newborn: A benign condition with temporarily elevated tyrosine levels in the neonatal period. Matches the hypertyrosinemia but would not typically cause prenatal abnormalities or death.

3. Phenylketonuria: Causes hyperphenylalaninemia and can lead to severe intellectual disability if untreated. Aligns with the hyperphenylalaninemia but death in infancy would be unusual.

4. Tyrosinemia type II: Also known as Richner-Hanhart syndrome. Characterized by hypertyrosinemia, eye and skin lesions, and intellectual disability. The lack of eye and skin findings makes this less likely for this patient.

5. Hawkinsinuria: A rare disorder of tyrosine metabolism causing hypertyrosinemia, metabolic acidosis, and failure to thrive. Can be considered given the hypertyrosinemia but additional features like metabolic acidosis are not mentioned for this patient.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Tyrosinemia type I: Characterized by hypertyrosinemia, this disorder can lead to liver failure, renal dysfunction, and early death if untreated. However, hyperphenylalaninemia and preeclampsia are not typical features.

2. Phenylketonuria (PKU): This disorder leads to very high phenylalanine levels and can cause intellectual disability, seizures, and behavioral problems if untreated. However, it does not usually cause hypertyrosinemia or complications like preeclampsia and early death.

3. Hawkinsinuria: A rare disorder of tyrosine metabolism that causes hypertyrosinemia and metabolic acidosis. Can be associated with failure to thrive in infancy. However, prognosis is generally good with treatment, and hyperphenylalaninemia is not expected.

4. Alkaptonuria: Caused by a defect in tyrosine degradation, leading to buildup of homogentisic acid. Characterized by darkened urine, early arthritis, and heart valve problems. However, it does not typically cause the other symptoms seen in this patient.

5. Tyrosinemia type II: Also known as Richner-Hanhart syndrome, this disorder causes hypertyrosinemia, eye and skin lesions, and intellectual disability. However, it is not associated with hyperphenylalaninemia, preeclampsia or early death.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Tyrosinemia type I: Characterized by hypertyrosinemia, elevated urinary succinylacetone, liver dysfunction, and high risk of early death if untreated. Consistent with this patient's hypertyrosinemia, elevated carboxylic acids, and death in infancy/early adulthood.

2. Phenylketonuria: Features hyperphenylalaninemia and intellectual disability if untreated, but death in infancy would be unusual. This patient has hyperphenylalaninemia but no mention of developmental delay.

3. Propionic acidemia: An organic aciduria that can present with hyperammonemia, metabolic acidosis, and early death. May explain the elevated carboxylic acids but the amino acid abnormalities are less consistent.

4. Methylmalonic acidemia: Another organic aciduria with similar features to propionic acidemia. The patient's metabolite profile is not entirely consistent.

5. Mevalonic aciduria: A rare disorder that can have prenatal onset, dysmorphic features, and early death. May cause organic aciduria but would not typically have amino acid abnormalities.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Tyrosinemia type I: Characterized by hypertyrosinemia, liver dysfunction, and early death if untreated. Consistent with abnormal prenatal development, death in infancy/childhood, and hypertyrosinemia.

2. Transient tyrosinemia of the newborn: Causes hypertyrosinemia in the neonatal period but is usually benign. Matches the hypertyrosinemia but less likely to cause the other severe symptoms reported.

3. Phenylketonuria: Causes hyperphenylalaninemia and can present with neonatal issues and early death if untreated. Matches the hyperphenylalaninemia and potentially the prenatal and childhood symptoms, but hypertyrosinemia is not a typical finding.

4. Maple syrup urine disease: Can cause neonatal coma, sepsis, and death. Elevated branched-chain amino acids are characteristic, rather than tyrosine and phenylalanine.

5. Homocystinuria: May present with failure to thrive in infancy and developmental delay. Typically causes elevated homocysteine and methionine rather than tyrosine and phenylalanine.",Hereditary metabolic disorders
['Hereditary orotic aciduria'],"1. Lysinuric protein intolerance: Consistent with failure to thrive, hepatosplenomegaly, hypotonia, and abnormal urine amino acids. Key features not reported include hyperammonemia, protein aversion, and osteoporosis.

2. Propionic acidemia: Matches with lethargy, hypotonia, feeding difficulties, and early mortality. Additional findings can include ketoacidosis, hyperammonemia, and abnormal urine organic acids, which were not mentioned.

3. Methylmalonic acidemia: Similar to propionic acidemia, with lethargy, hypotonia, feeding problems, and early death. Patients may also have ketoacidosis, neutropenia, and methylmalonic aciduria, which were not reported.

4. Mevalonic aciduria: Aligns with fever, hepatosplenomegaly, hypotonia, failure to thrive, and early mortality. Other characteristic features include recurrent inflammatory episodes, dysmorphic features, and mevalonic aciduria, which were not described.

5. Farber lipogranulomatosis: Matches with skin rash, joint swelling, hoarseness, hepatosplenomegaly, and early death. Key symptoms not mentioned include joint contractures, subcutaneous nodules, and laryngeal involvement.",Hereditary metabolic disorders
['Holocarboxylase synthetase deficiency'],"1. Propionic acidemia: Characterized by propionyl-CoA carboxylase deficiency, leading to accumulation of propionic acid and other toxic compounds. Consistent with the patient's cyanosis, hypotonia, metabolic acidosis, hyperammonemia, and early death.

2. Pyruvate carboxylase deficiency: Caused by decreased pyruvate carboxylase activity, resulting in lactic acidosis, hypotonia, developmental delay, and early death. Matches the patient's decreased enzyme activity, hypotonia, and death in infancy.

3. Methylmalonic acidemia: Another organic acidemia caused by defects in methylmalonyl-CoA mutase or related enzymes. Presents with metabolic acidosis, hyperammonemia, hypotonia, and lethargy. The patient's symptoms align with this diagnosis, but specific methylmalonic acid levels are not reported.

4. Nonketotic hyperglycinemia: Characterized by abnormal glycine metabolism leading to elevated glycine levels in blood and CSF. Can present with hypotonia, seizures, and early death. The patient's abnormal circulating glycine concentration suggests this condition, but CSF glycine is not mentioned.

5. Multiple carboxylase deficiency: Group of disorders affecting multiple biotin-dependent carboxylases. Can cause skin rash, hypotonia, metabolic acidosis, and organic aciduria. While the patient has some consistent symptoms and enzyme deficiencies, the hallmark organic acids are not specifically noted.",Hereditary metabolic disorders
['Ornithine transcarbamylase deficiency'],"1. Ornithine transcarbamylase deficiency: This is the most common urea cycle disorder. It fits with the patient's hyperammonemia, neurological symptoms, vomiting, and oroticaciduria. Early death can occur in severe cases.

2. Carbamoyl phosphate synthetase I deficiency: Another urea cycle disorder that matches the patient's presentation. It usually causes severe hyperammonemia in the neonatal period, but milder forms with later onset are possible.  

3. Citrullinemia type I: A urea cycle disorder that could explain the patient's symptoms. It often presents in the neonatal period but can have a later onset. Oroticaciduria is a key feature.

4. Argininosuccinic aciduria: This urea cycle disorder is consistent with the neurological symptoms, vomiting, and hyperammonemia. However, it is not typically associated with oroticaciduria.

5. Arginase deficiency: The least common urea cycle disorder, but it matches the patient's neurological presentation and hyperammonemia. Onset is often in late infancy or childhood. Oroticaciduria would not be expected.",Hereditary metabolic disorders
[],"1. Short-chain acyl-CoA dehydrogenase deficiency (SCAD): Consistent with ethylmalonic aciduria, decreased 3-hydroxyacyl-CoA dehydrogenase activity, and potential for early death. May have low blood carnitine levels.

2. Medium-chain acyl-CoA dehydrogenase deficiency (MCAD): Can present with vomiting, hypoglycemia, and early death. Usually have elevated medium-chain acylcarnitines. Ethylmalonic aciduria and decreased 3-hydroxyacyl-CoA dehydrogenase activity would be atypical.

3. Multiple acyl-CoA dehydrogenase deficiency (MADD) or Glutaric Acidemia Type II: A disorder of electron transfer flavoprotein which affects multiple acyl-CoA dehydrogenases. Can have ethylmalonic aciduria, low carnitine, decreased 3-hydroxyacyl-CoA dehydrogenase, and early death.

4. 3-hydroxyacyl-CoA dehydrogenase deficiency: Rare disorder directly caused by deficiency of 3-hydroxyacyl-CoA dehydrogenase. Can present in infancy or childhood with hypoglycemia, cardiomyopathy, and early death. Ethylmalonic aciduria would be unusual.

5. Ethylmalonic encephalopathy: Rare disorder caused by mutations in ETHE1 gene. Characterized by ethylmalonic aciduria, progressive neurologic deterioration, and early death. Decreased 3-hydroxyacyl-CoA dehydrogenase activity would not be expected.",Hereditary metabolic disorders
['Smith-Lemli-Opitz syndrome'],"1. Smith-Lemli-Opitz syndrome (SLOS): The patient's low-set ears, wide nasal bridge, anteverted nares, ptosis, syndactyly, intellectual disability, motor delay, generalized hypotonia, feeding difficulties, and elevated 7-dehydrocholesterol are all consistent with this diagnosis. The severe phenotype with death in infancy suggests a more severe form of SLOS.

2. Desmosterolosis: This rare disorder of cholesterol biosynthesis could explain the patient's congenital anomalies, neurological impairment, and abnormal sterol levels. However, the specific elevation of 7-dehydrocholesterol is more suggestive of SLOS.

3. Lathosterolosis: Another rare disorder of cholesterol metabolism that shares some features with SLOS, including developmental delay, hypotonia, and abnormal sterol levels. The patient's specific pattern of elevated 7-dehydrocholesterol and 8-dehydrocholesterol is more consistent with SLOS, though.

4. Congenital disorder of glycosylation (CDG): Some forms of CDG can present with a combination of facial dysmorphism, limb anomalies, intellectual disability, hypotonia, and failure to thrive. However, the specific abnormalities in cholesterol metabolism would be unusual for CDG.

5. Peroxisomal biogenesis disorder (e.g., Zellweger syndrome): These disorders can cause craniofacial anomalies, neurological impairment, hypotonia, and early death. However, the biochemical abnormalities typically involve very long-chain fatty acids and bile acid intermediates rather than cholesterol precursors.",Hereditary metabolic disorders
['L-2-hydroxyglutaric aciduria'],"1. L-2-hydroxyglutaric aciduria: The patient's L-2-hydroxyglutaric aciduria, intellectual disability, ataxia, cerebral atrophy, and death in infancy/childhood are all consistent with this rare autosomal recessive disorder of lysine metabolism. Other common features not reported include seizures, macrocephaly, and subcortical white matter abnormalities.

2. Canavan disease: This autosomal recessive leukodystrophy could explain the patient's intellectual disability, ataxia, cerebral atrophy, and early death. However, Canavan disease typically causes macrocephaly and diffuse white matter degeneration, and is not associated with L-2-hydroxyglutaric aciduria.

3. Glutaric aciduria type 1: The intellectual disability, ataxia, basal ganglia abnormalities, and potential for early death fit with glutaric aciduria type 1. However, this disorder is characterized by large head size, dystonia, and glutaric aciduria, rather than the L-2-hydroxyglutaric aciduria seen here.

4. Leigh syndrome: This mitochondrial disorder can present with intellectual disability, ataxia, basal ganglia changes, and early death. However, Leigh syndrome often includes other findings like optic atrophy, hypertrophic cardiomyopathy, and lactic acidosis. L-2-hydroxyglutaric aciduria would be atypical.

5. D-2-hydroxyglutaric aciduria: Although this disorder can cause intellectual disability, ataxia, cerebral atrophy, and early death, it is associated with elevated D-2-hydroxyglutaric acid rather than the L-isomer seen in this patient. Seizures, hypotonia, and enlarged lateral ventricles are other common features.",Hereditary metabolic disorders
['3-hydroxy-3-methylglutaric aciduria'],"1. Glutaric acidemia type II: The combination of metabolic acidosis, hypotonia, dicarboxylic aciduria, and early death is consistent with this disorder of fatty acid oxidation. However, seizures and 3-methylglutaconic aciduria are not typically seen.

2. Propionic acidemia: This disorder can present with irritability, hypotonia, seizures, and metabolic acidosis in infancy. Elevated 3-methylglutaconic acid is sometimes seen. However, dicarboxylic aciduria is not a classic finding.

3. Mitochondrial DNA depletion syndrome: The severe hypotonia, seizures, metabolic acidosis, and elevated urinary organic acids could fit with this disorder of mitochondrial function. Early death is also consistent. Additional genetic testing would be needed for diagnosis.

4. Pyruvate dehydrogenase deficiency: Presents with severe lactic acidosis, hypotonia, seizures, and early death. 3-methylglutaconic aciduria can be seen, but dicarboxylic aciduria would be unusual.

5. Zellweger syndrome spectrum disorder: Severe hypotonia, seizures, and early death, along with elevated urinary dicarboxylic acids can be seen in disorders of peroxisomal function like Zellweger syndrome. However, 3-methylglutaconic aciduria is not typical.",Hereditary metabolic disorders
['L-2-hydroxyglutaric aciduria'],"1. L-2-hydroxyglutaric aciduria: This rare neurometabolic disorder is characterized by elevated levels of L-2-hydroxyglutaric acid in urine, seizures, developmental delay, and early death. The patient's L-2-hydroxyglutaric aciduria is a key diagnostic finding.

2. Mitochondrial disorder: Various mitochondrial disorders can present with seizures, developmental regression, and metabolic abnormalities. However, L-2-hydroxyglutaric aciduria is not typically associated with mitochondrial disease.

3. Neonatal epileptic encephalopathy: A group of severe epilepsy syndromes presenting in infancy with intractable seizures and developmental impairment. The patient's seizures and early death fit, but the metabolic findings are less typical.

4. Inborn error of iron metabolism: Disorders like neonatal hemochromatosis can cause liver failure, metabolic derangements, and early death. The patient's decreased circulating iron goes against this, but it could be a secondary finding.

5. Severe combined immunodeficiency (SCID): SCID can present with fever, rash, failure to thrive, and early death due to infections. However, seizures and L-2-hydroxyglutaric aciduria are not typical features.",Hereditary metabolic disorders
['X-linked hypophosphatemia'],"1. Hypophosphatemic rickets: Characterized by low blood phosphate, bone deformities, and elevated alkaline phosphatase. However, early death and nephritis are not typical features.

2. Vitamin D-dependent rickets type 1: Causes rickets, hypophosphatemia, and can lead to early death. Nephritis is not a classic symptom.

3. Renal tubular acidosis with bone disease: Can present with nephritis, bone abnormalities, growth failure, and sometimes early death. Hypophosphatemia is not a prominent feature.

4. Infantile hypophosphatasia: A rare metabolic bone disorder causing hypophosphatemia, skeletal abnormalities, and sometimes kidney problems. Can be fatal in infancy in severe cases. Alkaline phosphatase is typically low, not elevated.

5. Dent disease: An X-linked renal tubular disorder that can cause nephritis, hypophosphatemia, rickets, and kidney failure. However, it is not usually fatal in infancy or early childhood.",Hereditary metabolic disorders
['Propionic acidemia'],"1. Nonketotic hyperglycinemia: Characterized by hyperglycinemia, hyperglycinuria, neurological symptoms (delayed development, seizures), and early mortality. However, the skin findings and other metabolic abnormalities are less typical.

2. Propionic acidemia: Can present with hyperammonemia, leukopenia, skin rash, developmental delay, and abnormal amino acid concentrations. Elevated urinary carboxylic acid and abnormal acylcarnitines would be expected.

3. Methylmalonic acidemia: Similar presentation to propionic acidemia, with hyperammonemia, leukopenia, skin rash, developmental delay, and abnormal amino acid concentrations. Elevated urinary carboxylic acid and abnormal acylcarnitines would be expected.

4. 3-Methylcrotonyl-CoA carboxylase deficiency: Can cause skin rash, leukopenia, developmental delay, and abnormal amino acid concentrations. Elevated urinary 3-hydroxyisovaleric acid and 3-methylcrotonylglycine would be diagnostic.

5. Multiple carboxylase deficiency (biotinidase deficiency or holocarboxylase synthetase deficiency): Can present with skin rash, neurological symptoms, metabolic acidosis, and elevated urinary organic acids. Specific enzyme deficiencies or response to biotin supplementation can distinguish the two forms.",Hereditary metabolic disorders
"['Methylmalonic acidemia with homocystinuria, type cblC']","Based on the provided symptoms, here are the top 5 potential diagnoses:

1. Methylmalonic acidemia: The patient's methylmalonic aciduria, developmental delay, hypotonia, and early death are consistent with this disorder. Other supporting features include the decreased plasma carnitine. Key symptoms not reported include hyperammonemia, metabolic acidosis, and ketosis.

2. Homocystinuria: The patient's hyperhomocystinemia, developmental delay, and abnormal brain white matter fit with this diagnosis. Additional findings that would support this include lens dislocation, marfanoid habitus, and thromboembolic events.

3. Propionic acidemia: Similar to methylmalonic acidemia, this disorder could explain the patient's developmental delay, hypotonia, gastrointestinal issues, and early mortality. Other expected findings would include metabolic acidosis, hyperammonemia, and ketosis.

4. Glutaric aciduria type 1: This disorder is characterized by developmental delay, hypotonia, and white matter abnormalities, as seen in this patient. Additional symptoms may include macrocephaly, dystonia, and encephalopathic crises. Urine organic acid analysis would be expected to show elevated glutaric acid.

5. Menkes disease: The patient's developmental delay, hypotonia, and early death could be explained by this disorder. Other supportive findings would include the abnormal white matter and gastrointestinal symptoms. Key features not reported include seizures, hypopigmented or kinky hair, and low serum copper and ceruloplasmin levels.",Hereditary metabolic disorders
['Biotinidase deficiency'],"1. Propionic acidemia: Characterized by neonatal or infantile onset of poor feeding, vomiting, lethargy progressing to coma and death if untreated. Urine organic acids show elevated 3-hydroxypropionate and methylcitrate.

2. Methylmalonic acidemia: Can present similarly to propionic acidemia in the neonatal or infantile period with lethargy, vomiting, coma and death. Urine organic acids reveal increased methylmalonic acid.

3. Isovaleric acidemia: Another organic acidemia that can cause severe neonatal or infantile presentation with poor feeding, vomiting, lethargy, coma and death. Urine organic acids are diagnostic, showing elevated isovalerylglycine.

4. Glutaric acidemia type 1: While later onset forms occur, severe neonatal presentation can involve encephalopathic crisis and early death. Urine organic acids show increased glutaric and 3-hydroxyglutaric acids.

5. Multiple carboxylase deficiency: Neonatal form is characterized by severe metabolic acidosis, seizures, hypotonia, vomiting, dehydration and often early death. Urine organic acids reveal elevated lactate, 3-hydroxyisovalerate, 3-methylcrotonylglycine, 3-hydroxypropionate and methylcitrate.",Hereditary metabolic disorders
['Carbamoyl-phosphate synthetase 1 deficiency'],"1. Ornithine transcarbamylase deficiency: A urea cycle disorder that can cause lethargy, hypotonia, spasticity, hyperammonemia, and early death. The patient's symptoms fit this diagnosis well.

2. Carbamoyl phosphate synthetase I deficiency: Another urea cycle disorder with symptoms similar to ornithine transcarbamylase deficiency, including lethargy, hypotonia, hyperammonemia, and death in infancy.

3. Pyruvate dehydrogenase complex deficiency: A mitochondrial disorder that can cause hypotonia, lethargy, feeding difficulties, and neurological dysfunction. Hyperammonemia is not typically seen, however.

4. Leigh syndrome: A severe mitochondrial disorder that can present with hypotonia, spasticity, feeding difficulties, and progressive neurological deterioration, often leading to early death. Hyperammonemia would be unusual, though.

5. Argininosuccinic aciduria: A rare urea cycle disorder that can cause lethargy, hypotonia, hyperammonemia, and early death, fitting with the patient's presentation. Spasticity and hyperreflexia are less common in this condition compared to ornithine transcarbamylase deficiency.",Hereditary metabolic disorders
['Vitamin B12-unresponsive methylmalonic acidemia'],"1. Methylmalonic acidemia due to methylmalonyl-CoA mutase deficiency: The patient's decreased methylmalonyl-CoA mutase activity is diagnostic of this condition. Death in infancy/childhood and metabolic acidosis are consistent symptoms.

2. Methylmalonic acidemia with homocystinuria, cblC type: This is another form of methylmalonic acidemia that could fit the patient's presentation. Additional symptoms not reported include homocystinuria, developmental delay, and cytopenias.

3. Propionic acidemia: Another organic acidemia that can present similarly to methylmalonic acidemia in infancy with metabolic acidosis and early death. However, methylmalonyl-CoA mutase activity would be normal.

4. Holocarboxylase synthetase deficiency: A disorder of biotin metabolism that can cause severe metabolic acidosis and early death. Additional symptoms may include skin rash and respiratory problems.

5. Glutaric acidemia type 1: While this disorder can also present with metabolic acidosis in infancy, it would not cause decreased methylmalonyl-CoA mutase activity. Other expected symptoms include macrocephaly and dystonia.",Hereditary metabolic disorders
[],"1. Pyruvate kinase deficiency: Hemolytic anemia, jaundice, splenomegaly, reticulocytosis. Does not typically cause neurological symptoms or metabolic acidosis.

2. Congenital erythropoietic porphyria: Hemolytic anemia, photosensitivity, red urine, abnormal porphyrins. Does not explain the neurological symptoms or metabolic acidosis.

3. Zellweger spectrum disorder: Hypotonia, seizures, failure to thrive, liver dysfunction, early death. Does not typically cause hemolytic anemia.

4. Hemophagocytic lymphohistiocytosis (HLH): Fever, splenomegaly, cytopenias, hemophagocytosis, elevated ferritin. May be triggered by infections. Does not explain the metabolic acidosis.

5. Mitochondrial disorder, such as pyruvate dehydrogenase deficiency: Lactic acidosis, neurological deterioration, seizures, early death. Anemia is not a typical feature.",Hereditary metabolic disorders
['Neonatal intrahepatic cholestasis due to citrin deficiency'],"1. Citrullinemia type I: The patient's hyperammonemia, respiratory distress, elevated plasma citrulline, and death in infancy are all consistent with this diagnosis. The key symptom not reported is orotic aciduria.

2. Argininosuccinic aciduria: Another urea cycle disorder that can present similarly to citrullinemia in the neonatal period with hyperammonemia, respiratory issues, and early death. However, the patient's citrulline would be lower and argininosuccinic acid would be elevated.

3. Methylmalonic acidemia: A severe organic acidemia that can cause neonatal hyperammonemia, respiratory distress, metabolic acidosis, and death. Additional findings may include ketoacidosis and elevated methylmalonic acid.

4. Propionic acidemia: Another organic acidemia with a similar presentation to methylmalonic acidemia in the neonatal period. Patients may also have hypoglycemia, ketoacidosis, and elevated propionylcarnitine.

5. Pyruvate dehydrogenase deficiency: A mitochondrial disorder that can present in the neonatal period with respiratory distress, hypoxemia, metabolic acidosis, and early death. Patients often have lactic acidosis and elevated pyruvate.",Hereditary metabolic disorders
[],"1. Methylmalonic acidemia: The patient's methylmalonic acidemia, aciduria, intellectual disability, seizures, hypotonia, and early mortality are all consistent with this group of disorders. The specific subtype would depend on the results of genetic testing.

2. Propionic acidemia: Another organic acidemia that can cause neurological impairment, metabolic disturbances, and multi-organ dysfunction similar to the patient's presentation. However, methylmalonic acid elevations are more specific to methylmalonic acidemia.

3. Combined methylmalonic acidemia and homocystinuria: This disorder combines features of methylmalonic acidemia and homocystinuria due to defects in cobalamin metabolism. The absence of reported homocysteine abnormalities makes this less likely than isolated methylmalonic acidemia.

4. Glutaric acidemia type 1: While this disorder can present with neurological deterioration, metabolic acidosis, and kidney problems, the patient's methylmalonic acidemia and anemia are not typical features.

5. Glycine encephalopathy: The patient's hyperglycinemia could indicate this disorder, which can cause lethargy, hypotonia, seizures, and intellectual disability. However, methylmalonic acidemia is not a typical finding, making this less likely than a primary organic acidemia.",Hereditary metabolic disorders
['Dihydropteridine reductase deficiency'],"1. Tyrosinemia type I: This disorder of tyrosine metabolism fits well with the patient's hypertyrosinemia, neurological symptoms (intellectual disability, seizures, hypotonia), failure to thrive, and early death. However, additional features of tyrosinemia type I like liver dysfunction and renal tubular dysfunction were not mentioned.

2. Phenylketonuria (PKU): The patient's hyperphenylalaninemia, microcephaly, intellectual disability, and seizures fit with untreated PKU. PKU does not typically cause cerebral atrophy or white matter changes, however. Presence of alopecia would be atypical.

3. Maple syrup urine disease: This disorder causes intellectual disability, seizures, hypotonia, cerebral atrophy and white matter changes, and can result in neonatal death if untreated. It is characterized by elevations of branched-chain amino acids (leucine, isoleucine, valine) rather than phenylalanine and tyrosine, however.

4. Menkes disease: This disorder of copper metabolism causes neurological deterioration, seizures, hypotonia, and cerebral atrophy. It can also cause abnormal hair (kinky hair) and failure to thrive. However, it is not typically associated with hypertyrosinemia or hyperphenylalaninemia.

5. Zellweger spectrum disorder: Peroxisomal biogenesis disorders can present with hypotonia, seizures, intellectual disability, and early death. They cause cerebral white matter abnormalities and can be associated with tyrosinemia. However, additional features like liver dysfunction, renal cysts, and dysmorphic features are usually present.",Hereditary metabolic disorders
[],"1. Multiple acyl-CoA dehydrogenase deficiency (MADD) / Glutaric aciduria type II: Consistent with ethylmalonic aciduria, COX-negative fibers, metabolic acidosis, and early death. Skin rash is not a typical feature.

2. Holocarboxylase synthetase deficiency: Matches the skin rash, feeding difficulties, metabolic acidosis, and early death. Would expect to see other metabolic abnormalities as well.

3. Propionic acidemia: The ethylmalonic aciduria, glycine abnormality, GI dysfunction, and early mortality fit, but skin involvement would be unusual. Typically presents with more severe acidosis.

4. Methylmalonic acidemia: Similar to propionic acidemia in presentation, with ethylmalonic aciduria, metabolic disturbances, and potential for early death. Skin rash is not expected.

5. Mitochondrial DNA depletion syndrome: Could explain the COX-negative fibers, metabolic abnormalities, GI dysfunction, and early death. Skin involvement is possible but less common. Usually presents with other organ involvement as well.",Hereditary metabolic disorders
['Carbamoyl-phosphate synthetase 1 deficiency'],"1. Citrullinemia type I: Characterized by low plasma citrulline, hyperammonemia, seizures, and cerebral edema. The patient's oroticaciduria and early death are also consistent with this severe urea cycle disorder.

2. Carbamoyl phosphate synthetase I deficiency: Another urea cycle disorder that could explain the patient's hyperammonemia, cerebral edema, seizures, and early death. Low citrulline can also be seen. Genetic testing would be needed to differentiate from citrullinemia type I.

3. Argininosuccinic aciduria: The low plasma citrulline and hypoargininemia could fit with this disorder, though argininosuccinic acid levels would likely be elevated. Can also present with hyperammonemia, seizures, and early death.

4. Ornithine transcarbamylase deficiency: The most common urea cycle disorder. Males with severe forms can present in the neonatal period with hyperammonemia, seizures, and cerebral edema leading to early death. Oroticaciduria may be present.

5. Pyruvate carboxylase deficiency: A rare disorder of gluconeogenesis that can present in the neonatal period with lactic acidosis, hyperammonemia, and early death. The low citrulline and other biochemical findings are less typical compared to the other diagnoses.",Hereditary metabolic disorders
['Canavan disease'],"1. Nonketotic hyperglycinemia: Characterized by seizures, encephalopathy, and early death; caused by defects in the glycine cleavage system leading to elevated glycine. The aminoaciduria and skin rash could be explained by the metabolic derangement.

2. Urea cycle disorders (e.g. ornithine transcarbamylase deficiency, citrullinemia): Present with hyperammonemia, encephalopathy, seizures, and early death if severe. Aminoaciduria is common, and abnormal aspartate levels may be seen in some types.

3. Molybdenum cofactor deficiency: Can cause seizures, encephalopathy and early death. Characterized by elevated sulfite, low uric acid, and abnormal purine and amino acid metabolism which could explain the aminoaciduria.

4. Propionic acidemia or methylmalonic acidemia: Present in infancy with ketoacidosis, hyperammonemia, seizures and encephalopathy. Can have elevated glycine and other amino acids, though aspartate is less typical. Skin rash not usually seen.

5. Serine biosynthesis disorders: Rare disorders that can present with seizures, encephalopathy and may be associated with elevated glycine. However, aspartate is not typically affected and skin involvement would be unusual.",Hereditary metabolic disorders
['Maple syrup urine disease'],"1. Maple syrup urine disease (MSUD): The combination of seizures, opisthotonus, respiratory insufficiency, feeding difficulties, and death in infancy, along with the elevated valine, leucine, and isoleucine, is highly suggestive of MSUD. The absence of the characteristic maple syrup odor in the urine does not rule out the diagnosis.

2. Propionic acidemia: This disorder can present similarly to MSUD, with lethargy, seizures, feeding problems, and death in infancy. It is usually associated with ketoacidosis and hyperammonemia, which were not reported here.

3. Pyruvate dehydrogenase deficiency: This mitochondrial disorder can cause seizures, hypotonia, respiratory dysfunction, and lactic acidosis. However, it would not explain the specific amino acid elevations seen.

4. Nonketotic hyperglycinemia: Presents with lethargy, seizures, respiratory dysfunction, and death in infancy. Glycine levels are elevated in blood and CSF, rather than the branched-chain amino acids.

5. Molybdenum cofactor deficiency: Can cause seizures and death in infancy, but is associated with dysmorphic features and brain malformations. Amino acid levels are typically normal.",Hereditary metabolic disorders
['Medium chain acyl-CoA dehydrogenase deficiency'],"1. Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: Consistent with the decreased 3-hydroxyacyl-CoA dehydrogenase level, abnormal circulating carnitine, and severe clinical presentation with early death. May also present with hypoglycemia and liver dysfunction, which were not reported.

2. Very long-chain acyl-CoA dehydrogenase deficiency: Another disorder of long-chain fatty acid oxidation that can cause similar symptoms, including abnormal carnitine levels and early death. Specific enzyme testing would be needed to differentiate from LCHAD deficiency.

3. Carnitine palmitoyltransferase II deficiency: Can present with a severe neonatal form causing congenital abnormalities, hypoglycemia, cardiomyopathy, and early death. Would expect low carnitine levels.

4. Glutaric acidemia type II: A disorder of electron transfer flavoprotein that affects fatty acid oxidation and can present with congenital anomalies, hypoglycemia, metabolic acidosis, and early death. Organic acid analysis may show characteristic elevations.

5. Medium-chain acyl-CoA dehydrogenase deficiency: Less likely given the abnormalities in long-chain fatty acid metabolism, but can also present with a severe neonatal form causing early death. Would expect a more normal carnitine profile and characteristic acylcarnitine elevations.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Phenylketonuria: Characterized by intellectual disability, seizures, motor delay, and hyperphenylalaninemia. Can lead to early death if untreated. White matter abnormalities may be seen.

2. Tyrosinemia type I: Can present with intellectual disability, seizures, and hypertyrosinemia. Causes progressive liver disease and renal dysfunction, often leading to early death. Neurological crises with dyskinesias may occur.

3. Maple syrup urine disease: Features intellectual disability, seizures, motor delay, and early death. Caused by impaired breakdown of branched-chain amino acids. Hyperphenylalaninemia and white matter changes may be present.

4. Glutaric aciduria type 1: Characterized by intellectual disability, motor delay, dyskinesia, and seizures. Can lead to death in infancy or childhood. Neuroimaging shows cerebral atrophy and white matter abnormalities.

5. Menkes disease: An X-linked disorder of copper metabolism causing intellectual disability, seizures, hypotonia, and early death. Hyperphenylalaninemia has been reported. Neuroimaging shows cerebral and cerebellar atrophy.",Hereditary metabolic disorders
['Wilson disease'],"1. Wilson disease: Generalized hypotonia, hepatosplenomegaly, elevated liver enzymes, decreased ceruloplasmin and circulating copper, increased urinary copper, copper accumulation in liver, early death. Key features not reported include Kayser-Fleischer rings, neuropsychiatric symptoms, and hemolytic anemia.

2. Niemann-Pick disease type C: Hepatosplenomegaly, elevated liver enzymes, early death. However, this condition typically causes more prominent neurological symptoms and does not have the characteristic copper metabolism abnormalities seen in this patient.

3. Mitochondrial DNA depletion syndrome: Generalized hypotonia, hepatomegaly, elevated liver enzymes, early death. However, the copper metabolism abnormalities are not typical of mitochondrial disorders.

4. Congenital disorder of glycosylation: Generalized hypotonia, hepatomegaly, elevated liver enzymes, early death. Copper metabolism is not typically affected in these disorders.

5. Gaucher disease type 2: Hepatosplenomegaly, early death. However, this condition is not associated with copper metabolism abnormalities and typically has more prominent neurological symptoms and bone involvement.",Hereditary metabolic disorders
['PMM2-CDG'],"1. Zellweger spectrum disorder: Characterized by cerebellar hypoplasia, intellectual disability, hypotonia, and early death. Other features like abnormal facial shape and eye abnormalities are consistent. Lacking hepatic dysfunction and renal cysts.

2. GM2 gangliosidosis (Tay-Sachs or Sandhoff disease): Causes cerebellar degeneration, developmental regression, cherry-red spot of the macula, and early death. Consistent with ataxia and hypotonia, but patient is missing seizures and cherry-red spot.

3. Joubert syndrome: Presents with cerebellar vermis hypoplasia, ataxia, hypotonia, intellectual disability, and abnormal eye movements. Matches patient's cerebellar and eye findings, but survival past infancy is common.

4. Pontocerebellar hypoplasia: A group of neurodegenerative disorders causing cerebellar and pontine atrophy, developmental delay, hypotonia, and early death. Fits patient's presentation, but additional features like seizures, spasticity, and feeding difficulties are absent.

5. Walker-Warburg syndrome: Characterized by cerebellar abnormalities, intellectual disability, hypotonia, eye anomalies, and death in early childhood. Also causes congenital muscular dystrophy, hydrocephalus, and seizures, which this patient lacks.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Tyrosinemia type I: Characterized by hypertyrosinemia, this disorder can cause liver failure, renal dysfunction, and neurological problems. Consistent with the patient's hypertyrosinemia, neonatal onset, and potential for death in infancy or childhood.

2. Phenylketonuria (PKU): Causes hyperphenylalaninemia due to deficiency of the enzyme phenylalanine hydroxylase. Untreated PKU can lead to intellectual disability, seizures, and behavioral problems. Matches the patient's hyperphenylalaninemia, though death in infancy would be atypical.

3. Maple syrup urine disease: A disorder of branched-chain amino acid metabolism that presents in the neonatal period with poor feeding, vomiting, lethargy, and a characteristic maple syrup odor to the urine. Can be life-threatening if untreated. While the patient's symptoms don't specifically mention the characteristic odor, the neonatal presentation and risk of death fit.

4. Homocystinuria: Caused by defects in methionine metabolism, leading to elevated homocysteine and methionine. Can cause eye problems, skeletal abnormalities, and intellectual disability. Less likely given the lack of mention of homocysteine or methionine abnormalities.

5. Alkaptonuria: A disorder of tyrosine degradation that causes accumulation of homogentisic acid. Leads to darkening of the urine and early-onset arthritis. Less likely, as it is generally a milder condition than the patient's presentation suggests, and the urine discoloration is a hallmark feature that was not mentioned.",Hereditary metabolic disorders
['Glutaryl-CoA dehydrogenase deficiency'],"1. Glutaric acidemia type 1: Characterized by macrocephaly, hypotonia, encephalopathic crises, and glutaric aciduria. The patient's symptoms of macrocephaly, hypotonia, abnormal cerebral morphology, and glutaric aciduria are consistent with this diagnosis. Death in infancy can occur.

2. Pyruvate dehydrogenase complex deficiency: Can present with hypotonia, lactic acidosis, and abnormal brain development. The patient has increased lactate and cerebral abnormalities. However, the glutaric aciduria and abnormal lysine are not typical.

3. Dihydrolipoamide dehydrogenase deficiency (MSUD type 3): Causes lactic acidosis, hypotonia, and encephalopathy. Elevated lactate matches, but the specific metabolic abnormalities seen in this patient are not characteristic.

4. Molybdenum cofactor deficiency: Features hypotonia, seizures, and abnormal brain development. Can have lactic acidosis and early lethality. The glutaric aciduria could fit, but this is not a primary amino acid disorder.

5. Hyperlysinemia: Characterized by elevated lysine levels, which matches the patient. However, this is usually a benign condition not associated with the severe features seen here like hypotonia, cerebral abnormalities, and death in infancy.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Tyrosinemia type I: Characterized by abnormal prenatal development, hypertyrosinemia, liver and kidney dysfunction, and often death in infancy or childhood if untreated. Hyperphenylalaninemia can also occur.

2. Transient tyrosinemia of the newborn: Causes elevated tyrosine levels in the neonatal period which can lead to abnormalities, but is usually benign and self-limiting. Does not typically cause severe symptoms or death.

3. Phenylketonuria: Presents with hyperphenylalaninemia and can cause abnormal development and neurological issues if untreated, but hypertyrosinemia is not a primary feature. Death in infancy would be unusual.

4. Maple syrup urine disease: Can cause severe neonatal presentation with poor feeding, lethargy, and death if unrecognized. Characterized by elevated branched-chain amino acids (leucine, isoleucine, valine) rather than tyrosine/phenylalanine.

5. Homocystinuria: Presents with developmental delay, eye problems, skeletal abnormalities and thromboembolism. Characterized by elevated homocysteine and methionine. Severe neonatal presentation is uncommon.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Tyrosinemia type I: Characterized by hypertyrosinemia, failure to thrive, short stature, and risk of early death. The patient's hypertyrosinemia, severe short stature, feeding difficulties, and death in infancy fit this diagnosis. Additional symptoms like liver dysfunction and renal tubular dysfunction were not reported.

2. Phenylketonuria (PKU): Features hyperphenylalaninemia, microcephaly, growth deficiencies, and intellectual disability if untreated. Consistent with the patient's microcephaly, hyperphenylalaninemia, being small for gestational age, and feeding problems. However, PKU alone may not explain the effusions and infant death.

3. Zellweger spectrum disorder: A group of congenital peroxisomal biogenesis disorders causing abnormal brain development, poor growth, and multi-organ dysfunction. Matches the patient's microcephaly, prenatal abnormalities, growth restriction, and early death. May also present with effusions and feeding issues. Biochemical abnormalities were not classic for Zellweger though.

4. Congenital disorder of glycosylation (CDG): A family of disorders affecting glycoprotein synthesis. Can cause microcephaly, failure to thrive, multi-system issues, and infant death in severe cases. Fits the overall clinical picture but specific CDG type is unclear without additional testing. 

5. Trisomy 18: A chromosomal disorder causing microcephaly, prenatal/postnatal growth restriction, congenital heart defects, and high infant mortality. While consistent with many of the patient's features, trisomy 18 is not typically associated with the reported metabolic abnormalities.",Hereditary metabolic disorders
['Ornithine transcarbamylase deficiency'],"1. Ornithine transcarbamylase deficiency: Most common urea cycle disorder. Symptoms consistent with hyperammonemia, vomiting, and childhood mortality. Would expect to see elevated glutamine and low citrulline on plasma amino acids.

2. Carbamoyl phosphate synthetase I deficiency: Another common urea cycle disorder that fits the patient's presentation. Key distinguishing feature from OTC deficiency would be the absence of orotic aciduria.

3. Citrullinemia type I: Fits the overall picture of a urea cycle defect. Would expect to see very elevated citrulline levels on plasma amino acids in addition to the presenting symptoms.

4. Argininosuccinic aciduria: The presence of argininosuccinic acid in the urine in addition to the hyperammonemia symptoms would suggest this diagnosis. 

5. Arginase deficiency: Least likely of the urea cycle defects given the patient's symptoms, as it tends to have a later onset and lacks the acute hyperammonemia and early mortality seen here. Would expect elevated arginine levels.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Tyrosinemia type I: Characterized by hyperphenylalaninemia, abnormal tyrosine concentration, elevated urinary carboxylic acids, and can be life-threatening in infancy if untreated. Other typical features like liver dysfunction and renal tubular dysfunction were not reported in this patient.

2. Phenylketonuria (PKU): The hallmark is hyperphenylalaninemia, but tyrosine concentration is usually decreased rather than elevated. Can cause abnormal prenatal development (e.g. microcephaly, congenital heart defects) if maternal PKU is untreated. Rarely fatal in infancy with modern newborn screening and treatment.

3. Hawkinsinuria: A rare disorder of tyrosine metabolism characterized by hypertyrosinemia, metabolic acidosis, and excretion of ""hawkinsin"" (an unusual cyclic amino acid). Can present in infancy with failure to thrive and metabolic acidosis. Patient's carboxylic acid profile would need to be reviewed for presence of hawkinsin.

4. Tyrosinemia type II (Richner-Hanhart syndrome): Characterized by elevated tyrosine, eye and skin lesions, and intellectual disability. Does not typically cause life-threatening symptoms in infancy.

5. Tyrosinemia type III: A rare disorder causing hypertyrosinemia and variable neurologic symptoms. Also does not typically lead to infantile death.",Hereditary metabolic disorders
['Pearson syndrome'],"1. 3-Methylglutaconic aciduria type I: Consistent with 3-methylglutaric aciduria, hypotonia, failure to thrive, and early mortality. Additional features can include cardiomyopathy, neutropenia, and neurological deterioration.

2. Barth syndrome: X-linked disorder characterized by cardiomyopathy, neutropenia, 3-methylglutaconic aciduria, hypotonia, and growth retardation. Renal involvement and early mortality can occur.

3. Mitochondrial DNA depletion syndrome: Group of disorders causing inadequate mtDNA leading to defective energy production. Can present with multi-system involvement including cardiac, renal, neurological, and metabolic abnormalities. Often fatal in infancy or early childhood.

4. Long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency: Fatty acid oxidation disorder with features including cardiomyopathy, hypoglycemia, lethargy, hypotonia, and liver dysfunction. Accumulation of 3-hydroxybutyric acid and other metabolites.

5. Pyruvate dehydrogenase complex (PDC) deficiency: Disorder of mitochondrial energy metabolism causing lactic acidosis, hypotonia, seizures, and progressive neurological deterioration. Can also involve other systems such as cardiac and renal.",Hereditary metabolic disorders
['Smith-Lemli-Opitz syndrome'],"1. Smith-Lemli-Opitz syndrome: Consistent with the patient's facial features, syndactyly, hypotonia, feeding difficulties, and elevated 7-dehydrocholesterol. Can be severe and lead to infant death.

2. Desmosterolosis: Can cause similar features to Smith-Lemli-Opitz syndrome, but would expect to see elevated desmosterol levels rather than 7-dehydrocholesterol.

3. Lathosterolosis: Another disorder of cholesterol synthesis causing developmental issues and abnormal sterol levels. Specific facial features may differ.

4. X-linked dominant chondrodysplasia punctata 2: Skeletal abnormalities and developmental delay can occur, but also often see skin findings (ichthyosis, skin atrophy). Sterol levels may be abnormal.

5. Greenberg dysplasia: Rare skeletal dysplasia that can have some overlapping features, but would also expect to see significant skeletal abnormalities on x-rays. Can be lethal in infancy.",Hereditary metabolic disorders
['Acute intermittent porphyria'],"1. Lysosomal acid lipase deficiency (Wolman disease): Presents with vomiting, abdominal pain, hepatosplenomegaly, failure to thrive, and early death. May also have adrenal calcifications.

2. Niemann-Pick disease type A: Characterized by hepatosplenomegaly, failure to thrive, and death usually by 3 years old. Cherry-red spot of the macula may be seen.

3. Glycogen storage disease type Ia (von Gierke disease): Symptoms include hypoglycemia, hepatomegaly, growth retardation, and lactic acidosis. Patients are at risk for recurrent infections. This patient is not reported to have hypoglycemia.

4. Galactosemia: Can present with vomiting, hepatomegaly, jaundice, failure to thrive, and sepsis in untreated infants. Cataracts may also be present. No mention of jaundice or cataracts in this patient.

5. Severe combined immunodeficiency (SCID): Characterized by recurrent, severe infections and failure to thrive, often leading to early death. Usually lack the typical GI symptoms and hepatosplenomegaly seen in this patient.",Hereditary metabolic disorders
['Citrullinemia type I'],"1. Citrullinemia type I: Characterized by elevated citrulline and ammonia levels, as well as death in infancy in severe cases. The patient's symptoms of elevated plasma citrulline, hyperammonemia, metabolic acidosis and neonatal death fit this diagnosis.

2. Argininosuccinic aciduria: Presents with elevated citrulline, accumulation of argininosuccinic acid, hyperammonemia, and neonatal death in severe cases. The patient's hyperammonemia, elevated citrulline, and neonatal death are consistent, but argininosuccinic acid levels were not mentioned.

3. Argininemia: Caused by arginase deficiency, leading to argininuria, hyperargininemia, and sometimes hyperammonemia. The patient's argininuria and abnormal circulating arginine levels fit, but it typically has a later onset and less severe course than other urea cycle disorders.

4. Hyperammonemia-hyperornithinemia-homocitrullinuria (HHH) syndrome: Features include hyperammonemia, hyperornithinemia, homocitrullinuria, and sometimes death in infancy. The patient's hyperammonemia and neonatal death fit, but ornithine and homocitrulline levels were not provided.

5. Carbamyl phosphate synthetase I deficiency: The most severe urea cycle disorder, often leading to neonatal death, hyperammonemia and absent or low citrulline levels. The patient's presentation could fit, but citrulline was elevated rather than decreased.",Hereditary metabolic disorders
[],"1. Methylmalonic acidemia: Delayed development, hypotonia, lethargy, hyperammonemia, methylmalonic acidemia/aciduria, decreased plasma carnitine. Usually presents in infancy and can be life-threatening.

2. Homocystinuria due to cystathionine beta-synthase deficiency: Delayed development, hypotonia, lethargy, hyperhomocystinemia. Does not typically cause methylmalonic acidemia. Other features like ectopia lentis and skeletal abnormalities are not reported here.

3. Combined methylmalonic acidemia and homocystinuria: Can cause all of the patient's symptoms including both methylmalonic acidemia and hyperhomocystinemia. Specific complementation groups (cblC, cblD, cblF, cblJ) each have slightly different features.

4. Propionic acidemia: Can present similarly to methylmalonic acidemia with delayed development, hypotonia, lethargy, hyperammonemia, and metabolic acidosis. Key distinguishing feature is propionic acidemia on organic acid analysis rather than methylmalonic acidemia.

5. Glutaric acidemia type 1: Presents with delayed development, hypotonia, and encephalopathic crises that can be life-threatening. Typically causes cerebral atrophy and macrocephaly. Methylmalonic acidemia and hyperhomocystinemia are not expected.",Hereditary metabolic disorders
['Very long chain acyl-CoA dehydrogenase deficiency'],"1. Propionic acidemia: Consistent with hyperammonemia, decreased plasma free carnitine, and risk of death in infancy. May also show abnormal alanine and other amino acid levels.

2. Methylmalonic acidemia: Can present similarly to propionic acidemia with hyperammonemia, decreased carnitine, and abnormal amino acids. Confirmation requires urine organic acid analysis.

3. Isovaleric acidemia: Another organic acidemia that can cause poor feeding, hypotonia, and hyperammonemia in infancy. May have a characteristic ""sweaty feet"" odor.

4. Ornithine transcarbamylase deficiency: A urea cycle disorder that commonly presents with hyperammonemia, neurological symptoms, and risk of neonatal death, especially in males.

5. Carnitine palmitoyltransferase II deficiency: A fatty acid oxidation disorder that can present in infancy with hypotonia, hyperammonemia, and low carnitine levels. Typically also have hypoketotic hypoglycemia and liver dysfunction, which were not mentioned in this case.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Tyrosinemia type I: Characterized by hypertyrosinemia, this disorder can cause failure to thrive, liver dysfunction, and early death if untreated. However, pulmonary issues are not typical.

2. Phenylketonuria (PKU): This common disorder of phenylalanine metabolism causes hyperphenylalaninemia and can lead to severe intellectual disability and other problems if untreated. However, it does not usually cause neonatal death if promptly treated.  

3. Maple syrup urine disease: This disorder of branched-chain amino acid metabolism presents in the neonatal period with poor feeding, lethargy, and a characteristic sweet odor to the urine. Without rapid treatment it can lead to coma and death. Respiratory problems are not a main feature.

4. Zellweger spectrum disorder: This group of peroxisomal biogenesis disorders causes profound hypotonia, distinctive facial features, seizures, and liver dysfunction. It often leads to death in infancy. While it can cause some amino acid abnormalities, hypertyrosinemia and hyperphenylalaninemia are not cardinal features.

5. Pyruvate dehydrogenase complex deficiency: Defects in this critical enzyme for energy metabolism cause severe lactic acidosis, hypotonia, seizures, and early death. Respiratory difficulties can occur, but hypertyrosinemia and hyperphenylalaninemia would be unusual.",Hereditary metabolic disorders
['Medium chain acyl-CoA dehydrogenase deficiency'],"The top 5 potential diagnoses based on the given symptoms are:

1. Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency: Consistent with decreased plasma carnitine, 3-hydroxyacyl-CoA dehydrogenase, hypoxemia, and risk of sudden death. Key symptom not reported is hypoketotic hypoglycemia.

2. Very long-chain acyl-CoA dehydrogenase (VLCAD) deficiency: Also fits with decreased plasma carnitine and 3-hydroxyacyl-CoA dehydrogenase. Additional matching symptoms include spasticity and risk of infant death. Rhabdomyolysis and cardiomyopathy are not mentioned.

3. Glutaric acidemia type 2: Multiple acyl-CoA dehydrogenase deficiency that matches the biochemical abnormalities. Spasticity, infant death, and ileus fit as well. Typical dysmorphic features and organic aciduria are not noted.

4. Carnitine-acylcarnitine translocase (CACT) deficiency: Rare disorder of carnitine transport with decreased plasma carnitine, sudden infant death, and multi-organ involvement as seen in this patient. Coma and hypoketotic hypoglycemia would be expected.

5. Propionic acidemia: While not a fatty acid oxidation disorder per se, this organic acidemia can present similarly with spasticity, ileus, and infant death. The metabolic abnormalities and peritoneal effusion also fit. Typical symptoms not mentioned include ketoacidosis and hyperammonemia.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Adenosine deaminase deficiency: Characterized by combined immunodeficiency and metabolic abnormalities including hypertyrosinemia. Consistent with the patient's recurrent infections and early death.

2. Purine nucleoside phosphorylase deficiency: Another metabolic disorder causing combined immunodeficiency, developmental delay, and early death. The patient's hypertyrosinemia and hyperphenylalaninemia could be seen.

3. Tyrosinemia type I: A disorder of tyrosine metabolism leading to liver failure, renal dysfunction, and neurologic crises. Explains the hypertyrosinemia but immunodeficiency is not typical. 

4. Phenylketonuria: Caused by impaired metabolism of phenylalanine, leading to hyperphenylalaninemia and intellectual disability if untreated. Does not usually cause immunodeficiency or death in infancy/childhood.

5. Severe combined immunodeficiency (SCID): A group of genetic disorders causing profound immunodeficiency and recurrent infections, often leading to early death. Metabolic abnormalities are not typically seen in most forms of SCID.",Hereditary metabolic disorders
['3-methylcrotonyl-CoA carboxylase deficiency'],"1. Non-ketotic hyperglycinemia: Characterized by elevated glycine levels in blood and urine, leading to early-onset seizures, hypotonia, apnea, and often death in infancy. The key symptoms of elevated glycine and infant death fit this diagnosis.

2. Propionic acidemia: A disorder of organic acid metabolism causing buildup of propionic acid and other carboxylic acids. Presents in infancy with poor feeding, hypotonia, seizures, and can progress to coma and death. Matches the elevated urinary carboxylic acids and death in infancy.

3. Methylmalonic acidemia: Another organic acidemia resulting in high levels of methylmalonic acid and other organic acids in urine. Also presents in infancy with lethargy, seizures, metabolic acidosis, and can be fatal if untreated. Aligns with the organic aciduria and infantile death.

4. Isovaleric acidemia: An inborn error of leucine metabolism leading to accumulation of isovaleric acid, a carboxylic acid. Symptoms include poor feeding, vomiting, lethargy, and can progress to coma and death. The elevated urinary carboxylic acids and death in infancy are consistent.

5. Canavan disease: A rare disorder causing progressive damage to nerve cells in the brain. Symptoms begin in infancy and include poor head control, enlarged head, hypotonia, and seizures. Some variants can cause death in the first few years of life. While less likely given the lack of neurological symptoms, it is still possible and could explain the aminoaciduria and infant death.",Hereditary metabolic disorders
['Succinic semialdehyde dehydrogenase deficiency'],"1. Glutaric acidemia type 1: Delayed development, hypotonia, seizures, and elevated urinary glutaric acid. Can cause early death. Patient's ataxia and lack of reported dystonia or macrocephaly make this less likely.

2. Propionic acidemia: Presents with developmental delay, hypotonia, seizures, and elevated urinary 3-hydroxypropionate. Causes episodes of metabolic decompensation that can be fatal in infancy or childhood.

3. Methylmalonic acidemia: Features delayed development, hypotonia, seizures, and elevated methylmalonic acid. Can be life-threatening in early childhood. Ataxia is not a typical finding.

4. Isovaleric acidemia: Characterized by neurodevelopmental delays, hypotonia, seizures in some cases, and elevated isovalerylglycine. Acute episodes can lead to early death. Ataxia would be unusual.

5. Multiple carboxylase deficiency: Can cause developmental delays, hypotonia, seizures, and multiple elevated urinary carboxylic acids. Severe forms may result in early death. Ataxia is not commonly reported.",Hereditary metabolic disorders
['Argininosuccinic aciduria'],"1. Propionic acidemia: Consistent with death in infancy, metabolic acidosis, vomiting, and hepatomegaly. May also present with hyperammonemia, neutropenia, and cardiomyopathy.

2. Methylmalonic acidemia: Can cause death in infancy, metabolic acidosis, vomiting, hepatomegaly, and tachypnea. Other features may include developmental delay, seizures, and renal dysfunction.

3. Urea cycle disorders (e.g., ornithine transcarbamylase deficiency): Can lead to neonatal death, metabolic acidosis, vomiting, tachypnea, and hepatomegaly. Hallmark feature is hyperammonemia.

4. Severe sepsis: The combination of tachycardia, tachypnea, metabolic acidosis, and death in infancy could be caused by overwhelming infection. However, sepsis would not typically cause hepatomegaly.

5. Carnitine palmitoyltransferase II deficiency: Can present with death in infancy, metabolic acidosis, hepatomegaly, and cardiomyopathy leading to tachycardia and tachypnea. Typically also causes hypoketotic hypoglycemia and rhabdomyolysis.",Hereditary metabolic disorders
['Gyrate atrophy of choroid and retina'],"1. Glycine encephalopathy: Characterized by hyperglycinemia, neurological symptoms (like blindness and headache), feeding problems, and early death. The patient's presentation is consistent with this diagnosis.

2. Gyrate atrophy of choroid and retina: Causes blindness, hyperornithinemia, and can be associated with anemia and short stature. Matches the patient's eye findings and ornithine abnormality.

3. Hyperornithinemia-hyperammonemia-homocitrullinuria (HHH) syndrome: Features include hyperammonemia, hyperornithinemia, neurological symptoms, failure to thrive, and protein intolerance/malabsorption. Aligns with many of the patient's metabolic and GI issues.

4. Serine deficiency disorders: Can present with low serine, microcephaly, growth retardation, and neurological symptoms. The patient has an abnormal serine level and other features consistent with this group of disorders.

5. Argininemia: Characterized by hypoargininemia, hyperammonemia, growth deficiency, and neurological symptoms. While the patient demonstrates some of these findings, argininemia is typically less severe than the patient's presentation.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Tyrosinemia type I: Characterized by abnormal prenatal development, hypertyrosinemia, liver and kidney dysfunction, and often death in infancy or childhood if untreated. Hyperphenylalaninemia can also occur.

2. Transient tyrosinemia of the newborn: Causes elevated tyrosine levels in the neonatal period which can lead to abnormalities, but is usually benign and self-limiting. Does not typically cause severe symptoms or death.

3. Phenylketonuria: Presents with hyperphenylalaninemia and can cause abnormal development and neurological issues if untreated, but hypertyrosinemia is not a primary feature. Death in infancy would be unusual.

4. Maple syrup urine disease: Can cause severe neonatal presentation with poor feeding, lethargy, and death if unrecognized. Characterized by elevated branched-chain amino acids (leucine, isoleucine, valine) rather than tyrosine/phenylalanine.

5. Homocystinuria: Presents with developmental delay, eye problems, skeletal abnormalities and thromboembolism. Characterized by elevated homocysteine and methionine. Severe neonatal presentation is uncommon.",Hereditary metabolic disorders
['Carbamoyl-phosphate synthetase 1 deficiency'],"1. Ornithine transcarbamylase deficiency: Generalized hypotonia, feeding difficulties, hyperammonemia, and cerebral edema leading to early death are consistent with this severe urea cycle disorder. Apathy may result from the toxic effects of ammonia on the brain.

2. Propionic acidemia: This organic acidemia can present in the neonatal period with poor feeding, hypotonia, lethargy, and hyperammonemia. Cerebral edema and early death may occur without prompt treatment. Characteristic metabolic acidosis is not reported in this patient.

3. Methylmalonic acidemia: Another organic acidemia with a similar presentation to propionic acidemia. Lethargy/apathy, hypotonia, feeding problems, hyperammonemia, and risk of cerebral edema and neonatal death. Metabolic acidosis would be expected.

4. Pyruvate dehydrogenase deficiency: This mitochondrial disorder can cause severe lactic acidosis, hypotonia, feeding problems, and lethargy in infancy. Hyperammonemia and cerebral edema are less common features. Apathy may reflect neurological deterioration.

5. Molybdenum cofactor deficiency: Infants with this rare disorder can have intractable seizures, severe encephalopathy, and early death. Hypotonia and feeding difficulties are common, but hyperammonemia is not typically seen. The absence of seizures in this patient makes it less likely.",Hereditary metabolic disorders
['Canavan disease'],"1. Canavan disease: Matches the patient's motor delay, hypotonia, seizures, early death, and abnormal brain myelination. The abnormal aspartate levels also fit, as Canavan disease is caused by a deficiency in aspartoacylase. However, blindness and hearing loss are not typical of this condition.

2. Krabbe disease (Globoid cell leukodystrophy): The patient's motor delay, seizures, hypotonia, vision loss, abnormal myelination and early death are all consistent with the infantile form of Krabbe disease. Hearing loss can also occur. An enzyme assay showing deficient galactosylceramidase activity would support this diagnosis.

3. Zellweger spectrum disorder: This peroxisomal biogenesis disorder can cause profound hypotonia, seizures, vision and hearing impairment, and early death as seen in this patient. The abnormal myelination and circulating metabolites also fit. However, other typical findings like dysmorphic features and liver dysfunction are not mentioned.

4. Maple syrup urine disease: The patient's neurological deterioration, seizures, hypotonia and early death could be explained by this disorder of branched-chain amino acid metabolism. It is usually associated with a characteristic sweet odor, which is not described here. Amino acid testing would be diagnostic.

5. Nonketotic hyperglycinemia: This disorder of glycine metabolism causes lethargy, hypotonia, seizures and apnea in infants, with high mortality. The patient's course fits, but additional findings like hiccups and myoclonic jerks are not mentioned. Glycine levels in plasma and CSF would be elevated.",Hereditary metabolic disorders
"['Methylmalonic acidemia with homocystinuria, type cblC']","Based on the given symptoms, the top 5 potential diagnoses are:

1. Combined methylmalonic acidemia and homocystinuria, cblC type: Consistent with hydrocephalus, microcephaly, intellectual disability, hyperhomocystinemia, and methylmalonic aciduria. May also present with feeding difficulties and failure to thrive, not mentioned in this case.

2. Combined methylmalonic acidemia and homocystinuria, cblD type: Similar presentation to cblC type, with neurological symptoms, hyperhomocystinemia, and methylmalonic aciduria.

3. Combined methylmalonic acidemia and homocystinuria, cblF type: Also characterized by neurological symptoms, hyperhomocystinemia, and methylmalonic aciduria, but may have a milder course compared to cblC and cblD types.

4. Isolated methylmalonic acidemia, mut type: Can present with neurological symptoms, respiratory insufficiency, and methylmalonic aciduria, but would not explain the hyperhomocystinemia.

5. Glycine encephalopathy: A severe disorder affecting brain function, presenting with hypotonia, seizures, and respiratory insufficiency. May have elevated glycine levels in addition to the mentioned metabolic abnormalities.",Hereditary metabolic disorders
['Medium chain acyl-CoA dehydrogenase deficiency'],"1. Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (LCHADD): The patient's abnormality of prenatal development, death in infancy, vomiting, gastrointestinal inflammation, abnormal carnitine levels, and specifically decreased 3-hydroxyacyl-CoA dehydrogenase activity are all consistent with this diagnosis.

2. Very long-chain acyl-CoA dehydrogenase deficiency (VLCADD): Shares some features with LCHADD like abnormal prenatal development, severe infantile presentation, and abnormal carnitine levels. However, the specific 3-hydroxyacyl-CoA dehydrogenase deficiency points more towards LCHADD.

3. Carnitine palmitoyltransferase II deficiency, infantile form: Can also present in infancy with severe episodes of hypoglycemia and liver dysfunction. Carnitine levels may be abnormal. However, 3-hydroxyacyl-CoA dehydrogenase activity would be normal.

4. Medium-chain acyl-CoA dehydrogenase deficiency (MCADD): Another fatty acid oxidation disorder that can present with vomiting, lethargy, and hypoglycemia in infancy. However, it typically has normal carnitine levels and 3-hydroxyacyl-CoA dehydrogenase activity.

5. Glutaric acidemia type II: A defect in electron transfer flavoprotein can impair multiple acyl-CoA dehydrogenases and cause a severe infantile presentation. However, it would be less likely to specifically decrease 3-hydroxyacyl-CoA dehydrogenase and may have additional characteristic metabolites.",Hereditary metabolic disorders
['Biotinidase deficiency'],"1. Maple syrup urine disease: Generalized hypotonia, leukopenia, metabolic acidosis, and hyperammonemia can occur. Usually presents in the first week of life and can be rapidly fatal without treatment.

2. Propionic acidemia: Can cause poor feeding, hypotonia, and lethargy in the first days of life, progressing to metabolic acidosis, hyperammonemia, and death if untreated. Leukopenia may be seen.

3. Isovaleric acidemia: Another organic acidemia that can present with poor feeding, vomiting, hypotonia, and progression to metabolic acidosis and hyperammonemia. Characteristic ""sweaty feet"" odor may be noted.

4. Ornithine transcarbamylase deficiency: A urea cycle defect leading to hyperammonemia, which can cause lethargy, hypotonia, seizures, and death. Typically X-linked, affecting males more severely.

5. Pyruvate dehydrogenase deficiency: Can present in the neonatal period with hypotonia, lethargy, and metabolic acidosis. Leukopenia is not typically a prominent feature.",Hereditary metabolic disorders
['Tyrosinemia type 2'],"1. Tyrosinemia type II (Richner-Hanhart syndrome): Consistent with the patient's keratitis, conjunctivitis, photophobia, epiphora, hyperkeratosis, intellectual disability, seizures, and hypertyrosinemia. The prognosis matches the reported death in childhood.

2. Tyrosinemia type III: Matches the intellectual disability and seizures, but this milder form does not typically cause the eye and skin symptoms seen in the patient.

3. Tyrosinemia type I: Can cause eye and skin symptoms similar to the patient's, but the absence of liver dysfunction and failure to thrive makes this less likely.

4. Alkaptonuria: Another disorder of tyrosine metabolism, but the characteristic symptoms of dark urine, ochronosis, and arthritis are not reported in this patient.

5. Nonketotic hyperglycinemia: A metabolic disorder that can present with intellectual disability, seizures, and early death, but it does not fit well with the eye and skin symptoms or hypertyrosinemia.",Hereditary metabolic disorders
['Phenylketonuria'],"1. Phenylketonuria: Characterized by hyperphenylalaninemia, this disorder can cause abnormal prenatal development, intellectual disability, and early death if untreated. The patient's abnormal tyrosine concentration is also consistent, as phenylalanine is converted to tyrosine in normal metabolism.

2. Tyrosinemia type I: This disorder leads to elevated tyrosine and can present with failure to thrive, liver dysfunction, renal tubular dysfunction, and risk of early death. The patient's abnormal prenatal development and neonatal complications fit with a severe presentation.

3. Tyrosinemia type II: Also known as Richner-Hanhart syndrome, this disorder causes elevated tyrosine, painful skin lesions, and eye problems. While it can be severe, it is less likely than type I to cause prenatal complications and neonatal death.

4. Tetrahydrobiopterin (BH4) deficiency: BH4 is a cofactor for phenylalanine hydroxylase, and its deficiency can cause hyperphenylalaninemia and abnormal neurotransmitter synthesis. Severe forms can be life-threatening in infancy.

5. Hawkinsinuria: A rare disorder of tyrosine metabolism that can cause failure to thrive, metabolic acidosis, and liver dysfunction. Prognosis is variable but neonatal complications are described. The patient's hyperphenylalaninemia is less consistent with this diagnosis.",Hereditary metabolic disorders
[],"1. Medium-chain acyl-CoA dehydrogenase deficiency (MCADD): An inherited disorder of fatty acid oxidation. Symptoms include hypoglycemia, vomiting, lethargy, seizures, coma, and sudden death. 3-hydroxydicarboxylic aciduria is a key finding.

2. Glutaric acidemia type 2: A metabolic disorder affecting fatty acid and amino acid metabolism. Presents with hypotonia, metabolic acidosis, hypoglycemia, hyperammonemia, cardiomyopathy, and early death. Organic acid analysis shows 3-hydroxydicarboxylic aciduria.

3. Propionic acidemia: An inherited disorder of amino acid metabolism causing lethargy, vomiting, dehydration, hypotonia, seizures, and intellectual disability. Can present in the neonatal period with hyperammonemia and progress to coma and death if untreated.

4. Mitochondrial DNA depletion syndrome: A group of disorders characterized by a severe reduction in mitochondrial DNA. Symptoms include hypotonia, feeding difficulties, failure to thrive, lactic acidosis, hyperammonemia, seizures, and early death. 

5. Pyruvate dehydrogenase complex deficiency: A disorder of energy metabolism affecting the nervous system. Presents with hypotonia, seizures, lactic acidosis, and abnormal organic acids in urine. Can be life-threatening in infancy.",Hereditary metabolic disorders
['Alkaptonuria'],"1. Fatty acid oxidation disorders: The combination of death in infancy, vomiting, and dark urine (myoglobinuria) could fit with a severe fatty acid oxidation disorder. However, additional symptoms such as hypoketotic hypoglycemia and hepatomegaly are not reported.

2. Organic acidemias (e.g. methylmalonic acidemia, propionic acidemia): Can present in infancy with vomiting, lethargy, metabolic acidosis, and hyperammonemia. Some forms can have a severe neonatal-onset presentation. Dark urine is not a typical finding.

3. Urea cycle disorders (e.g. ornithine transcarbamylase deficiency, citrullinemia): Usually present with hyperammonemia, vomiting, lethargy, and rapid decompensation, but dark urine would be unusual. 

4. Mitochondrial disorders: Can have a wide range of presentations, but severe neonatal or infantile-onset forms can present with lactic acidosis, hypotonia, feeding difficulties, and early death. Dark urine is not a classic finding.

5. Tyrosinemia type I: A severe form can present in infancy with failure to thrive, vomiting, jaundice, and hepatomegaly. Dark urine can be seen due to liver dysfunction. However, the lack of reported liver findings makes this less likely.",Hereditary metabolic disorders
['Maple syrup urine disease'],"1. Maple Syrup Urine Disease (MSUD): The patient's seizures, lethargy, growth delay, metabolic acidosis, hyperammonemia, and elevated branched-chain amino acids (valine, leucine, isoleucine) are all consistent with this diagnosis. The severe presentation and death in infancy suggest a more severe form of MSUD.

2. Propionic Acidemia: This organic acidemia can present with seizures, lethargy, growth delay, metabolic acidosis, and hyperammonemia. However, the specific elevations in branched-chain amino acids are more suggestive of MSUD.

3. Methylmalonic Acidemia: Another organic acidemia that can cause seizures, lethargy, growth delay, metabolic acidosis, and hyperammonemia. As with propionic acidemia, the amino acid profile is more consistent with MSUD.

4. Urea Cycle Disorders (e.g., Citrullinemia, Argininosuccinic Aciduria): These disorders can present with lethargy, growth delay, hyperammonemia, and neurological symptoms. However, the presence of elevated branched-chain amino acids and absence of other characteristic amino acid abnormalities make these diagnoses less likely.

5. Isovaleric Acidemia: This disorder can cause lethargy, metabolic acidosis, and hyperammonemia, but it is typically associated with an isolated elevation of leucine, rather than the combined elevations of valine, leucine, and isoleucine seen in this patient.",Hereditary metabolic disorders
['Ornithine transcarbamylase deficiency'],"1. Citrullinemia type I: Characterized by hyperammonemia, elevated citrulline and glutamine, oroticaciduria, and severe neurological symptoms like hypotonia, lethargy, seizures and coma. Matches this patient's presentation.

2. Ornithine transcarbamylase deficiency: The most common urea cycle defect, an X-linked disorder that often presents in infancy with vomiting, lethargy, coma, cerebral edema and hyperammonemia. Elevated glutamine and alanine are common. Could fit this patient but citrulline is usually normal or decreased.

3. Argininosuccinic aciduria: Another urea cycle defect with hyperammonemia, elevated citrulline, and neurological deterioration, but argininosuccinic acid is the diagnostic metabolite which was not reported in this patient.

4. Carbamoyl phosphate synthetase I deficiency: A severe urea cycle defect with hyperammonemia, cerebral edema, lethargy progressing to coma, and death often in the neonatal period. However, citrulline is usually low in this condition.

5. Pyruvate dehydrogenase complex deficiency: A metabolic disorder that can present with lactic acidosis, hypotonia, lethargy, and neurological decline. It doesn't fully explain this patient's hyperammonemia and specific amino acid abnormalities.",Hereditary metabolic disorders
